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DNA is organized within chromosomes not only to permit a large amount of DNA to 
occupy a very small space, but also to serve essential functional roles.  Varied levels of 
organization enable proper DNA replication, repair, transcription, segregation and cell division.  
A key player in maintaining proper global organization of the chromosome are condensins.  
Condensins dynamically interact with DNA and play critical roles in chromosomal duplication 
functions, including DNA segregation.   
Pseudomonas aeruginosa (PA) is a virtually ubiquitous gram-negative bacterium capable 
of inhabiting a wide range of ecological niches, including the human host. A key to the survival 
and pathogenicity of PA in such diverse environments stems from its metabolic versatility, a 
large regulatory network including multiple virulence factors, and its dynamic ability to adapt 
via epigenetic factors and mutational plasticity.   The evolution of PA during lung infections is of 
particular concern on account of its devastating impact on lung function for cystic fibrosis 
patients.  PA has the ability to differentiate into different physiological states allowing it to 
adapt to different environments.  This lifestyle switching is involved in the progression of 
infection as seen by the different growth morphologies during acute and chronic infection 
states.  Therefore, a better understanding of how these genes are regulated and capable of 
switching into different physiological states could significantly help in preventing and treating 
PA progression during infection.   
Typically, condensins are known for their roles as chromosomal organizers and 
maintainers. One of the key findings in this study showed that they are also global regulators of 




DNA throughout the chromosome making it the ideal mediator between the control of gene 
expression and alterations in DNA structure.  Here, we investigated the roles that PA 
condensins, SMC-ScpAB and MksBEF have on cell physiology and gene regulation in PA.   
Transcriptomic analysis of PAO1 condensin deletion mutants revealed substantial changes 
in gene expression, in particular, for pathways involved in virulence.  Many of these affected 
pathways were found to be oppositely regulated for ΔmksB and Δsmc, reminiscent of acute and 
chronic infection phases, respectively.  ΔmksB revealed upregulated genes in the type 3 
secretion system (T3SS), and downregulated type 6 secretion system (T6SS), iron uptake, 
biofilm and adhesion genes while Δsmc gene expression was opposite.  Interestingly, the 
double deletion mutant (ΔΔ) revealed significant overlap with ΔmksB for T3SS and 
biofilm/adhesion genes however overlap was also seen with Δsmc for iron uptake genes related 
to siderophores.  ΔΔ also revealed hundreds of uniquely upregulated genes including the 
pyochelin regulon, several virulence effectors, as well as quorum sensing and cell motility 
genes.  Overall, each condensin deletion strain, showed a unique transcriptional profile (100+ 
uniquely regulated genes) implicating different regulatory pathways.  
Physiological studies on condensin deletion strains in PAO1 were in line with 
transcriptional analysis, showing opposite differentiation states where deletion of smc 
produced sessile biofilm growing cells and deletion of mksB produced planktonic growing cells 
with reduced biofilm formation [1].  Physiologically, ΔmksB and ΔΔ look very similar for growth 
where phenotype of the double knockout was dominated by an absence of MksB [1] reflecting 




Using biofilm formation as a reporter for mksB phenotype, complementation studies 
unexpectedly revealed that the link between MksB and biofilm is context dependent.  Using the 
degron system and ATPase MksB point mutations, MksB was confirmed to be directly linked to 
biofilm formation while complementation of the mksB gene after a full mksB deletion, 
however, was not possible.   These results indicate significant changes to cis effects in the mksB 
region of the chromosome or even secondary consequences resulting from the mksB deletion.   
ATPase MksB point mutations also revealed that the link between MksB and biofilm is 
conformational dependent.  ATPase point mutants have been previously shown to generate 
specific conformational intermediates of the MksB ATPase cycle  [2, 3].  Two of the three 
generated ATPase MksB mutants, E864Q and S829R, reflected severe biofilm defects.  
Strikingly, a third mutant, D864A, was capable of full biofilm function.  All of these mutations 
interfere in some aspect of dimerization of the SMC head domains.  These results reveal that 
MksB intermediate conformations, rather than ATPase activity, is relevant for MksB regulatory 
function.  Conformational dependence on phenotype was also seen for SMC [1]. 
Notably, physiological studies on PA14 condensins revealed that condensin phenotypes 
are largely strain dependent.  Although slight deviations were seen for growth studies, 
condensin deletions revealed a much smaller effect than PAO1. Overall, this implicates 
significant differences in how condensins are integrated into the regulatory networks of the 
PAO1 and PA14 strains and highlights a possible fortuitous integration by condensins into the 
regulatory system of PAO1. 
Strikingly, when mksB is removed in PAO1, a significant inversion in the chromosome 




markers in segregation (the chromosomal dimer resolution site, dif, found at the terminus of 
segregation) and replication (the origin of replication, oriC) illuminating asymmetry in the PAO1 
chromosome. These markers are highly coordinated with nucleotide bias or (GC skew), which is 
an underlying signaling code in bacterial DNA where there is an abundance of guanines on the 
leading strand and cytosines on the lagging strand. Typically, the terminus of replication and dif 
align as most bacterial chromosomes are symmetric, making differentiation between their 
underlying processes difficult.   
Therefore, we used the asymmetric PAO1 chromosome as a model to study the 
coordination between segregation, replication and nucleotide usage bias. Experimentally, 
replication was found to terminate opposite from oriC while segregation terminated at the 
asymmetric dif  [5].  GC skew analysis showed switches in polarity at the oriC and dif sites, while 
the terminus of replication was almost 700 kbp away.  Overall, this shows a lack of coordination 
between replication and segregation and that nucleotide bias is aligned with both processes. 
Using location markers for replication and segregation, we bioinformatically analyzed all 
complete sequenced bacterial chromosomes from NCBI [6].  Our findings show that nucleotide 
bias is correlated with dif but not the terminus of replication for all chromosome types, 




Chapter 1:  Introduction 
Pseudomonas aeruginosa (PA) has reached a critical threat status after developing 
resistance to last line carbapenem antibiotics.  “Superbugs” have increasingly emerged in the 
headlines as lethal outbreaks of bacterial strains completely resistant to antibiotics.  These 
outbreaks are a grim realization that multi-drug resistant strains have inherent mechanisms in 
place for developing full resistance to currently available antibiotics.  Over 2 million illnesses and 
23,000 deaths occur annually from multi-drug resistant bacteria, a figure put forward by the US 
Centers for Disease Control and Prevention (CDC) in a 2013 report, and the figure is expected to 
rise as drug resistance develops [7].  Antibiotics which were once regarded as cures for infections 
are now understood to be a depleting treatment option. Combatting multi-drug resistant strains 
and the development of alternative antibiotic strategies is necessary for future generations.   
PA is exceptionally difficult to treat being a highly robust gram-negative bacterium with 
low membrane permeability.  PA has innate systems in place to survive in diverse environments 
including notable metabolic diversity and numerous virulence factors.   Adaptive features include 
a significant regulatory network and mutational plasticity.  One more intriguing aspect of PA 
adaptability is its ability to epigenetically control physiological lifestyle.  Lifestyle switching is an 
essential component to the progression of infection, therefore understanding this process could 
lead to viable therapeutic targets.   
Here we explore a novel pathway for epigenetic lifestyle switching and global regulation, 
PAO1 condensins.  Condensins are conventionally known for their maintenance of the 




compaction and segregation.  Therefore, global gene regulation is a newly reported function of 
condensins linking chromosomal organization with gene expression.  In order to better 
understand this coordination, we introduce condensins and review PA lifestyle switching, 
infection phases, and known virulence systems.   
In a separate study, we found that deletion of the mksB condensin gene triggers a large 
inversion in PAO1 [4].  This discovery reflected a poorly understood phenomenon of nucleotide 
bias and their coordination with chromosomal segregation and replication.  This nucleotide skew 
is an inherent code in the DNA providing a global pattern which acts as markers for major location 
points for both replication and segregation.  Here, we introduce concepts related to the 
phenomenon of nucleotide usage bias. 
1.1  Chromosome organization 
The PA chromosome is organized along with chromosomal associated proteins into the 
nucleoid of the cell. The chromosome of PA is roughly 1000 times longer than the cell. In 
addition to significant compaction, the chromosome must also be compatible with essential 
cellular processes including DNA replication, segregation and gene expression.  Therefore, the 
overall process is highly dynamic, involving significant interplay between DNA binding proteins 
and processes occurring in the cell.  The PA chromosome, and all prokaryotic DNA, is organized 
in hierarchical levels in order to achieve maximum compaction and compatibility with cell 
dynamics.  These levels allow a higher order structuring for better control of the compaction 
process. Nucleoid associated protein mediated folding contributes to local organization and 






Figure 1- 1: Chromosome organization.  Local level organization, by nucleoid associated 
proteins and global level of organization by condensins.   
 
1.1.A  Local organization, nucleoid associated proteins (NAP’s) 
In Escherichia coli (E. coli), there are 12 major identified nucleoid associated proteins 
(NAP’s), NAP’s including HU (Heat Unstable), IHF (Integration Host Factor), FIS (Factor for 
inversion stimulation), H-NS (Histone-like nucleoid-structuring), Lrp (Leucine-responsive 
regulatory protein), CbpA, CbpB, DnaA, Dps, Hfq, IciA and StpA [8, 9].  StpA is an H-NS 
paralogue that can functionally substitute for H-NS.  H-NS paralogues also exist in other species 




mvaT and mvaU [10].  Divergence is seen in other strains as well indicating that NAP’s have 
evolved independently.   
NAP’s can be highly abundant (up to 55,000 molecules per cell in E. coli for some of 
them [11])  and play a diverse role as chromatin organizers, transcription factors, and as general 
accessory proteins for chromosomal maintenance, including replication[12]. The expression 
level of nucleoid-associated proteins is dependent on growth phase.  Some NAPs are abundant 
during stationary growth but significantly reduced during planktonic growth or vice versa [13].  
This variation in expression levels allows cells to modulate the compaction level of the 
chromosome based on growth conditions.   Variations between different growth phases for the 
major NAP’s are shown in Table 1-1.  










HU 30,000 – 55,000 < 18,000 [14] [13] 
IHF 12,000 55,000 [13] 
FIS 60,000 500 [13] 
H-NS 20,000 8,000 [13] 
Lrp 1,300 – 3,000 130 [15] [13] 
Dps 6,000 180,000 [13] 
 
Functions for the NAP’s are quite diverse. These proteins occupy wide portions of 
genomic DNA [9,10] and are involved in a series of genome functions, such as transcription (Hu, 
IHF, H-NS, StpA, and Fis) [11–15], translation (Hu, HNS, StpA, and Hfq) [16–19], replication (HU, 
IHF, Fis, and Dps) [20–23], DNA protection (Dps) [24,25], and DNA packing (Hu, H-NS, Fis, and 




NAP’s play an important role in chromosomal compaction.  At the local level of 
organization, NAP’s, induce bends and twists and lead to bridging of neighboring sections of the 
chromosome.  These sections are approximately 10kb in length and form and dissolve based on 
processes occurring on the chromosome.   Twisting and bending of the DNA induces curvature 
and folds, reducing the stiffness of the complex, making the chromosome thicker and shorter, 
helping with overall compaction.   
Overall, NAP’s play important and dynamic roles in governing global gene expression 
and local level organization of the chromosome in bacteria.  This helps with the overall 
structuring of individual chromosomal loops which are organized at the global level.   
1.1.B  Global organization, condensins 
At the global level of organization, the prokaryotic chromosome is organized into large 
loops which radiate from a central scaffold region. Evidence of this higher order structure of the 
prokaryotic chromosome has been seen in electron micrographs.  These loops can range from 
100 to 400 kbp long providing a means of compacting large portions of the chromosome and 
generating significant conformational changes to the DNA. These loops contribute to 
chromosomal organization as well as segregation and subsequently, the sub-cellular layout. 
One of the major contributors to large loop formation in the prokaryotic chromosome are 
condensins. Condensins are chromosome maintenance proteins which have the ability to bind 
DNA and to cooperatively bind with one another.  This provides condensins with the ability to 
form DNA bridges.  Condensins form large stabilized chromosomal loops by acting as 




Large chromosomal loops are further organized into higher order structures which cluster 
together in large regions (800 kb-1Mb) called macrodomains. These macrodomains are 
characteristically found within the same intracellular positions and impose specific dynamics 
and segregation patterns on the genes they carry.  Due to their relative proximity, individual 
macrodomains show higher frequencies of recombination. Macrodomains have been identified 
in E. coli, but are speculated to be present in many bacterial chromosomes [21].  
Domains which resemble those of E. coli were found by our group [5] in PA which were 
related by segregation patterns and cellular positioning.  These macrodomains reflected 
segregation patterns, where large macrodomains segregated together in clusters of gene 
regions.  Overall, macrodomains are an important component in chromosomal organization and 
an integral aspect in both segregation and subcellular layout.   
Condensins have an intrinsic ability to aggregate and form clusters along the chromosome 
which allows them to provide a scaffolding element to the prokaryotic chromosome.  
Condensins have been obtained from the protein scaffold of isolated bacterial chromosomes 
indicating their involvement in chromosome structuring [22].  This scaffold structure, generally 
found in the center, gives added stability to the large chromosomal loops which emerge from it. 
[23].  Condensins, therefore, play pivotal structural roles in chromosomal organization.   
One aspect which aids in DNA compaction is supercoiling. Supercoiling reduces the space 
that DNA takes up in the cell by twisting the DNA strands into a more compacted and energized 
form, which as described previously, can be formed into large loops.  Supercoiling is particularly 
important during chromosomal division events in which greater compaction of the 




Positive supercoils are induced by the byproduct of strand separation during replication 
and transcription.  During these processes, the region ahead of the polymerase complex is 
unwound.  The resulting stress is compensated with positive supercoils ahead of the complex.  
However, positive supercoiling results in global tension throughout the DNA strand.  In order to 
relieve this stress, topoisomerases rewind DNA, generating negative supercoils behind the 
polymerase complex [24].   
Additional contributors to supercoiling are condensins.  The 13S condensin from frogs was 
reported to generate positive supercoils through DNA reshaping.  Negative supercoils, which 
dominate bacteria the majority of the time,  was also found to be induced by the prokaryotic 
MukBEF condensin [25].   
Overall, condensins dynamically interact with DNA and play critical roles in chromosomal 
organization and duplication functions, including DNA segregation.  This study also shows that 
condensins are global regulators of hundreds of genes, many of which are involved in PA 
virulence.   
1.2  Condensins 
1.2.A  Structure of condensins 
Three condensin complexes have been identified in prokaryotes, SMC-ScpAB, MukBEF, 
and MksBEF (SMC-ScpAB and MksBEF in PA).   The main biochemically active component, the 
SMC subunit, belongs to the SMC family of ATPases which is highly conserved from bacteria to 




The smc subunit is a homodimer.   Each SMC monomer includes the following structural 
layout: The N-terminal region contains a Walker A site with the conserved sequence (G-X-S/T-G-
X-G-K-S/T-S/T) [28].  The C terminal domain contains a Walker B site with the conserved 
sequence (h-h-h-h-D), where h represents hydrophobic amino acids. Also present on the C 
terminal domain is the signature C-motif and D-loop [28] [26]. In between these termini regions 
are two coiled coil regions which self fold through anti-parallel coiled coil interactions at a hinge 
domain.  Two of these monomers interact through the hinge domain to form a homodimer and 
the SMC subunit [29] (Figure 1-2 A). 
 
Figure 1- 2: Condensin structure. (A) Each SMC monomer in condensins consists of two 
globular domains at the N and C termini, two coiled α-helixes and a globular hinge domain 
between them. Each monomer self fold onto itself forming a functional ABC-type ATPase head 
domain. Association between two monomers occurs at the hinge domain for form a dimer. 




(B) Engagement of the two head domains for each monomer occurs through ATP binding.  Each 
monomer head domain contains a Walker A motif from the N terminus and Walker B motif 
from the C terminus of the first monomer.  The C-terminal domain of the second monomer 
contains the C-motif and D-loop.  Disengagement of the head domains occurs though ATP 
hydrolysis.   
The ATPase head domain in the overall SMC subunit contains two ATPases  [30].  For 
each ATPases, the Walker A site functions in ATP binding.  The Walker B site functions in ATP 
hydrolysis.  The Signature C-motif and D-loop function in stabilizing the binding and hydrolysis 
of ATP [28] (Figure 1-2 B).   
Overall, the main SMC subunit of the condensin complex binds DNA.  The principle DNA 
binding site is located on the proximal hinge region of the SMC subunit head domain where 
there are positive patches of arginine and lysine which interact with negatively charged DNA.  
[31].  The location of this binding site implies that condensins likely embraces DNA within its V 
shaped structure .    
Non-SMC subunits are essential for regulation of the complex and promoting inter-
molecular interactions between condensins.  These proteins positively affect  DNA bridging 
activity [32] and negatively affect DNA binding activity  when complexed with the SMC subunit 
[32-34].  The Kleisin family of non-SMC subunits includes ScpA, MukF, and MksF.  The kleisin 
family of non-SMC subunits includes ScpB, MukE, and MksE [35]. Non-SMC subunits bind to the 
head domain of the main SMC subunit and can oligomerize with other SMC subunits, playing a 




ATP modulates the activity of condensins by altering its architecture and interaction 
with DNA [18, 24-26].  When bound to ATP, the complex dimerizes at the head domain and 
hydrolysis of ATP opens the condensin structure.  For most condensins, binding of ATP also 
induces DNA binding while hydrolysis helps release it.  Notably, DNA binding by the MksB 
condensin is negatively regulated by ATP which distinguishes it from other known SMC 
proteins.  The different effect of ATP on DNA binding for MksB highlights the idea that several 
specialized condensins might be involved in organization of bacterial chromosomes.  Overall, 
basic chromosome compaction through intermolecular interactions is enhanced by ATP.   
1.3  Chromosome architecture 
1.3.A  Chromosome segregation 
Precise DNA segregation is essential for proper inheritance of the chromosome.  In 
bacteria, replication and segregation occur simultaneously (Figure 1-3).  The ParABS partitioning 
system, condensins and topoisomerases all help to segregate most bacterial chromosomes, 





Figure 1- 3: Schematic for Pseudomonas aeruginosa (PA) chromosomal organization during 
replication and segregation.  Fully replicated chromosomes are represented as blue lines and 
partially replicated by black lines.  Replisomes are marked as green diamonds.  Segregation 
starts at parS, proximal to oriC and ends at dif. 
The ParABS system found in most proteo-gamma bacteria, involves three components.  
The first is the parS site which is a sequence located proximal to oriC.  The second is the DNA 
binding protein, ParB, which binds to parS forming a nucleoprotein complex.  The third 
component is the ATPase type protein, ParA, that provides the energy for segregation starting at 
the parS site.   
The ParABS system utilizes these components to effectively segregate the chromosome.  
One proposed model this is accomplished by is through a translocation mechanism.   Chromatin 




affinity to the parS site, but also to adjacent sites on the chromosome with less affinity, known 
as spreading [36].  In this model, the ParB/DNA complex is translocated by interaction with ParA 
which binds to DNA non-specifically [37].  When the ParB/DNA complex binds to ParA, the atpase 
activity is stimulated, followed by its dissociation from DNA.  This allows the ParB-DNA complex 
to be translocated in waves of interactions [38].   
In addition to the ParABS system, condensin complexes are also essential for faithful 
chromosome segregation [3].   Condensins provide chromosomal structuring and scaffolding 
stability which contribute to proper segregation.  Deletion of condensins display chromosome 
segregation defects, including the formation of anucleate cells [27].  
Condensins play a major role in segregation by their maintenance of the oriC position, 
where they are recruited to the oriC loci by ParB [39].  Deletions of condensins show defects in 
oriC localization.  A complete loss of oriC localization, as seen in E. coli, results in disorganization 
of the entire chromosome and failure to locate proper loci to opposite halves of the cell [40, 
41].  In other strains like PA, segregation of oriC localization was either delayed or accelerated, 
affecting overall segregation patterns [5]. Maintenance of the oriC position is therefore 
essential for proper segregation.  These studies suggest an important link between 
chromosome organization and segregation where condensin localization on the oriC region 
dictates the organization and segregation of the remaining chromosome.   
Topoisomerases also play an essential role in segregation. Topoisomerase II in particular 
is responsible for the decatenation of intertwined DNA molecules through the breaking and 




II is essential for the segregation of duplicated DNA.  In many bacteria, Topoisomerases work in 
conjunction with condensins.   
In E. coli, MukBEF recruits Topoisomerase IV to the oriC region by directly binding to the 
C-terminal domain of its ParC catalytic subunit [42, 43].  The formation of this complex was 
found to stimulate Topoisomerase IV activity.  Topoisomerase IV promotes decatenation while 
MukBEF contributes to maintaining oriC positioning.  Both of these actions play an important 
role for proper chromosome segregation [43].   
Inactivation of  MukBEF induces severe growth defects which affect segregation and 
renders cells hypersusceptible to novobiocin [32, 44].  Mutations in Topoisomerase I and DNA 
gyrase allow partial suppression of these MukBEF phenotypes [45]. These mutations increase 
DNA compaction, compensating for the chromosomal disorganization resulting from the 
deletion of mukB. More however, needs to be elucidated to better understand how these 
different mechanisms are coordinated.  
The recruitment of condensins by ParB was found to be part of a larger coordinated 
pathway of segregation in PA.   It was found that condensins are synthetically lethal with ParB 
while deletion of either condensin gene or parB by themselves was not.  This revealed that 
condensins and the ParABS system make up essential and distinct components involved in PA 
segregation [5].   
Deletion of condensins in PA was also coupled with significant alterations in 
macrodomains [5, 46].  Condensin are therefore involved in global organization of the 




scaffold helps maintain the structure and integrity of varying DNA conformations, including 
maintenance of oriC, which plays a major role in segregation.   
1.3.B  Subcellular layout 
Bacterial chromosomes are organized at the subcellular level.  Fluorescence experiments 
have shown that different loci on the chromosome occupy specific regions inside the cell [46].  
This organization has a distinct pattern which is maintained throughout the cell cycle.  The PA 
chromosome organizes itself longitudinally within the cell  [5, 46].  This configuration places the 
origin, oriC, at one pole (the new cell pole), and the dif, chromosome dimer resolution site, at 
the opposite pole (the new cell pole) (Figure 1-4).  This organization is in contrast to a 
transverse organization in which both the oriC and dif region lie along the mid cell and the left 







Figure 1- 4: Chromosomal orientation in bacteria, longitudinal and transverse. Chromosomes 
are organized between oriC and the Terminus of replication. Different species use different 
orientations.  Growth factors can also alter orientation strategies.  In the Longitudinal 
orientation, oriC and the Terminus are located at opposite cell-poles and the arms run parallel 
to each other along the. In the Transverse orientation, both oriC and the Terminus are located 
mid-cell and each arm are at opposite ends of the cell. 
The starting sites for replication and segregation are proximal to each other on the 
chromosome, at the oriC and parS sites respectively.  After replication is initiated in PA, 
segregation occurs concomitantly [46].  The newly replicated DNA is pulled away from the oriC 
locus starting site and moves to the opposite end of the cell while the un-replicated dif migrates 
to the mid-cell position.  After replication and segregation is complete, the cells can fully divide.  




replicated dif region occupies the new cell pole position, in the longitudinal orientation (Figure 
1-3).  
Condensins were also found to contribute to chromosomal layout by way of their role in 
maintaining chromosome structure and integrity [5].  One of the main functions of condensins 
as mentioned previously, is their role in creating a chromosome scaffold structure which helps 
maintain and stabilize DNA conformations.   Deletion of the PAO1-UW condensin, mksB results 
in an inversion at the ribosomal RNA sites, rrnA and rrnB, located on opposite chromosomal 
arms.  This inversion reverted the asymmetric chromosomal layout, back to a symmetric 
organization [4].   
This discovery helped illuminate a new and pivotal role that condensins have on overall 
chromosome structure.  Further studies were performed here in order to determine the 
implications of these chromosomal changes and their coordination with replication, segregation 
and nucleotide bias, an inherent signaling code in most bacteria.   
1.4  Pseudomonas aeruginosa  
As of 2017, Pseudomonas aeruginosa (PA), a gram-negative multi drug resistant strain, was 
placed on a top three list of critical threats by the World Health Organization, WHO, in addition 
to Acinetobacter baumannii and Enterobacteriaceae [47]. PA is a virtually ubiquitous bacterium 
capable of inhabiting a wide range of habitats, including the human host [48]. This bacterium is 
an opportunistic pathogen commonly forming infections as skin rashes, and ear and urinary tract 
infections in healthy people.  In immunocompromised individuals, PA can infect the airways and 




as one of the main perpetuators in chronic lung infections, particularly in patients with cystic 
fibrosis which affects 70,000 people worldwide [49].  PA infects approximately 75% of CF patients 
older than 25 years old making it one of the most prevalent gram-negative species during chronic 
lung infections. Therefore, understanding PA pathogenicity and its modes for adaptation is vital 
for the remediation of PA infections.   
1.4.A.  PA intrinsic fitness 
 PA is a highly robust bacterial strain which can occupy numerous ecological niches. PA is 
commonly found in soil and water. However, it can also occur on the surfaces of plants and 
animals. Currently, there are over 200 (as of 04-30-2019, 228) complete PA strains and clinical 
isolates that have been sequenced on the NCBI database [6].  The PA chromosome has a 
relatively large genome (between about 5-7 Mb). The larger size is due to gene complexity likely 
due to horizontal gene transfer from other bacteria and viruses (125, 126).   
This complexity in the DNA allows PA to overcome varying environmental stressors not 
always tolerated by other organisms. PA encodes a number of different enzymes involved in 
various metabolic pathways.  This gives PA high nutritional versatility where it can utilize 
several different organic compounds for growth, including fossil fuels.   Cellular respiration of 
PA is also highly flexible.  PA can grow in the absence of O2 if an alternative terminal electron 
acceptor is available such as nitrate [50].   
Another aspect which contributes to the overall robust fitness of PA is its decreased 
permeability.  PA is a gram-negative bacterium.  These bacteria have an extra outer membrane 




difficulty to permeate the membrane, PA has several different efflux pumps which shuttle 
toxins out of the cell.   
A notable mode for bacterial fitness is the formation of biofilms.  PA has multiple 
pathways which regulate biofilm formation, an essential lifestyle form which garners structure 
and protection to the growing PA community.  These include quorum sensing mechanisms, 
two-component systems GacA/GacS, RetS/LadS, and intracellular messaging by c-di-GMP.   
Lastly, PA has multiple virulence factors which help promote survival.  These include 
various toxins which can break down material in its surrounding environment in order to obtain 
nutrients.  The combination of inherent systems for metabolic versatility, virulence factors, and 
lowered permeability provide ample adaptation features for PA to exploit numerous 
environmental niches.  
1.4.B.  Pseudomonas aeruginosa biofilms 
One aspect which makes PA so difficult to target is its ability to form biofilms.  Biofilms are 
a community of cells that grow together on a surface, surrounded by a protective 
exopolysaccharide matrix that provides both a structure and protection to the community 
against harmful agents [51].  Biofilms can act as both liquid and solid often being described as a 
“slime”.  If they are in an environment where they can collect sediment, or where they can 
accumulate rust or calcium deposits, these biofilms can develop into a hard-solid state.    
Therefore, biofilms are found in a range of environments from the buildup in water pipes to 
chronic infections in human lungs.    




comes from the extra-cellular matrix.  The components of the matrix includes different types of 
extracellular polymeric substances (EPS), including extra-cellular DNA and RNA (<1%), proteins 
including enzymes(<1-2%) and exopolysacharides (1-2%) [52].   Exopolysacharides and DNA 
have been implicated in the stability of the overall biofilm matrix contributing to cell-cell 
adherence. [53, 54].   
Biofilms have proven exceptionally difficult to eradicate.  In the case of infections, 
antibiotics and white blood cells are less effective against established biofilms.  A number of 
reasons contribute to this enhanced resistance.  The first reason includes reduced penetration 
across biofilms.  Exopolysacharides help in reducing diffusion of white blood cells and other 
large molecules.   This is particularly the case for positive aminoglycosides, which are possibly 
bound by the negative charges from exopolysacharides [55].  The second factor is decreased 
growth rate as this is a phenotype associated with many cells growing in biofilms (section 
1.4.C.1).   Many antibiotics target replication machinery so slower growing cells can often avoid 
being targeted, or at least less effectively.  The third reason is the expression of resistance 
genes.  In PA, these include beta lactamase, and β-Galactosidase which becomes an issue when 
in combination with reduced permeability of the biofilm as certain drugs can be better 
targeted. Multi-drug efflux pumps, specific for drugs can also be upregulated contributing to 
overall drug resistance.   Lastly, the presence of persister cells, a cell morphology that is 
dormant (section 1.4.C.2), helps make removal of biofilms extremely difficult.  For the cases of 
antibiotics which can effectively permeate the biofilm matrix such as fluoroquinolones, 





1.4.B.1  Biofilm structure: pel, psl, alginate, and DNA 
Biofilm development is a highly dynamic process which is constantly changing according 
to its environment.  Overall, several different structures can be generated in a biofilm.  The 
simple types include patchy monolayers or biomasses.  When more organized, they can form 
mushroom type structures when grown in still liquid and filamentous streamers when grown in 
moving liquid.  Biofilms can move together by rippling or rolling across the surface, or by 
detaching in clumps [57].  Biofilms can also change locations by dispersal, where cells in the 
inner portion of the biofilm modify to planktonic cells and swim out to new locations [58]. 
Advanced biofilms act as a city in which major resources including water, nutrients and 
oxygen, are brought throughout the community of cells via channels [59].   The overall structure 
then provides a scaffold engineered for the distribution of nutrients to all parts of the biofilm 
community, even deeply embedded cells within the biofilm. 
It has been shown that the major constituents for biofilm matrix adhesion are exo-
polysacharides and extra-cellular DNA.   P. aeruginosa produces at least three exo-
polysaccharides, psl, pel, and alginate.  The psl exo-polysacchride has been identified as an 
important factor in the initiation and maintenance of biofilms [60].  The structure of psl was 
identified as repeating units of a neutral, branched pentasaccharide consisting of D-glucose, D-
mannose and L-rhamnose monosaccharides [61] (Figure 1-5).  In addition to its structural role in 
biofilm, Psl has also been linked to roles in pathogenesis and protection against the immune 
system [62], in antibiotic resistance [63] as well as a signaling molecule for diguanylate cyclase, 




to form a positive feedback loop with c-di-GMP [64].  
 
Figure 1- 5:  Structure of the psl component of biofilms.  Psl consists of repeating units of a 
neutral, branched pentasaccharide consisting of D-glucose, D-mannose and L-rhamnose 
monosaccharides The structure of Pel includes partially acetylated 1,4 linked N-
acetylglucosamine and N-acetylgalactosamine, however,  the structure has not been fully 
established [61]. 
The pel polysaccharide is a cationic polymer composed of partially acetylated 1,4 linked N-
acetylglucosamine and N-acetylgalactosamine [65]. Currently, the chemical composition and 
structure of pel polysaccharide have not been fully established [66]. The cationic behavior of pel 
was reported to help facilitate its binding to extracellular DNA in the biofilm stalk. Like psl, it 
plays an important role in the structural maintenance of the biofilm.   
Pel and psl are both important in the initial stages of biofilm growth where it maintains 
the integrity of biofilms by functioning as structural scaffolds [67]. Colvin et al 2012 found that 
psl and pel play redundant roles in the PA01 strain in which the deletion of either 
exopolysaccharide results in compensation by the other[68]. Depending on the strain studied, 
the role of pel and psl in biofilm formation can have variations [68].  The PA01 strain of PA is 




pel exclusively on account of it lacking three necessary genes in the pel operon [67]. 
Overall, both pel and psl have the characteristic of promoting cell-cell and cell-surface 
interactions [69] which explains why when overexpressed, they have also been linked to hyper-
adherence and hyper-aggregation [70].  Together, pel and psl form the primary structure 
scaffold for biofilm development, providing the first line of defense as the biofilm begins to 
develop.   
Alginate, a linear unbranched polymer composed of D-mannuronic acid and L-guluronic 
acid [71] (Figure 1-6).  Alginate contributes to the structural stability and protection of mature 
biofilms by adding to the already established layers of pel and psl components.  They also play 
an important role in water and nutrient retention [72].  Alginate acts as a porous material.   This 
allows the establishment of gradients in the biofilm for nutrients, oxygen and other resources. 
Isolates that overproduce alginate are often found to be mucoidal variants, a marker for the 
last stages of chronic lung infection.  It was found that when pel and psl are deleted, alginate is 





Figure 1- 6:  Structure of the alginate component of biofilms. Alginate is a linear unbranched 
polymer composed of D-mannuronic acid and L-guluronic acid [61]. 
 
Extra-cellular DNA (E DNA) plays an important role in the overall adherence and 
formation of biofilms.  E DNA can be produced by cell lysis or through the release of small 
vesicles from the outer membrane [73].  Using flow-chambers to monitor biofilm growth, 
Whitechurch et. al have shown that PA cell growth was diminished in the presence of DNase 1, 
while growing extensive colonies without [53]. They also showed that DNase I can dissolved 
already formed biofilms.  This shows the importance of extracellular-DNA on biofilm growth.  
Therefore, the combination of at least pel or psl with alginate and extracellular-DNA is 
therefore essential in order to form fully mature biofilms in PA 
1.4.C  PA Morphotypes 
1.4.C.1  Planktonic and sessile: major lifestyles 
Basic regulatory mechanisms and mutational plasticity ensures survival against stressors 
in different environments.  On account of these adaptive mechanisms, PA generates 
morphologies with particular phenotypes.  One general morphotype incorporates the 
planktonic lifestyle in which cells grow as single cells and are actively motile using flagella [74].  
Planktonic growth is geared for optimum mobility and acquisition of nutrients from its 
environment be it in soil or in a host organism. Typically, this lifestyle is found in environmental 
strains with enhanced toxin secretion of proteases that allow the breakdown of material 




environments while exploiting resources. Typically, this morphotype is more vulnerable to 
antibiotics and host immune system defenses.   
Another major broad morphotype includes cells having a sessile lifestyle which is 
associated with biofilm growth.  The sessile lifestyle slows down in growth rate as one of its 
prime objectives is survival and biofilm formation.  Typically, downregulation is seen for genes 
involved in motility and protease toxins which are secreted in planktonic cells. Sessile cells 
often upregulate genes involved in adhesion, such as exopolysacharides, thereby enhancing 
stickiness during biofilm formation.   Together, planktonic and sessile morphotypes make up 
the two major lifestyles of PA. From these modalities, additional morphotypes can show further 
divergence.  
1.4.C.2  Additional morphotypes  
An important morphotype which can emerge from either planktonic or sessile growth 
styles are persister cells. Two different types of persister cells have been postulated. The first 
type is thought to occur stochastically in a cell population by prior to the antibiotic treatment 
[75].   The second type occurs in response to to environmental stimuli such as a variety of 
antibiotics [76].  Persister cells are characterized by a dormant state, transient, lifestyle in which 
no growth occurs  [77].  Therefore, persister cells have been reported to play an important role 
in surviving antibiotics as they are more difficult to target. 
Another specific type of morphotype is small colony variants (SCVs). This particular cell 
variant has been shown to be derived directly from biofilms and is primarily associated with the 




been reportedly associated with phenotypes predominate in the sessile lifestyle, including 
slower growth and enhanced biofilm formation.  Prevalent in about 3% of cells in the chronic 
infection state, SCVs have been attributed to a sharp decline in CF patient prognoses.  These 
variants are generated from a number of different ways, but the simplest way is directly from 
biofilms. 
Additional evolutionarily driven morphotypes, include variants having a higher specificity 
of phenotypes derived from divergent evolution.  These morphotypes are weeded out based on 
mutational plasticity, optimized for particular niches.  Often time, these variants are derived 
from isolates during chronic CF infections.  These varied, yet specific, morphotypes have been 
shown to have a large number of varied SNP’s with a specific group of common mutations.  
These mutations were reported to be located in regions of regulation involving stress response, 
QS, and alginate pathways that lock the cell variant into a solid mode of mucoidal growth 
geared for survival in the lung.   
Together, cell morphotypes derived from regulation, mutations, and a combination of 
both mechanisms, achieve maximal diversity in a cell population against stressors.  Changes are 
engineered on the bases of stimuli and progress to an optimized state in highly stressful 
environments.   
1.4.D.  The biofilm lifecycle 
The biofilm lifecycle is a highly dynamic process, in which certain developmental pathways 
can occur under proper environmental parameters (Figure 1-7).  Initially, cells start off as fast 




surface while weakening the host immune system through toxin secretion.  Initially, long range 
attachment occurs through positive Van der Waals forces with a surface.  This force counters a 
net negative electrostatic charge possessed by many environmental surfaces.  When closer in 
range, flagella and pili can contact the surface and aid in adhesion [78].  Attachment at this 
stage is reversible and cells can move closer together using pili using twitching motility.  With 
time, the population increases on the surface forming aggregates of microcolonies.   
 
Figure 1- 7: The biofilm lifecycle.  The biofilm lifecycle starts as planktonic growing cells.  Cells 
attach to the surface and grow micro-colonies which develop into three-dimensional biofilm 
structures. Finally, dispersion occurs releasing clumps of planktonic cells.  
 
After attachment, physiological changes can occur which help transition growing cells into 
the biofilm growth stage, where cells become irreversibly attached. It is believed that this 
switch is partially due to quorum sensing induction [79]. Many genes are activated including 
genes responsible for the production of compounds found in the matrix of developing biofilms, 




which biofilms grow from a single layer (from joined microcolonies), and progress to an 
advanced multilayer system.  Biofilms eventually progress into well- developed three-
dimensional communities [80].  After a certain amount of growth of biofilm is reached, a large 
group of cells are changed back into the planktonic growth stage in order to be released during 
dispersion to spread and colonize new areas for the next round of biofilm growth.  
Additional morphotypes, in particular persister cells, play an important role in antibiotic 
resistance in biofilms.  When biofilms are exposed to antibiotics that can penetrate the matrix, 
like fluoroquinolones, most of the population is eradicated.  A small fraction of surviving 
persisters are able to remain however.  When the drug is removed, biofilms can be reformed 
from these persister cells.  This is one of the ways in which PA can survive through antibiotic 
treatment and continue the PA lifecycle [56].  These biofilms will then again disperse as 
planktonic to find new infection sites and the process continues.  Overall, the biofilm cycle itself 
is an important component of the propagation of infection and disease persistence of PA in 
host systems and is an endless cycle if left untreated.   
1.4.E.  Lifestyle switching and regulation 
In response to environmental changes, PA is able to switch from a planktonic (free 
swimming) to a sessile (biofilm forming) lifestyle.  A planktonic lifestyle enables dispersion and 
travel to new environments, while a biofilm lifestyle offers protection as a community of cells in 
stressful environments [81, 82]).  The transition between motile and sessile lifestyles is crucial 
for PA adaptation and requires the ability of PA to respond appropriately to changes in the 




may provide potential antibiotic targets for combatting infections. The biofilm lifecycle 
highlights the phenomenon of lifestyle switching between the planktonic and sessile growth 
states.  This switching is essential for the propagation of the biofilm lifecycle and is the basis for 
the progression of infection.  However, it is not exactly clear how this switching occurs. 
One intriguing aspect of the lifestyle switching phenomenon, is that the changes in 
regulation affect not only the initial cell where change occurs, but for multiple dividing 
generations after it, often times, even if the signal is removed.  This epigenetic regulation 
provides a powerful manner in which PA can alter the physiology of the entire community for 
multiple generations.  This same phenomenon is also seen in scv generation and bi-stable 
virulence switching of the bexR regulon in which the effects are reversible yet present for 
multiple generations.  
Much of what we know regarding lifestyle switching in Pseudomonas aeruginosa is in the 
form of regulatory pathways (Figure 1-8).  PA possesses a large regulatory network of pathways 
which are highly dynamic and display a great deal of overlap for phenotypes attributable to 
each lifestyle.  This overlap increases the complexity and response systems involved in the 
switching process, emphasizing the importance this process has on PA survival and adaptation.  
Condensins were found to be global regulators involving a number of virulence pathways 
related to biofilm formation and the different lifestyle states.  It is speculated that they are 
involved in regulating a global switch involving several regulatory pathways.  Here, we discuss 
some of the major known pathways involved in lifestyle switching with particular emphasis on 
pathways involved in biofilm formation in order to understand the scope in which condensins 





Figure 1- 8: Regulatory pathways in P. aeruginosa which contribute to sessile and planktonic 
traits.   
There are three quorum sensing systems in PA.  Two of these systems incorporate the 
AHL quorum sensing signal, N-Acyl homoserine lactone.  These include the Las and Rhl systems.  
The Las system includes the transcriptional regulator, LasR, and the synthase, LasI, which 
synthesizes the AHL signal, N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) [84, 
85].  The Rhl system includes the transcriptional regulator, RhlR, and the synthase, Rhl, which 
synthesizes the AHL signal, N-butyryl-L-homoserine lactone (C4-HSL) [86].  The Las Quorum 
sensing system was found to be essential for the creation of mature biofilms, where LasI 
mutant formed very thin biofilms that lacked the three-dimensional architecture [87].  A link 
has also been reported between Las and the expression of the Pel polysaccharide, a component 




The Rhl system, however, has shown mixed results regarding its effect on biofilm 
formation.  In some reports, Rhl is also a major factor by contributing through DNA release or 
directly via the synthesis of exopolysacharides.  [88-90].   In other reports by contrast, no link 
could be found [87, 91].  These conflicting reports indicate that additional parameters play a 
role in the Rhl regulation of biofilm formation.  Therefore, the two quorum sensing systems Las, 
and Rhl, have been found to play a role in the regulation of biofilm formation and toxin 
secretion and can contribute to the switch from a planktonic to sessile/biofilm lifestyle.   
The PQS system (2-heptyl-3,4-dihydroxyquinoline) acts as a connector signal between 
the las and rhl quorum sensing systems [92]. Therefore, the QS systems have a great deal of 
overlap and internal regulation.  The PQS system, like that of Las and Rhl systems have been 
connected to biofilm formation and virulence factors.  Null mutations of the PQS system results 
in reduced biofilm formation and the decreased production of pyocyanin, elastase, PA-IL lectin 
and rhamnolipids and host immune responses [93].  In addition, the PQS system has also been 
found to be involved in iron uptake (pyocyanin and pyoverdine), the regulation of secreted 
toxins including ToxA and the protease PrpL, and the disruption of the host mitochondrial 
function [94, 95].  Overall, the PQS signal helps to maintain biofilms and regulates a number of 
virulence factors in both sessile and planktonic lifestyles.   
The IQS system or Integrated Quorum Sensing system is the newest system discovered 
[96].  The IQS is able to enhance PQS production depending on the P. aeruginosa strain.  The 
IQS system is tightly controlled by las under normal culture conditions but is also activated 
by phosphate limitation.  Together, The QS systems are highly integrated and positively 




RetS and LadS are sensor kinases involved in two-component signaling in PA [97].   Both 
RetS and LadS reciprocally regulate genes involved in the planktonic and sessile lifestyles.  A 
RetS deficient strain showed a marked decrease in virulence from reduced toxin production 
(LipA and ToxA), an important aspect of planktonic growth, and an increased ability to form 
biofilms through the upregulation of psl and pel genes [98].   LadS in contrast, controls the 
expression of genes involved in producing exopolysacharides such as alginate and pel and psl.  
It also was found to negatively regulate swarming motility.  Therefore, both RetS and LadS 
contribute to the control over the lifestyle switch.  
RetS and LadS were found to converge on a master virulence regulator, GacA.  Gac A is a 
response regulator that works with GacS, the sensor, in a conserved two-component system.  
RetS and LadS can influence levels of the small regulatory RNAs RsmZ and RsmY which regulate 
gene expression by binding to RsmA [97].  The GacS/GacA system regulates a broad range of 
virulence and stress response genes [99].  Overall, the GacS/GacA system has been proposed to 
control the reciprocal expression of the planktonic and sessile lifestyles, related to acute and 
chronic infection phenotypes [98].   
The c-di-GMP second messenger is a signaling system that regulates many bacterial behaviors.  
Some of these include flagella rotation, type IV pili retraction, exo-polysacharide production 
(psl/pel), surface adhesion expression, antimicrobial resistance, stress responses, , secondary 
metabolite production, and biofilm dispersion.  [100, 101].  Interestingly, the concentration of 
c-di-GMP was found to be associated with the lifestyle switch between planktonic and sessile 
lifestyles [102]. C-di-GMP has been found to be connected with the Gac/Rsm system, the SagS 




pathway, acts in concert with the two-component system, BfiSR, to enable Pseudomonas 
aeruginosa biofilm formation by altering SadC production levels of c-di-GMP [103]. High 
concentrations of c-di-GMP results in biofilm phenotypes while low concentrations are 
associated with motility and planktonic growth [104] . This association between lifestyle 
switching and c-di-GMP is present in several different species including (Escherichia coli, 
Pseudomonas aeruginosa, and Salmonella enterica serovar Typhimurium) [105]. cAMP is also 
involved with mediating PA biofilm formation.  Almblad et al. showed that high levels of cAMP 
reduce c-di-GMP levels through the transcriptional regulator, Vfr, which reduces overall biofilm 
formation [106].  Hemagglutinin is a filamentous adhesion protein which also directly 
contributes to biofilm formation [107] [108].  Hemagglutinin mutants In P. fluorescens result in 
significant reductions in biofilm growth, extracellular matrix production, motility and overall 
attachment to host cells.  In addition, mutants displayed marked reductions in infection ability 
implying a role as a virulence factor in pathogenicity [107].   
RpoS (σS), is a major regulator of stress response and predominately expressed during 
stationary growth [109].  in PA, RpoS has also been shown to be upregulated in biofilms under 
stress conditions and is considered to be the master regulator of stress responses [110]. RpoS is 
post-translationally regulated by the HsbR-HsbA partner switching system [111].  HsbA, the 
anti-sigma factor, plays a role in lifestyle switching depending on its phosphorylation state.  
When phosphorylated, it binds to HsbR, the response regulator which binds to RpoS.  When 
unphosphorylated, it binds to FlgM, the anti-sigma factor of HsbA.  This plays a role in the 
release or sequestration of either of the two sigma factors which in turn, play a role in 




The SiaA/D system also plays a role in biofilm formation by regulating the synthesis of c-
di-GMP using the sensor kinase, SiaA, and diguanylate cyclase, siaD,  [101, 112].  Increased c-di-
GMP levels has been implicated in biofilm formation [102].  Other targets for SiaA/D mediated 
regulation include the psl polysaccharide, the CdrAB two-partner secretion system and the 
CupA fimbriae, all of which also activate biofilm formation in the sessile lifestyle [112].  PpkA, a 
serine/threonine kinase has also been reported to play a role in biofilm formation, as well as 
other virulence factors, in the type 6 secretion system  [113]. PpkA, acts on the Fha1, a core 
scaffolding protein, through phosphorylation [114, 115] .  This allows post-translational 
regulation of Hcp-PIS which is required for the assembly of PA T6SS HSI-1 [114, 115].  The type 
6 secretion system (T6SS) is involved in a number of different functions.  These include 
pathogenesis, biofilm formation and stress sensing [116].  PppA, a serine/threonine kinase, was 
found to act as a repressor for Hcp-1 export by acting as an antagonist for ppkA and acting on 
Fha1 [117] therefore, it can act as a repressor for biofilms.  PpyR also affects biofilm formation 
by serving as an additional regulator in psl production through the psl operon.  In addition, it 
has been found to contribute to the regulation of LasB, pyoverdine synthesis and PQS quorum 
sensing production, while reducing swimming motility [11].   
A different type of factor for lifestyle control, was identified as the BexR virulence bi-
stable switch [118].  This is a type of switching mechanism which allows large changes in 
regulation to be turned on and off, controlled by the BexR regulon (PA2432). When activated, a 
set of virulence genes, including the quorum sensing proteases, PA0572 and the aprA toxin 
gene from the type 1 secretion system, as well as lipase A, and the MexXY-OprM efflux pump, 




population. Overall, BexR acts as a switching point to control the expression of a diverse set of 
genes [118]. 
Iron also serves as a signal in Pseudomonas aeruginosa biofilm development and is a 
necessary component for PA survival [119].  Iron acquisition in PA occurs through the 
siderophores pyoverdine and pyochelin [120].  These siderophores are acquired though 
recognition at specific cell surface outer membrane receptors, TonB dependent receptors. 
Uptake of ferripyoverdine in P. aeruginosa PAO1 occurs through the FpvA receptor protein 
which utilizes the energy transducing protein TonB1.  This binding sends a signal to the 
membrane-spanning anti-sigma factor FpvR which activates the sigma factors FpvI and PvdS  
[121].  PvdS regulates pyoverdine production and exo-toxin A [122].   FptA is an outer 
membrane receptor precursor of pyochelin which is regulated by the transcriptional regulator 
PchR (PA4227) [123].   
Other heterologous siderophores, xeno-siderophores, ferrisiderophores and 
heme/hemophores can also be incorporated with TonB dependent receptor systems [120, 124].  
Many of these systems are controlled by the central regulator, Fur, which can also regulate 
many sigma factors and other regulators [125].   Pyocyanin, a bluish green pigmented toxin has  
been able to contribute to iron uptake from transferrin [126] as well as its precursor, 
Phenazine-1-carboxylic acid (PCA) [124]. PCA and Pyocyanin can reduce ferric Fe3+ bound to 
host proteins to ferrous Fe2+ allowing uptake through the Feo system [127].    
The precursor to pyocyanin, PCA, is regulated by a number of different factors including 




Pseudomonas quinolone signal (PQS) to the transcriptional regulator, MvfR, is required for WT 
pyocyanine production [128].  The repressor QscR, encoded upstream of phz2, has a negative 
effect on the expression of both phz operons through an unknown mechanism [129]. Lastly, 
sequestering of RsmA by RsmZ and RsmY results in increased expression of pyocyanin along 
with the other previously described phenotypes [98].    
The type I, 2 and 3 secretion systems play a role in the planktonic lifestyle state and are 
implicated during the acute infection state.   These systems and the infection states are 
described in more detail in (section 1.1.F). This is a review of how these systems are regulated. 
In the Type 1 secretion system (T1SS), the HasAp haem uptake protein is regulated by the 
quorum sensing system in PA [130].  The virulence toxin, AprA is regulated by the BexR 
virulence regulator which controls bi-stability in PA [118].   
The type 2 secretion (T2SS) is involved in toxin secretion.  These include LasA, LasB, ToxA, 
and PlcH, PlcN (phospholipases). Inactivation of quorum sensing contributes to the 
downregulation T2SS expression including lipases [85].  The phoB/R genes (PA5360-PA5362) 
regulates PlcH and PlcN [131]. Regulation of Hxc T2SS genes is done by a cell surface signaling 
system, PUMA3 which includes genes in the vreAIR operon [132].     
The type 3 secretion system (T3SS) is regulated by a number of ways.  One major is by 
ExsA (PA1413) which binds upstream of the promoter to control genes in the regulon [133]. 
ExsD (PA1714) and PtrA(PA2808) act as anti-activators for ExsA. ExsC is an anti-anti activator of 
ExsD.  When concentrations of Ca2+ are high, ExsE can bind to the anti-anti activator ExsC , 




ExsE is secreted, making ExsC free to bind to ExsD (the anti-activator).  This frees ExsA to be 
able to activate T3SS expression [134].  ExsA is also activated by PsrA (3006) [135].  Although 
this is the primary mode of control, T3SS can also be suppressed by PtrB (rec-A mediated) 
under the stress of DNA damage [136]. 
Interestingly, condensins were discovered to be global regulators between these two 
physiological lifestyles. Regulation incorporated multiple pathways involved in biofilm 
formation and virulence factor expression.  This discovery adds an additional component to our 
understanding of lifestyle switching.  Overall, the causes of the physiological changes associated 
with PA adaptation involving lifestyle switching are undoubtedly multifactorial and still very 
much elusive. The discovery that condensins play a role in global regulation between lifestyles 
shows that chromosomal organization is somehow involved in the differentiation of lifestyle 
states. The duality of these phenotypes into a relative biphasic system also indicates the 
possibility that condensins play a role in epigenetic regulation.  It is speculated that these 
proteins could act as a biphasic switch in response to environmental changes, enabling 
differentiation states in PA. 
1.4.F.  Chronic and acute infection states  
PA is introduced into the human host as an environmental strain and transitions with time 
from an acute infection phase to a chronic infection phase [49].   During the acute infection 
phase, symptoms are exacerbated within the patient on account of the host immune system 
response.  If diagnosed accurately and timely, acute infections are generally treatable with 




enter the bloodstream, and even cause death.  In contrast, during the chronic infection phase, 
patient symptoms are considered low-grade and sometimes even undetectable.  One of the 
hallmarks of chronic infections is their extreme resistance to antibiotics and significant capacity 
for evading the host defenses.   
In terms of the physiological attributes of bacteria during these infection phases, the 
acute infection phase is associated with a planktonic state.  Phenotypes include increased 
motility (flagella and pili type IV also used for adherence) and enhanced toxin secretion from 
the type 1, 2 and type 3 secretion systems (Figure 1-9) [137, 138]. Both secretion types increase 
the severity of acute disease and are also less likely to be expressed during chronic infections 
[139].  Aspects of the type 1 secretion system has also been implicated in this infection type.   
The type 1 secretion system (T1SS) utilizes an ABC (ATP-binding cassette) transporter with 
an outer membrane protein in order to export toxins [140].  T1SS encodes has (heme 
acquisition system) consisting of a heme receptor (hasR) and a protein that binds heme, HasAP, 
a haemophore [141].  This protein allows utilization of iron by binding haem from haemoglobin.  
This is an important step during the initial stages of infection.  The other major protein involved 
in this system is AprA, an alkaline protease involved in various types of PA infections [142].   
The type 2 secretion system (T2SS) is a membrane bound protein secretion machinery 
that is used to transport of a group of proteins, many being lipases, proteases, and other toxins, 
across the outer membrane into the extracellular space.  Major toxins from the type 2 secretion 
system include elastases (LasA and LasB) (elastases), Protease IV (PrpL),a quorum sensing 




the destruction of various tissues, which contributes to cell damage and disease.  Exotoxin A is 
one of the most toxic virulence factors of PA.  It is responsible for tissue necrosis by blocking 
protein synthesis [143].  Elastases A and B are also involved with tissue damage.  LasB has been 
reported to degrade mucins and surfactant proteins which help to allow bacterial clearance 
[144].  Protease IV degrades surfactant proteins and inhibits surfactant host defense and 
biophysical functions  [145].  
The type 3 secretion system (T3SS)  is a membrane-spanning structure and needle that 
can inject toxins directly into mammalian cells [146].  Major toxins of the T3SS system include 
ExoS/T/U/ and Y.  ExoU, ExoS and ExoT cause death in animal models of pulmonary infection 
and possible humans [147].  Phospholipase C, a hemolysin, is another toxin which is secreted 
during the acute infection phase.  These toxins are capable of interacting with the membranes 
of eukaryotic cells, causing hydrolysis of phosphatidylcholine and sphingomyelin, resulting in 
cell lysis [148].  Other virulence factors in the acute infection model include hydrogen cyanide 
and lipopolysaccharides [149, 150].   Cyanide can inhibit Cytochrome c oxidase, a terminal 
electron acceptor in the electron transport chain, effectively shutting down cellular respiration 
and causing cell death [151].   
Lastly, in order to bypass direct interaction with the host, PA can use outer membrane 
vesicles as a mechanism for the long-distance delivery of multiple virulence factors to cause 
cytotoxicity. It has been shown that B-lactamase, alkaline phosphatase, hemolytic 





The chronic infection phase in PA is characterized by a distinct set of phenotypes which 
are associated with a biofilm lifestyle and specific virulence factors.  Chronic infection 
phenotypes include enhanced biofilm formation and exopolysaccharide production, increased 
c-di-GMP levels, enhanced type 6 secretion effectors and frequently, increased antibiotic 
resistance and iron scavenging capabilities (Figure 1-9). Often, there are also reduced motilities 
and effector proteins of the type 3 secretion system and reduced virulence 19[153].  These 
common phenotypes are shared amongst Pseudomonas aerugionsa, Staphylococus aureus, and 
Bhurholderia cepacia strains during chronic infections, indicating that the chronic infection 
phase may possibly be an optimized cell lifestyle for sustained survival in the lung.  
The type 6 secretion system (T6SS) involves a needle like complex resembling a phage like 
tail structure, [115] to inject toxins directly into both host cells as well as bacterial to fight off 
competition.  There are three sub-types within this system incorporating different Hcp 
Secretion Island (HSI) genes, HSI-1, HSI-2, and HSI-3.  Toxins produced from the HSI-system 
include Tse1, Tse2, and Tse3 [117].  HSI-1 is also involved in biofilm formation as described 
previously [154].   HSI-2 enhances bacterial internalization into host epithelial cells.  
Information for HSI-3 is limited. 
In order to evade the host immune system, it has been reported that PA can synthesize 
structural homologs of the human α2-macroglobulin as a form of mimicry.  Six gene elements 
are included in the overall complex formation and are found in the magABCDEF operon.  The 
α2-macroglobulin complex is proposed to emulate the process by human α2-macroglobulin by 




Bacteriophage is a virus capable of infecting and replicating in bacteria.  It has been 
integrated into the chromosome of PA.  Bacteriophage pf1 in particular, contribute to bacterial 
lysis functions which releases extracellular DNA that can contribute to the structure of biofilms 
[156].    It has been reported that bacteriophage pf1 genes are upregulated in biofilm cells 
[157].   
As previously mentioned, studies have demonstrated that high iron concentrations favor 
the formation of biofilms [119, 158, 159]. However, in vivo conditions have low iron 
concentration since the host has iron sequestering mechanisms working to uptake iron such as 
lactoferrins in mucosal secretions and transferrins in serum [160]. In order to overcome this, PA 
has several pathways in place for iron uptake.  Briefly, they including varying siderophores 
(pyoverdine, pyochelin and TonB dependent iron uptake), xeno-siderophores, and heme 
extractors (has and phu systems) [161]  Pyocyanin and its precursor phenazine, can also 
contribute to iron acquisition through the FEO system [127] .   Pyocyanin is a toxin secreted by 
PA which is capable of oxidizing and reducing other molecules [162].  This allows it to kill 
microbes which compete with it as well as mammalian host cells during infection. Pyocyanin is 
often detected in the sputum of cystic fibrosis patients during chronic lung infections [163]. 
In addition, iron-sulfur cluster biogenesis was shown to be upregulated in PA in response 
to iron starvation [164].  This trend was also seen in other strains including. S. epidermidis 





Figure 1- 9: General summary of acute and chronic infection phase phenotypes expressed in 
bacteria. 
These characterizations of infection phases, however, are not black and white.  During the 
chronic infection state, it has been reported that there is also a mix of cell types, albeit, with a 
higher prevalence for the sessile biofilm stage [167].  Additionally, virulence of the secretion 
systems also showed variation, with a higher prevalence for the chronic type 6 secretion, but 
there was always some degree of diversity in the population [168].   
Populations with variation in lifestyle and virulence is necessary for diversity and is an 
essential component during infection stages. The ability to revert back and forth into these 
different physiologies ensures diversity and progression of infection.   The evolution of PA 
during lung infections is of particular concern on account of its devastating impact on lung 




We report here that the two condensins in Pseudomonas aeruginosa, SMC-ScpAB and 
MksBEF, are involved in the differentiation of the bacterium and impose opposite physiological 
states. Understanding the switch in lifestyle could provide insight into the major transition 
between acute level and initial chronic infection stages of p.a. into advanced chronic infection 
levels.  This finding could help illuminate ways to better target PA and treat infection, before 
changing into a state that is untreatable. 
1.5  PAO1 and PA14 strains 
PAO1 is a widely used laboratory strain while PA14 is considered a highly virulent clinical 
isolate.  Both strains act as opportunistic human pathogens with intrinsic resistance to 
antibiotics and disinfectants.  Included in their repertoire are a variety of extracellular virulence 
factors including proteases, hemolysins, pyocyanin, pili, lipopolysaccharide, alginate, and the 
type 3 secretion system effector proteins, ExoS, ExoT, ExoU, and ExoY.  Additionally, lifestyle 
switching and the formation of biofilms with type 6 secretion system proteins inherent in both 
strain types. 
Several studies involving different models of infection have reported that PA14 is more 
virulent than PAO1 [169-171] .  The PAO1 and PA14 strains of Pseudomonas aeruginosa have a 
similar core genome where approximately 91.7% of PA14 genome exists in PAO1, and 95.8% 
PAO1 genome exists in PA14 [172].   The PAO1 chromosome (GenBank Assembly: 
GCF_000006765.1) is about 6.3 Mb with 5572 protein genes and 106 RNA genes  while the 
UCBPP-PA14 (GenBank Assembly: GCA_000014625.1) is about 6.5 Mb having  5892 protein 




[173].  These differences in genome size account for 58, PA14 gene clusters that are absent in 
PAO1.  Two pathogenicity islands (PAPI-1 and PAPI-2) have been identified in the PA14 genome 
[174].  The PAPI-1 island is about 108 kb while the PAPI-2 island is about 11 kb [174]. 
Different results have been reported for the impact of gene differences found on these 
islands.  Harrison et al 2019 reported that the global contributions to virulence of both PAPI-1/2 
together significantly attenuated virulence of PA14 in acute pneumonia and bacteremia 
models. In contrast, loss of one island did not show a measurable change [175]. 
Analysis of individual genes for several studies have shown link to virulence [174, 176].  
Comparison of extra PA14 genes to other strains, however, did not show a correlation with 
virulence [172].  Lee et. al studied the 58, PA14 gene clusters that are absent in PAO1 to 
determine if any contributed to the enhanced virulence of PA14 in a Caenorhabditis elegans 
pathogenicity model.  Of these extra genes, none were required or predictive of virulence in 
other strains.  They concluded that the higher virulence in PA14 is multifactorial and 
combinatorial in terms of total pathogenicity related genes which interact differently in 
different genetic backgrounds [172].  
Recent developments in RNA seq have illuminated roles for small RNAs in regulation.  
Comparison of PAO1 and PA14 show novel unique and conserved sRNA which were strain 
specific or had strain specific expression indicating a possible role in virulence regulation [177].  
Supporting this, The PAPI-1 pathogenicity island encodes a small RNA PesA which was found to 




Overall, enhanced virulence in could be combinatorial, residing on the overall global 
effects of how these genes are incorporated specifically into a particular strain with possible 
contributions for regulation by factors such as small RNAs.  More progress needs to be made in 
order to better understand virulence and the differences between particular strains. 
1.6  Nucleotide usage bias  
There are four nucleotides which make up genetic code, Adenine (A), Guanine (G), 
Thymine (T) and Cytosine (C). When no selective pressure is present in a system, a random 
distribution of all four nucleotides among a single DNA strand is expected known as Chargaff or 
parity rule 2 [179] [180, 181].  However, in most prokaryotes, this distribution of nucleotides is 
not random.   
Several types of nucleotide bias have been found encoded in bacterial genomes. One 
example in E. coli are the Ter sites, also known as DNA replication terminus binding-site.  Ten 
closely related ter sites are present on the chromosome designated TerA, TerB up to TerJ. Each 
site has 23 base pairs.   Depending on the strain, either the Tus or Tau proteins bind to Ter sites, 
preventing progress of the DNA replication fork from the opposite direction.  Therefore, this 
system of blockage on Ter sites entraps the terminus of replication into a confined region of the 
chromosome [182]. 
Another example of nucleotide bias are KOPS (FtsK orienting polar sequences) sites which 
have the sequence GGGNAGGG, and are asymmetrically found in the two chromosome arms. 
FtsK, a DNA translocase protein, preferentially engages KOPS which guides it towards the 




and XerD proteins bind at the two dif sites to form a complex followed by strand exchange, 
catalyzed by FtsK, and recombination which separates chromosome dimers [184] (Figure 1-10). 
KOPS sequences are present in most bacteria as well as FtsK and XerC and XerD homologs.  
 
Figure 1- 10: dif and the XerC/D recombinase system.  (A) The consensus dif sequence showing 
XerC and XerD binding sites.  (B) Kops bias seen in leading and lagging strands for plus and 
minus strands in E. coli MG1655.  These sequences align with the dif sequence.  (C) 
Chromosome dimers are resolved by the XerC/XerD recombination system which occurs at the 
dif site.  FtsK is a DNA translocase motor protein which brings together two dif sites guided by 
numerous KOPS (FtsK orienting polar sequences; 5′-GGGNAGGG-3′), which are distributed along 
both arms from oriC to dif.  FtsK induces XerD catalytic activity required for the first DNA strand 
exchange.  The second strand exchange event is modulated by XerC, completing the 
recombination reaction.
 
 Capital letters indicate >50% frequency in representative strains, 




In addition to these examples, global nucleotide compositions are typically found to be 
asymmetric with a clear nucleotide bias between the chromosome arms which overlap with the 
leading (G/T abundant) and lagging strands (A/C abundant) [181, 185]. This nucleotide bias 
phenomenon is known as GC skew and AT skew.   
The cause for this phenomenon is still unclear.  The current hypothesis is that it is 
primarily due to the higher incorporation of guanines versus cytosines in the leading strand 
during replication [186, 187]. Supporting this idea, GC-skew switches polarity at the origin of 
replication, oriC.  Interestingly, the opposite GC-skew switch is found at the chromosomal dimer 
resolution site, dif, implying an alternative contribution to its origin [181, 188]. 
Nucleotide bias, therefore, serves as an inherent signaling code, switching polarity and 
thereby marking the location for oriC and dif.  How this nucleotide bias is affected by 
chromosome asymmetry (placement of dif relative to oriC), and its coordination with 
segregation and replication has not been investigated.  This thesis, therefore, looks at the 
coordination between nucleotide bias in conjunction with major processes of segregation and 
replication both in the PAO1 strain (model organism), and across all sequenced bacterial 




Chapter 2:  Methods 
2.1  Genome modification through allelic replacement 
Modifications to the genome was done through bacterial conjugation using the method 
of Simon et. al (1986) [189].  Recipient P. aeruginosa cells and donor E. coli strain SM10 (λpir) 
cells carrying the suicide vectors were grown in LB medium at 37 °C to an OD600 of 0.2.  Cells from 
each strain were then harvested and combined containing 5×107 of the SM10 (λpir) cells and 
2×108 of P. aeruginosa cells in a total volume of 20 μl LB medium and spotted on an LB-agar plate.  
The conjugating cells were incubated 37 °C overnight, then collected, resuspended in 2 ml of 10 
mM magnesium sulfate solution.  Cells were then plated onto Vogel-Bonner minimal medium 
(VBMM: 0.083 M Magnesium sulfate, 0.48 M citric acid monohydrate, 2.87 M Dipotassium 
phosphate anhydrous, 1.28 M Sodium Ammonium Phosphate) agar plates supplemented with 
gentamicin (30 μg/ml). Colonies were re-streaked onto LB-agar plates containing 15% sucrose 
and incubated 37 °C.  Strains generated using FRT cassettes (Flp recognition sequences) flanking 
drug resistance markers had their drug markers removed by electroporation with pFLP2 
harboring the flippase (Flp) recombinase gene in order to recombine the FRT cassettes as done 
previously [190].  Colonies were then cross checked for sensitivity to carbenicillin which is present 
on the pEX18Ap and pFLP2 plasmids by streaking on LB plates supplemented with carbenicillin.  






2.2 Plasmid and strains 
For experiments done with PAO1, PAO1-Lac (ATCC 47085) was used as the wild-type 
(WT).  For experiments done with PA14, UCBPP-PA14 was used as the wild-type (WT). E.coli and 
P. aeruginosa cells were grown in Luria broth (LB medium or M9 medium plus 0.4% glycerol and 
0.4% Casamino Acids (Difco) under aerobic conditions at 37oC unless noted otherwise.  Cell 
growth was measured by the optical density (OD) at 600 nm (OD600) using a UV-1601 UV-visible 
spectrophotometer.  A complete list of plasmids is provided in Table 1, a list of strains in Table 
2, and primers in Table 3 in the Appendix.  
 
2.2.A Construction of plasmids 
Constructs used to generate deletion and knock-in strains utilized the pEX18Ap suicide 
vector [190] as a backbone which incorporated the oriT region and the ColE1 origin of 
replication, the gentamicin resistance gene, GmR, flanked by FRT cassettes, the sacB gene and 
the ampicillin resistance gene, AmpR (Figure 2-1). The sacB gene encodes Levansucrase, an 
enzyme that converts sucrose to levan polysaccharides which accumulates in the periplasm and 
is toxic to cells [191].  Levansucrase activity confers sucrose sensitivity in P. aeruginosa in the 
presence of 10% sucrose, allowing it to be used as a counter selectable marker.  The oriT region 
allows the plasmids to transfer from E. coli to P. aeruginosa. pEX-∆mksB [1], used for condensin 
deletion constructs, was derived from pEX18Ap [190] and incorporates approximately 500 bp up 
and downstream of the mksB gene onto flanking regions of an FRT cassette containing a 
gentamicin resistance marker.  pUCP-mksB [27], derived from the pUCPP22 vector [192], 




the subcloning of an sspB gene to generate an arabinose inducible expression vector used in the 
degron system.  The pYM101 vector [193] was used as a source for the lacIq gene and the T7 













Figure 2- 2: Plasmid map of suicide vector pEX-∆mksB 
 
The pEX-∆mksB::mksB plasmid was generated to incorporate a mksB gene into a ΔmksB 
strain (at the mksB locus) to test for complementation.  To generate this construct, an FRT 
cassette (section 2.1) flanking a gentamicin resistance gene, FRT GmR, and an approximate 500 
bp fragment of the downstream region of mksB was PCR amplified from the pEX-∆mksB vector 
using primers Sbf1 forward and Opa30.  This fragment was digested with the restriction 
enzymes SbfI and HindIII (New England Biolabs) and ligated with T4 DNA ligase (New England 
Biolabs) into the Sbf1/HindIII sites in the pEX18Ap suicide vector.  Next, a fragment 
incorporating the entire mksB gene and approximately 500 bp upstream was PCR amplified 
from a PAO1 genomic template using primers Opa31 BamHI and Rev mksB1 Blp1, then digested 




To replace endogenous mksB by a DAS4-tagged version, the pEX-mksB-Das4 plasmid was 
constructed.  To this end,  amplification of an approximate 600 bp fragment and the C-terminus 
of mksB, c-mksB , was obtained from genomic DNA just before the stop codon using primers 
degron 7 which incorporated a KpnI site and degron 8  which incorporated a DAS4 linker (For 
more details on primers used, see Table 3 of the Appendix).  Amplification of the resulting 
fragment was done using primers degron 7 and degron 9 which added a Das4 tag, stop codon, 
and a BlpI restriction site.  This was digested and ligated into the Kpn1 and Blp1 sites in the pEX-
∆mksB construct.  
To incorate the sspB protein through inducible expression, the pSspB plasmid was 
generated.  The sspB gene was amplified from a PAO1 genomic template using primers degron 
10 and degron 11 and digested and ligated into the PacI and XbaI sites in a pUCP-mksB cloning 
vector, effectively replacing the mksB gene with sspB.  The pUCP-mksB vector was obtained 
from our lab [27] . 
To generate three different mksB ATPase mutants, the plasmids pEX-mksB-D864A, pEX-
mksB-E865Q, and pEX-mksB-S829R were constructed. To this end, pEX-mksB-D864A was 
generated by PCR amplification of an approximate 600 bp fragment using primers opa180 and 
opa184 from PAO1 genomic DNA.  This fragment is located about 240 bp upstream from the 
stop codon of mksB.  Opa180 contains a restriction site for KpnI.  The opa184 primer 
incorporates a single base pair change, cytosine, from an adenine, at the 2,591 bp position in 
the mksB gene.  This changed the sequence from “GAC” to GCC”.  A second fragment 
approximately 270 bp was generated using primers opa181 and opa183.  Opa184 is the reverse 




approximate 270 bp fragment.  Opa181 contains the restriction site for BlpI. The two resulting 
fragments were joined using PCR mediated assembly, digested with KpnI and BlpI and inserted 
into pEX-∆mksB obtained from our lab [1].   
The pEX-mksB-E865Q plasmid was generated by PCR amplification of an approximate 600 
bp fragment using primers opa180 and opa186 from PAO1 genomic DNA.  This fragment is 
located about 240 bp upstream from the stop codon of mksB.  Opa180 contains a restriction site 
for KpnI.  The opa184 primer incorporates a single base pair change, cytosine from a guanine, at 
the 2,593 base pair position in the mksB gene.  This changed the sequence from “GAG” to CAG.  
A second fragment approximately 270 bp was generated using primers opa181 and opa185.  
Opa186 is the reverse complement of opa185. Both primers incorporate a single base pair 
change generating an approximate 270 bp fragment.  Opa181 contains the restriction site for 
BlpI. The two resulting fragments were joined using PCR mediated assembly, digested with KpnI 
and BlpI and inserted into pEX-∆mksB  obtained from our lab [1].   
The pEX-mksB-S829R plasmid was generated by PCR amplification of an approximate 550 
bp fragment using primers opa180 and opa188 from PAO1 genomic DNA.  This fragment is 
located about 340 bp upstream from the stop codon of mksB.  Opa180 contains a restriction site 
for KpnI.  The opa188 primer incorporates two base pair changes, a cytosine and a guanine (in 
order), from a thymine and cytosine (in order), at the 2,485 and 2,486 base pair positions in the 
mksB gene.  This changed the sequence from “TCC” to “CGC”.  A second fragment 
approximately 370 bp was generated using primers opa181 and opa187.  Opa188 is the reverse 
complement of opa187.  Both primers incorporate the two base pair changes generating an 




fragments were joined using PCR mediated assembly, digested with KpnI and BlpI and inserted 
into pEX-∆mksB obtained from our lab [1].   
To delete the mksB2 gene in PA14, the pEX-∆mksB2 plasmid was generated.  Construction 
of this plasmid included amplifying an approximate 500 bp fragment from the upstream region 
of mksB2 using primers Apa 1 and Apa 2 and cloned into the pEX-∆mksB vector between KpnI 
and Blp1.  Next, an approximate 500 bp fragment from the downstream region of mksB2 was 
amplified using primers Apa 3 and Apa 4 and cloned into the RsrII and HindIII sites.   
To replace the original promoter upstream of the mksB2 gene in PA14 with a lacIq-PT7 
inducible promoter, the pEX-lac-mksB2 plasmid was generated.  To this end, a modified version 
of pEX18Ap with the EcoRI site removed, pEX18Ap*, was used for cloning.  An approximate 300 
bp fragment directly downstream of the mksBEF2 promoter was PCR amplified with primers 
containing SpeI (primer P3) and PstI (primer P4) sites.  Next, an approximate 300 bp fragment, 
200 bp upstream of the mksBEF2 promoter was amplified, with primers P1, containing the KpnI 
site and P2, containing the and EcoRI site.  These amplified fragments were then combined 
using PCR mediated assembly, digested and ligated into the KpnI and PstI sites of of pEX18Ap*.  
The lacIq gene and the T7 early promoter, PT7, was then amplified from a pYM101 plasmid [193] 
and cloned in between the two fragments at the SpeI and EcoRI sites. 
For deletion of both the mksB2 and mksG genes in PA14, the pEX-∆mksB2-∆mksG plasmid 
was generated.  For construction, amplification was done from PA14 genomic DNA of an 
approximate 500 bp fragment from the downstream region of the mksG gene using primers Apa 




sites.   
2.2.B  Construction of PAO1 strains 
PAO1 mksB-E865Q was generated by mating SM10 (λpir) cells harboring the pEX-mksB-
E865Q plasmid with the recipient PAO1 ∆mksB strain through allelic replacement.  These steps 
include plating on VB 30 Gm followed by LB 10% sucrose which allowed counter-selection.  The 
gentamicin resistance gene was removed by transforming cells which encodes Flp recombinase, 
followed by plating on LB 200 µg/ml carbenicillin [190].  Chromosomal insertion was verified 
using DNA sequencing and PCR. 
PAO1 mksB-S829R, and PAO1 mksB-D864A were similarly generated as above, using 
their corresponding plasmids pEX mksB-S829R and pEX mksB-D864A respectively. 
To test for mskB complementation, the PAO1 ∆mksB::mksB (∆B::B) strain was 
generated which incorporated the mksB gene into a PAO1 ∆mksB strain.  This strain was 
similarly generated as above using the plasmid pEX-∆mksB::mksB.  Chromosomal insertion was 
verified using PCR 
2.2.B.1  Degron system strains 
To construct strains for DAS4 mediated degradation, the sspB gene was first deleted 
from PAO1 ∆mksB [1] and wild-type PAO1-Lac using the allelic replacement method with 
pEXG2-ΔsspB. Next, the mksB gene was replaced by its DAS4-tagged version using the allelic 
exchange method with the pEX-mksB-Das4 plasmid.  The gentamicin gene was removed as 
previously described generating PAO1 ∆sspB ∆mksB::mksB-DAS4 (PAO1 Das4), followed by 




∆mksB::mksB-DAS4-PsSpB (PAO1 Das4-PsSpB) and  PAO1 ∆sspB ∆mksB::mksB-DAS4-pUCP22 
(PAO1 Das4-Pucp22 ) respectively.   
2.2.C  Construction of PA14 strains 
2.2.C.1  PA14 deletion strains  
PA14 deletion strains were generated using the allelic exchange method as described in 
section 2.1 and are listed in Table 2 in the Appendix.   Each condensin mutant listed below 
includes both a GmR strain (containing a gentamicin resistance marker flanked by an FRT 
cassette) and a ∆Gm strain (gentamicin marker removed).  For GmR strains, the GmR FRT 
cassette is located on the locus that was last to be replaced. Deletions were confirmed using 
PCR.  The order in which each deletion was generated is indicated: 
PA14 ∆mksB1 was generated using pEX-∆mksB1. 
PA14 ∆smc was generated using pEX-∆smc. 
PA14 ∆mksB2 was generated using pEX-∆smc. 
PA14 ∆mksB1 ∆mksB2 was generated using first, pEX-∆mksB1 then pEX-∆mksB2. 
PA14 ∆mksB1 ∆smc was generated using first, pEX-∆smc then, pEX-∆mksB1. 
PA14 ∆mksB2 ∆smc was generated using first, pEX-∆smc then, pEX-∆mksB2. 
PA14 ∆mksB1 ∆mksB2 ∆smc was generated using first, pEX-∆mksB1 then using pEX-∆mksB2. 
then, pEX-∆smc. 




2.2.C.2  PA14 conditional mutant strains 
Another set of PA14 deletions were generated in the same fashion as above, however, a 
lacIq-PT7 replaced the original promoter of the mksB2 gene.  This promoter replacement was 
generated by conjugation of SM10 (λpir) cells harboring the pEX-lacmksB2 plasmid with PA14 
WT cells followed by plating onto LB with 15% sucrose.  Condensin deletions were then 
generated using this as a parent strain.  Each mutant listed below (except for PA14 lacB2) 
includes both a GmR strain and a ∆Gm strain.  For GmR strains, the GmR is located on the locus 
that is last to be replaced. Deletions were confirmed using PCR.  The order in which each 
deletion was generated is indicated: 
PA14 lacB2  
PA14 lacB2 ∆mksB1 generated using pEX-∆mksB1 
PA14 lacB2 ∆smc generated using pEX-∆smc 






Figure 2- 3: PCR confirmation of PAO1 ∆mksB:mksB (∆B::B).  Rows 2 through 4 include samples 
PCR amplified using primers Opa11 and Opa42.  Expected fragments include; ∆B::B1 GmR: 6007 
bp, WT:  4953 bp and ∆B::∆Gm: 2680 bp.  Rows 6 through 8 include samples PCR amplified 
using primers Opa11 and Opa22.  Expected fragments include; ∆B:B1 GmR: 5939 bp, ∆B::∆Gm: 





Figure 2- 4:  PCR confirmation of PA14 condensin deletion strains containing a gentamicin 
















Figure 2- 6:  PCR confirmation of PA14 condensin deletion strains with a lacIq-PT7 inducible 
promoter upstream of mksB2.  Results include the smc, mksB1 and mksB2 loci.  
2.3  The degron system 
The degron system allows controlled degradation of proteins by the ClpXP protease.  The 
system uses a Das4 tag (AANDENYSENYADAS), that binds to the C-terminus of the protein to be 
degraded. This tag is optimized for binding to both ClpXP as well as the adaptor protein, SspB, 
which makes degradation dependent on the presence of SspB.    
For our study, a DAS4 tag was cloned at the 3`end of mksB.  The sspB gene was removed 




Castang et. al [194]. Next, the mksB gene was replaced by the DAS4 tagged version using the pEX-
mksB-Das4 construct into the PAO1-∆SspB strain. Finally, the SspB expression plasmid, pSspB was 
incorporated by electroporation into these strains. SspB was induced by adding 0.1 mM L-
arabinose.  Degradation was confirmed by western blot.  
2.4  Biofilm formation 
Biofilm formation was evaluated as previously described [195].  Cells were grown in LB 
or M9 medium supplemented with 0.4% Casamino acids and 0.4% glycerol to stationary phase 
then diluted 1:100 in M9 medium and 0.4% glycerol.  100 ul were placed into each well of a 
polyvinyl chloride (PVC) microplate and incubated at 37oC for the indicted times.  0.1% crystal 
violet was used to stain 20 µl of cells for 10 minutes then the liquid was removed. Each well was 
then rinsed three times with phosphate buffered saline (PBS) and air dried for 15 min.  The 
remaining cells were then resuspended in 100 ul of 95% ethanol.  In order to measure the 
about of biofilm formation, absorbance readings were measured at 600 nm.   
2.5  Fixed cell fluorescence microscopy  
Anucleate cells were analyzed as previously described [196].  Cells were grown either LB 
or M9 medium supplemented with 0.4% Casamino acids and 0.4% glycerol to an OD600 of 0.6.  
300 µl were then fixed in 70% ice cold ethanol and incubated on ice for 20 minutes.  Cells were 
then rinsed with PBS (phosphate buffered saline).  An aliquot of rinsed cells were then put onto 
poly-lysine coated microscope slides, stained with 100 nM DAPI and 1x Sypro-Orange.  After 




stains proteins which makes it possible to view anucleate cells.  Cells devoid of DNA do not 
fluoresce so they can be distinguished from normal cells which contain DNA.  
2.6  Competition growth 
To study competitive growth for condensin mutants, we used condensin strains which 
contained gentamicin resistance markers and the WT strain.  Overnight cultures of mutant and 
WT were mixed at 1:1 ratios and approximately 2x104 cells were put into fresh LB (5 ml).  The 
cells were then further incubated at 37oC while shaking.  Every 8 hours, the cell culture was 
reinoculated into fresh medium at an approximate OD600 of 0.2 to 0.5.  Before each dilution, 
aliquots of the mixture were removed and spot plated onto LB agar plates as well as LB with 30 
µg/ml gentamicin plates.  This allowed us to calculate the total cells as well as mutant cells.  The 
strain loss rate was determined by fitting the data to single exponential decay. 
2.7  Minimal inhibitory concentration (MIC) analysis 
To test susceptibility of mutants to antibiotics, overnight cultures of indicated strains 
were reinoculated and grown to an OD600 of approximately 1.0.  Cells at a density of 5x104 cells 
per ml were inoculated into each well place in the presence of antibiotic at 2 fold increasing 
concentrations.  Cells were then grown approximately 20 hours at 37oC.  The minimal inhibitory 
concentration was determined as the lowest concentration which inhibited growth.   
2.8  RNA-Seq experimental methods 
RNA-Seq analysis was performed for PAO1 condensin mutants during two separate 
experiments.  The first experiment includes the first replica analyzing PAO1 WT, Δsmc, and ΔΔ.  




All together samples PAO1 WT, Δsmc, and ΔΔ had a total of three replicas, one replica from 
experiment 1 and two replicas from Experiment 2.   ΔmksB included only two replicas derived 
from Experiment 2. 
2.8.A  Hot Phenol method 
RNA in all replicas was extracted using the hot phenol method [197]. All samples were 
grown overnight in Luria-Bertani medium at 37 °C.  The samples were reinoculated by diluting 
the sample 100x into fresh Luria-Bertani medium and grown to an OD600 of 0.6 for analysis of 
the exponenetial phase.   
 5 ml of culture was combined with 1:10 v/v of water saturated phenol ethanol (add 0.5 
ml of water saturated phenol ethanol mixture) to the culture at room temperature.  This was 
followed by centrifugation at 4,000 rpm at 4oC for 10 mins to pellet the cells.  The supernatant 
was removed and cells lysed with 800 µl of 0.5 mg/ml of lysozyme dissolved in TE pH 8.0.  80 ul 
of 10% SDS was added, mixed and the sample placed in a 65oC water bath for 2 mins.  88 µl of 1 
M NaOAc pH 5.2 and 1 ml of hot water saturated phenols prewarmed in 65oC, was added and 
inverted 10 times.  The mix was placed in a 65oC water bath for 6 minutes, inverted every 60 
seconds while in the bath.  The tube was chilled on ice then centrifuged for 10 minutes at 4oC 
13,000 rpm.  The top layer was pipetted off and put into a new centrifuge tube with equal 
volume of chloroform added and inverted 10 times then centrifuged again at a 4oC at 13,000 
rpm.  Again, the top layer was pipetted off and put into another microfuge tube.  Ethanol 
precipitation was then performed by adding 1/10 volume of 3 M NaOAc pH 4.2, 1 mM EDTA 




incubated at -80oC at least two hours.  The RNA pellet was then pelleted by centrifugation at 
13,000 rpm for 25 min s at a 4oC, washed with ice cold 80% ethanol and centrifuged at 13,000 
rpm for 5 mins at 4oC.  The ethanol was then removed and pellet air dried for 20 mins in a fume 
hood and resuspended in 100 µl DEPC water. 
2.8.B  DNase treatment 
Genomic DNA was removed from the isolated RNA samples of PAO1 WT, Δsmc, ΔmksB 
and ΔΔ from using recombinant DNAse I treatment from Invitrogen, catalog number AM2235 
[198]. The nucleic acid solution for all samples was diluted to 10 μg nucleic acid/50 μL. DNase I 
Buffer was added to 1X concentration in the RNA sample.  1 μL DNase I (2U) was added to 10 μg 
of RNA in a 50 μL reaction and incubated at 37°C for 30 minutes. The RNA sample was then 
extracted with phenol/chloroform to inactivate DNase I then Ethanol precipitated a final time.   
2.8.C  rRNA depletion 
The total RNA that is obtained includes a pool of mRNA’s, rRNA and small RNA’s. rRNA 
generally comprises approximately 80 to 90% of total RNA.  In order to ensure that a strong 
signal is obtained for mRNAs, the RNA population was enriched by the targeted removal of 
ribosomal RNAs using the ribo-Zero rRNA depletion kit (gram-negative bacteria) Magnetic kit 
by  Illumina company catalog # MRZGN126, for replicas 2 and 3 and MICROBExpressTM Kit from 





2.8.D  Sequencing  
 Alignment of counts to the PAO1-UW genome was performed by Oklahoma Medical 
Research Foundation, OMRF in Oklahoma City, Oklahoma resulting in a list of PAO1 genes with 
their corresponding number of reads. 
2.9  RNA-Seq data normalization pipeline 
Sequencing of trancript reads were done in the OMRF facility in Oklahoma City, 
Oklahoma using Illuminma.  Counts were alligned to the PAO1 genome in order to obtain the 
number of reads for corresponding PAO1 genes processed at OMRF. These reads were then 
further processed for optimization of the signal to noise ratio.   
2.9.A  rRNA Exclusion 
First, reads for rRNA were excluded in order to ensure that differences in rRNA reads 
across samples would not skew subsequent normalization of the data.  rRNA genes that were 
excluded include the following: 16S rRNA (PA0668.1), PA0668.2, PA0668.3, 23S rRNA (PA0668.4), 
23S rRNA (PA4280.2), PA4280.3, PA4280.4, 16S rRNA (PA4280.5), 23S rRNA (PA4690.2), PA4690.3, 
PA4690.4, 16S rRNA (PA4690.5), 23S rRNA (PA5369.2, PA5369.3, PA5369.4, 23S rRNA (PA5369.5).  
2.9.B  RPKMM calculation 
Second, reads corresponding to PAO1 genes except rRNA genes, were converted to 
RPKMM values (Reads Per Kilobase per Million reads mapped).   The extra M in this name 
denotes the removal of rRNA prior to RPKM calculation.  The formula for the calculation of 




𝑅𝑃𝐾𝑀𝑀 =  
𝑅𝑒𝑎𝑑 𝑐𝑜𝑢𝑛𝑡𝑠 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡
(𝑔𝑒𝑛𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡 (𝐾𝑏)∗ ∑ 𝑎𝑙𝑙 𝑟𝑒𝑎𝑑𝑠∗1𝑥10^6)
      Equation 2- 1 RPKMM calculation 
 2.9.C  Thresholding of noise  
Third, thresholds were then applied to RNA reads as a means of filtering probable noise.  
This was needed due to the different sequencing depths between experiments (lower for 
replica 1).  Genes having zero reads in either replicas 2 or 3 were removed from analysis and 
the resulting RPKMM list was indexed accordingly. In total, 117 genes having zero reads were 
removed.   
2.9.D  RPKMM averaging  
Fourth, RPKMM values were averaged according to a conditional threshold on replica 1.  
Averaging was done on a conditional basis because replica 1 contained a significantly higher 
percentage of rRNA and therefore lower useable counts than replicas 2 or 3.  A conditional 
cutoff was applied as <=1 for replica 1 in which the average RPKMM was calculated as either 
the sum of replicas 2 and 3 (when <=1), or the sum of all replicas (when >1).  
2.9.E  RPKMM ratios for each mutant 
Lastly, ratios were determined as RPKMM of the sample/ RPKMM of WT in order to 
assess fold change values relative to each mutant.   
2.10  RNA-Seq bioinformatic functions 





2.10.A  Hierarchical clustering 
Clustering analysis was performed on the basis of hierarchical clustering.  Hierarchical 
clustering generates clusters in a consecutive fashion from a set of datapoints based on 
proximity in space.  At the beginning of clustering, each datapoint represents its own cluster.  
These clusters are then sequentially merged according to their similarity.  Similarity is based on 
proximity of the objects in space [200].   
The city block method was used in order to calculate the distance between the cluster 
or objects [201]. The City block distance between two points, xs and xt, with n dimensions is 
calculated as: 
dst= ∑ |xsj-xtj|nj=1                                                              Equation 2- 2 City block distance 
 
Linkages establish how clusters are generated by defining the distance from a point or 
newly formed cluster to other clusters from the dataset.   For our analysis, linkages of distances 
were established using the average linkage method.  This is in contrast to other linkage 
methods such as single linkage (which links the closest distance of points in two adjacent 
clusters), or centroid linkage (which links by the distance of the centers of clusters).  The 
average linkage method produces clusters with low within-cluster variance and similar sizes.  
Linkages are calculated as the average distances between all points within a cluster or object 
and another cluster or object.   
When two objects, or clusters are considered the most similar based on linkages, they 




into one large cluster.  The results of the building of merges between objects is a hierarchical 
tree which can visualized in a dendrogram [202].   
2.10.B  Principle Component Analysis (PCA) with Cluster Analysis  
Principle component analysis, or PCA, is a tool for dimension reduction of multivariate 
data while retaining trends and patterns.   Thousands of dimensions can be reduced to a set of 
two or three, which contain most of the information from the original data set.  This enables 
more intuitive visualization of large data sets.   
PCA analysis linearly maps data using orthogonal transformation [203].  This mapping 
involves the projection of data onto principal components which are each, a single axis in space.  
Principle components are arranged orthogonally to one another eliminating redundancy of 
variables.  Each principle component therefore, is a new variable generated by a linear 
combination of the original data. PCA ranks principle components based on having the greatest 
variance of projected data. This maximizes the information kept while reducing the number of 
dimensions.  The first few principle components incorporates the majority of the original data, 
allowing a large number of variables to be interpreted in two to three dimensions.  
PCA analysis (SVD method) was performed using MATLAB on data which overlaid data 
that was also clustered using the hierarchical clustering method with pdist set as city block and 
average in MATLAB properties as described in 2.3.A.  Therefore, clusters could be visualized on 
the PCA plot relative to each other.   This method of analysis allowed highlighting of statistically 




 Information regarding biological pathways was obtained from Kyoto Encyclopedia of 
Genes and Genomes (KEGG) [204], Virulence factor database (VFDB) [205], Pseudomonas 
Genome Database (Pseudomonas Genome Database (PseudoCAP)[206] [207] as well as other 
noted literature sources [104, 118, 121, 125, 155, 208-216].  A database was compiled of 
relevant pathways and used during the bioinformatic analysis. 
2.10.C  Violin and box plots 
Violin plots with overlapping boxplots was generated using a modified script written by 
Bechtold, B. [217] which was run in MATLAB [199].  Violin plots overlaid with box plots indicate 
relative distributions of condensin mutant gene expression values as a log2 ratio (RPKMM 
sample/RPKMM WT).   Red lines indicate 2 fold upregulation while green dashed lines indicate 
2 fold downregulation.  Box plots indicate the median value of each regulon as a central circle, 
the larger box portion indicates the 25th and 75th percentiles of gene distributions and the 
whiskers indicate QL + 1.5*QL and QL – 1.5*QL for the maximum and minimum respectively.  
2.10.D  Venn diagrams 
Venn diagrams were generated using script written by Heil, J. [218] which was run in 
MATLAB.   
2.10.E  Elbow method (cluster optimization) 
In order to separate the data into meaningful clusters, we estimated the optimal cluster 
number using the elbow method.  The elbow method plots unexplained variance versus the 




unexplained variance (most compacted cluster) in which adding cluster numbers no longer has a 
significant effect on variance.  
Script for the elbow method was written in MATLAB.   The sum of square distances was 
calculated for each postulated cluster number up to 500 clusters.  Each iteration calculated the 
square distances between individual datapoints and their designated centroids.  These values 
were summed for each postulated cluster number and divided by the total sum of square 
distances for one cluster (representing the maximum unexplained variance).  The unexplained 
variances for each cluster were then plotted against cluster number.   Two lines were fitted 
against the data simultaneously, using linear regression analysis.  The optimum cluster number 











Chapter 3:  Physiological characterization of PA condensins  
3.1  Introduction 
Condensins are global regulators of gene expression (Chapter 4-1).  Physiological studies 
on condensin deletion strains in PAO1 are in line with transcriptional analysis, showing opposite 
differentiation states where deletion of smc produced sessile biofilm growing cells and deletion 
of mksB produced planktonic growing cells with reduced biofilm formation [1].  Physiological 
studies in sections 3.2.B and 3.2.C in this chapter related to PAO1 have been previously 
published: 
Zhao, H., Clevenger, A., Ritchey, J. W., Zgurskaya, H. I., & Rybenkov, V. V. (2016). Pseudomonas 
aeruginosa condensins support opposite differentiation states. J Bacteriol. 
doi:10.1128/JB.00448-16 
Here, several parallel studies were performed in order to address the issue of 
complementation for mksB which revealed unexpected features regarding context 
dependence.  In addition, we explored the roles that the PA condensins SMC-ScpAB and 
MksBEF have on PA14 cell physiology in order to determine the stability of phenotype across 








3.1.A  Summary of PAO1 strains 
 
Table 3- 1:  Summary of PAO1 condensin mutant strains used in Section 3.2.   lacIq-PT7 is an 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible promoter placed upstream of the mksB 







3.2  Complementation of mksB reveals context dependence 
3.2.A  Conventional complementation tests reveal irrevocable alterations to the 
chromosome 
Since the ΔmkB strain was found to be related to biofilm growth defects in both a 
physiological study as well as transcriptomic analysis [1] (Chapter 4), biofilm formation was 
used as a reporter for mksB phenotype.  In order to test for complementation, the mksB gene 
was incorporated into a ΔmkB strain using several complementation strains and evaluated for 
its effect on biofilm formation.  The complementation strains used included an IPTG inducible 
promoter upstream of mksB (mks’) (Dr. Hang Zhao) , an IPTG inducible plasmid carrying mksB 
that was transformed into PAO1 ∆B (PAO1 ∆B-P22-mksB) (Dr. Hang Zhao), and a knock-in mksB 
construct that was generated by inserting the mksB gene back onto the ∆mksB locus (PAO1 
∆mksB::mksB) (Figure 3-1).  The mks’ and PAO1 ∆mksB-P22-mksB strains expressed mksB in the 






Figure 3- 1: mksBEF operon organization.  The generation of PAO1 ∆mksB::mksB results in a 
FRT scar after removal of the FRT cassette as well as remnants of the mksB down region. (A) Full 
operon of mksBEF with no modifications to the chromosome (B) PAO1 ∆mksB showing an FRT 
scar flanked by the mksB up and down regions.   (C) mksB knock-in construct PAO1 ∆mksB::mksB 
showing an FRT scar and residual mksB down region scar prior to the intergenic region. 
 
 
Significant defects were observed for the ∆B1 strain as well as the PAO1 ∆mksB-P22-
mksB (both with and without IPTG) and the knock-in strain (Figure 3-2), showing a lack of 
complementation of mksB. 
This method can deduce if a link exists between MksB and biofilm formation with the 
condition that cis effects or secondary consequences of gene deletion do not impede 
complementation of mksB.  In sections 3.2.B and 3.2.C, it is shown that mskB was 
complemented using both the degron system and ATPase point mutations.  Therefore, the 
results here for conventional complementation tests show that a full mksB deletion and 
subsequent changes to cis or secondary effects resulted in irrevocable changes that could not 
be remediated with the incorporation of the mksB gene.  
The mks’ strain, both +/- IPTG, shows the same levels of biofilm formation as WT.  This 
shows that there was not complete repression of mksB in mks’ when the system was placed on 
the chromosome.  This could be due to a possible leaky expression in the system which has 





Figure 3- 2:  Biofilm assay of PAO1 conventional complementation strains.   Biofilm assay of 
WT, ∆mksB ∆Gm (∆B) (plus and minus IPTG), a lacIq-PT7 inducible promoter upstream of  (mks’) 
(plus and minus IPTG), IPTG inducible plasmids (pUCP22) carrying mksB transformed into PAO1 
∆B (∆B/p22,  ∆B/p22-mksB, (∆B/p22-mksB) and a knock-in mksB construct which inserted the 
mksB gene onto the ∆mksB locus (∆B::B). 
 
3.2.B  A link between MksB and biofilm formation is confirmed using the degron 
system 
On account of possible cis or secondary effects, complementation for mksB was tested 
using the degron system (Figure 3-3).  The degron system incorporates a Das4 tag attached to 
the C-terminus of the protein which is recognized by the ClpXP mediated degradation system.  




constraints.  The control of degradation occurs because the Das-4 tag is optimized for binding to 
ClpXP in the presence of SspB.  Therefore, generation of a system in which SspB presence is 
inducible, allows control of mksB degradation.   
 
Figure 3- 3:  Schematic for steps in the degron system of protein degradation.  The protein of 
interest is tagged with a Das4 tag specific which is specific to the adaptor SspB protein.  The 
adaptor and tagged protein combined with the ClpX/P protease to form a complex which leads 
to degradation of the tagged protein. 
To set up the degron system for mksB, we first removed the gene for the protease 
adapter protein, sspB from PAO1 WT.  The mksB gene was then replaced with a mksB gene 
containing a C-terminal Das4 tag. This tagged protein was affectively targeted for protease 
degradation in the presence of a plasmid that contains pUCP22-SspB (pSspB).  pSspB was 
incorporated into the PAO1 ∆sspB ∆mksB::mksB-DAS4 strain using electroporation.  A control 
strain was generated which incorporated an empty pUCP22 vector into PAO1 ∆sspB 
mksB::mksB-DAS4.  Expression levels show a depletion of mksB in cells that express the plasmid 
pSspB, but not in the WT strain (Figure 3-4 A).    
The biofilm assay shows that when mksB is absent, there are major defects in biofilm 




PAO1 ∆mksB::mksB-Das4-pUCP22 + Ara show the same level of biofilm formation as WT.  When 
the degron system is introduced and turned on, these levels drop significantly back down to 
that of ∆mksB, implicating mksB in biofilm growth.  
Because the cell physiology changes in response to the production of the SspB protein, 
we conclude that the presence of MksB is linked with biofilm formation.  Since MksB is 
associated with biofilm formation, yet the incorporation of mksB into PAO1 ∆mksB was not able 
to complement the phenotype, it can also be deduced that the deletion of mksB changed cis or 
secondary effects which resulted in irrevocable chromosomal changes.   
 
Figure 3- 4: Biofilm formation defects. (A) Depletion of MksB using the degron system. DAS4-
tagged but not wild-type MksB is depleted in cells that express plasmid-encoded SspB (pSspB) 
as determined using immunoblotting. (B) Inducible depletion of MksB impairs biofilm 
formation. Biofilm formation (+/-SD; n=3) was measured for PAO1 WT, ∆mksB (none), or ∆sspB 





3.2.C  The association of MksB with biofilm formation is dependent on 
conformation, not ATP turnover 
ATP is essential for the function of condensins.  The binding and hydrolysis of ATP is what 
modulates the opening and closing of the overall SMC protein.  In order to gain insight into the 
role that ATPase activity plays on mksB function as well as providing an alternative method for 
complementation, we generated point mutations in the ATPase head domain of mksB.  Point 
mutations result in the expression of MksB which are locked into specific intermediates in the 
ATPase cycle.  This method gives insight into the role that ATPase activity plays on mksB 
function without introducing detrimental effects caused by a full mksB deletion.   
Three types of mksB ATPase mutants were generated (Figure 3-5 A).  The first is a D864A 
mutant in the Walker B region.  This mutation prevents ATP binding and therefore, prevents 
dimerization of the SMC heads [2].  The second mutant included E864Q in the walker B region 
[3].  This mutant prevents ATP hydrolysis, but allows ATP binding which stabilizes the dimeric 
SMC heads.  The third mutant included S829R in the C motif.  This mutant interferes with head 
dimerization but allows ATP binding [185].  All of these mutations interfere with the 
dimerization of the SMC heads.  These mutants were found to be expressed at normal levels 
(Figure 3-5 B).   
Overall, two out of the three ATPase mutants including E864Q and S829R showed similar 
defects in biofilm as that of ∆mksB for biofilm formation (Figure 3-5 C).  One of the mutants, 
D864A, however did not show any effect and had the same level of biofilm formation as that of 
WT.  These results show that specific ATPase intermediates are essential for the function of 




that can still perform the regulatory function of MksB.  Interestingly, this shows that MksB 
intermediate conformations rather than ATPase activity, are relevant for the regulatory function 
of MksB.   
 
Figure 3- 5: Biofilm formation of MskB ATPase mutants.  (A) Effects of ATPase mutations on 
the conformation of condensins. (B) Immunoblot analysis of expression levels for the tested 
mutants. (G) Biofilm formation by the indicated ATPase or deletion mksB mutants (+/- SD, n=6). 
Note formation of oligomers by MksBEQ, which is consistent with head disengagement defects 






3.3 Condensin phenotypes are strain specific  
PA14 has two copies of MksBEF, MksBEF1 and MksBEF2 in addition to SMC-ScpAB.  Not 
much is known about this second copy of MksBEF.  Because there are multiple versions of 
condensins, we hypothesized that the different versions play a specialized role in PA14 which 
possibly contribute to different lifestyle states as seen in PAO1.  In order to analyze the role of 
condensins in PA14, several strains were generated which incorporated condensin deletions 
(Table 3-1).  The lacIq-PT7 promoter was used in strains in order to replace the original promoter 
upstream of the mksB2 gene for its controlled expression using IPTG.  Deletions were generated 
using the allelic replacement method with the pEX-∆mksB1 [1] and pEX-∆smc plasmids [27] and 
the pEX-∆mksB2 and pEX-∆G plasmids.  Strains were confirmed by PCR and/or sequencing 












Table 3- 2:  Summary of PA14 condensin mutant strains used in section 3.3.  Strains are named 
in the order that genes were deleted/modified.  lacIq-PT7, is an Isopropyl β-D-1-
thiogalactopyranoside (IPTG) inducible promoter system placed upstream of mksB2. Each 
condensin mutant listed below includes both a GmR strain (containing a gentamicin resistance 
marker flanked by an FRT cassette) and a ∆Gm strain (gentamicin marker removed). Strains 
which include the GmR FRT cassette are always denoted as GmR.  Further details for strains are 
provided in Table 2 in the Appendix.   
 
3.3.A  PA14 Condensin mutants show minor defects in biofilm formation 
To test if condensins had any effect on biofilm growth, as was seen in PAO1, we grew 




grew biofilms adhered to the sides of the PVC well.  Therefore, to quantify relative amounts of 
biofilm growth, the cells were stained with 0.1% crystal violet and measured for OD600.  Each 
sample was done in triplicate.  Some slight reductions in biofilm were seen for the PA14 ∆smc, 
PA14 ∆mksB2, PA14 ∆mksB1 ∆smc and the triple knock out PA14 ∆mksB1 ∆smc ∆mksB2, with 
the largest reduction for PA14 ∆mksB2 (Figure 3-6).  All of these reductions, however, were 
within error bars of WT indicating they were not significantly changed.  Therefore, the 
regulation of biofilm formation by MksB is unique to PAO1.   
 
Figure 3- 6: Biofilm formation of PA14 deletion mutants.  Cells were grown at 37oC for 72 
hours.  ∆∆∆ denotes ∆mksB1 ∆mksB2 ∆smc. 
 
3.3.B  PA14 condensin mutants exhibit growth and cellular fitness on par with 
WT  




opposite physiological states.   To test the role that condensins have in the PA14 strain, growth 
curves in planktonic media, growth on solid media, biofilm formation and competition growth 
were analyzed.  For growth in planktonic medium, cells were grown in LB media at 37oC and 
checked for OD600 at the indicated time points.   No changes from WT are seen for any of the 
mutants (Figure 3-7 A).  For colony growth, CFU/OD was calculated for each mutant.  These 
results were done in triplicate (Figure 3-7 B).  Overall, no major deviations were seen between 
the mutants (CFU/OD).  This shows that condensin mutants are nearly identical to WT with no 
significant defects.   
 
Figure 3- 7: Growth of PA14 condensin mutants. (A) Growth curve at 37oC in LB medium while 
shaking for the indicated condensin mutants.  (B) Growth on solid LB agar plates for indicated 




3.3.C  Competitive growth of PA14 condensin mutants against WT result in slight 
strain losses 
The competitive growth assay compares the cellular fitness of a particular strain against 
another.  For our purpose, we compared condensin deletions against WT.  Each mutant strain 
contained the gentamicin resistance marker.  Cells were mixed at a 1:1 ratio, then inoculated 
into fresh LB medium and grown at 37oC with dilutions every 8 hours.  Aliquots at each time 
interval were plated onto LB and LB plus gentamicin plates.  Mutant cells were determined by 
the number of colonies on the gentamicin plate and the total number of cells were determined 
on the LB only plate and their CFU/OD calculated. The strain loss rate was calculated by fitting 
the data to its rate for single exponential decay.   
All mutant strains showed some degree of strain loss rate.  The results show a slightly 
higher strain loss rate for lacB2 ∆B1 with 0.5 mM IPTG (Figure 3-8).  These values are 
significantly smaller than the effect seen in PAO1 which showed a strain loss rate for ∆smc at 0.4 
[1], comparing to the highest result in PA14 at 0.025 for lacB2 ∆smc.  Overall, we see a small 
effect from condensin inactivation.  Competition growth done less frequent dilutions including 
12 and 24 hours resulted in no change. Also, when strains were grown individually, no change 
was seen.  This result is apparent only when cells are growing during  exponential phase and in 
the presence of WT.  This indicates that cells are not sick by themselves but are slightly affected 





Figure 3- 8: Strain loss rate of competition growth for PA14 condensin mutants versus WT.  
Strain loss rate for competition growth of PA14 condensin mutants versus PA14 WT for the 
indicated strains.  Cells were diluted into fresh LB media every 8 hours for 48 hours.  Slopes for 
strain loss were calculated for each strain. 
3.3.D  A low frequency of anucleate cells is observed in condensin mutants 
To test if condensin inactivation in PA14 affected chromosome compaction, we looked at 
the frequency of anucleate cells.  Improper chromosome compaction yields one cell with 
unseparated DNA and the other cell lacking DNA entirely (anucleate).  In order to analyze the 
frequency of anucleate cells, bacteria were grown in LB or M9 supplemented with 0.4 % 
glycerol as indicated. 
Proteins were stained with Sypro-Orange and DNA with DAPI to allow visualization and 
distinction between DNA and the rest of the cell.  Cells were counted as a total as well as the 




mksB2 background.  The results show that very few cells were anucleate with a maximum of 
3/909 or 0.3% for the lacB2 ∆B1 ∆smc strain and a single anucleate cell for the other strains 
(Figure 3-9).  PA14 cells faired significantly well despite the inactivation of condensins.   
 
Figure 3- 9:  Frequency of anucleate cells of PA14 condensin mutants.  Cell were grown in LB 
and M9 at 37oC.   
3.3.E  Effect of antibiotics on growth  
3.3.E.1  Antibiotic susceptibility is unchanged in PA14 mutants relative to WT  
 
Minimal inhibitory concentration analysis of several antibiotics was tested on PA14 
condensin deletions strains derived from a PA14 lacB2 parent strain grown at 37oC in LB 
medium overnight (Table 3-3). These antibiotics have a range of targets including the ribosome, 
DNA gyrase, DNA, and the cell wall. The indicated minimum concentrations that inhibited 




occurred that were greater than 2 fold relative to WT.  Condensins, therefore, show no impact 
on drug susceptibility. 
Table 3- 3:  Minimal inhibitory concentration results.  Table showing antibiotics and their 
effect on PA14 condensin mutants with a lacB2 background 





Ribosome Streptomycin 8 to 16 8 to 16 8 to 16 16 8 
Ribosome Kanamycin 62.5 62.5 62.5 62.5 62.5 
Ribosome Gentamicin 1 to 2 1 1 1 1 
Ribosome Chloramphenicol 4 4 4 4 4 
Ribosome Spectinomycin 500 500 500 500 500 
DNA 
Ethidium 
Bromide 2000 2000 2000 2000 2000 
DNA Mitomycin-C 2 to 4 2 to 4 2 to 4 4 2 to 4 




125 125 125 125 62.5 
cell wall 
formation Vancomycin 2000 2000 2000 2000 2000 
 
3.3.E.2  Persister cell formation of condensin mutants is similar to WT 
Persister cells are a morphotype in a small subpopulation in bacteria which allow survival 
in hostile environments. These persister cells can form prior to antibiotic or as a response to it.  




This mode of growth provides opportunities for multidrug tolerance and plays a major role 
during chronic infections.   
In order to test the formation of persister cells and their variation among the generated 
condensin deletions, gentamicin, norfloxacin and streptomycin, were tested at 4x and 64 x 
concentrations greater than MIC concentration for a one hour and spot plated onto LB agar 
plates to determine colony growth at CFU/OD (Figure 3-10).  The 64x concentration for 
gentamicin and streptomycin did not grow colonies.  For gentamicin, additional testing was 
done on 12x and 20x concentrations.  All mutant strains and WT showed decreased colony 
growth after the indicated treatments with antibiotics.  Overall, no major variation was seen 
between WT or any of the condensin mutants indicating no major alterations occurred to 






Figure 3- 10:  CFU/OD of persister cell formation.  Gentamicin, norfloxacin, and streptomycin 
at the indicated concentrations (either 4x, 12x, 20x, 64x relative to MIC) and were added to the 
indicated PA14 condensin mutants with a lacB2 background for 1 hour at 37oC while shaking.   
 
3.3.F  Pigment production changes in PA14 condensin strains  
During the generation of condensin deletion strains, pigment changes were observed for 
the PA14 ∆B1 ∆B2::∆Gm and PA14 ∆B1 ∆B2 ∆smc::∆Gm strains.  Pigment production in 
Pseudomonas aeruginosa results from pyocyanin, seen as a bluish green color, and pyoverdine, 
seen as a greenish yellow (Figure 3-11).  These pigments have been implicated in virulence and 




pyoverdine production (Figures 3-12 and 3-13).  Overall, the results show a significant decrease 
in pigment production, in particular for pyocyanin for cells that were grown at 37oC while 
shaking.  
 
Figure 3- 11: Condensin mutant strains grown at 37oC while shaking for 16 hours. 
 
 
Figure 3- 12: Quantification of pyocyanin production in PA14.  ∆∆∆ is the triple condensin 
mutant ∆B2 ∆B1 ∆smc.  (A) Cells grown at 37oC while shaking for 6,16 and 32 hours. (B) Cells 





Figure 3- 13: Quantification of pyoverdine production in PA14.  ∆∆∆ is the triple condensin 
mutant ∆B2 ∆B1 ∆smc.   (A) Cells grown at 37oC while shaking for 6, and 16 hours. (B) Cells 
grown at 37oC no shaking for 32 hours. 
In construction of the strains, ∆B1 was deleted first, followed by ∆B2 and then ∆smc.  ∆B1 
∆B2::GmR is green showing pyocyanin production while ∆B1 ∆B2::∆Gm is yellow, indicating that 
the phenotypic change occurred during recombination while removing  the gentamicin cassette.  
This indicates possible downstream polar effects after the removal of the GmR promoter. Since 
mksG is part of the mksBEF2 operon and found directly downstream of mksB2, we hypothesized 
that removal of the gentamicin gene, may have blocked mksG expression after removal of the 
GmR promoter, possibly resulting in pigment change.   
In order to assess if this phenotype is linked to mksB2 and mksG, we generated a ∆B2 
∆G::GmR strain to test its effect on pigment change.  The results show that this strain 
maintained a green pigment (pyocyanin production) (Figure 3-14), indicating that mksG in the 
∆mksB2 background cannot alter pigment production.  In line with this, a ∆B2::∆Gm strain also 




However, other combinations of mutants were able to alter phenotype.  In order to see if 
polar effects from a ∆B1 and ∆B2::∆Gm background were consistent, a second strain, ∆B2 
∆B1::∆Gm was generated from a ∆B2::∆Gm parental strain.   This is in contrast to the ∆mksB1 
∆B2::∆GmR showing green pigment which was generated from a ∆B1::∆Gm parental strain.  The 
∆B2 ∆B1::GmR strain interestingly showed a change from green to yellow pigment (Figure 3-14). 
Therefore, strains having a background of ∆B1 combined with ∆B2::∆Gm resulted in 
pigment changes from green to yellow (reduced pyocyanin) indicating a possible association 
with this combination of mutations. These results show that ∆B1 and ∆B2 in combination with 
possible downstream polar effects resulted in pigment change.  In order to fully elucidate if 
mksG is a contributor to this phenotype further studies will be necessary for deleting mksG in 
combination with both mksB1 and mksB2.   
 
Figure 3- 14:  PA14 generated strains and their resulting pigments.  Cells were grown at 37oC 




Chapter 4:  Transcriptomic analysis of PAO1 condensin mutants  
4.1  Introduction 
Physiological assays on PAO1 condensins revealed opposite differentiation states and a 
role in PA virulence [1].  Here, the regulatory role of PAO1 condensins was determined by 
transcriptomic analysis of condensin mutants using RNA-Seq which incorporates next-
generation deep sequencing technology.  To this end, we collected cells from our condensin 
mutant samples and PAO1 WT grown in exponential phase for RNA isolation and sequencing. 
RNA-Seq data was optimized to reduce noise using thresholds across samples.  PCA analysis was 
performed based on hierarchical clustering of expression data.  Integration of pathway 
information during clustering analysis highlighted major affected pathways for differentially 
expressed genes.  Expression data for these pathways were further analyzed and compared 
across samples in order to derive transcriptomic profiles for each condensin mutant.  
4.2  Removal of noise using thresholding 
RNA was isolated from condensin mutant samples and PAO1 WT during the exponential 
phase of cell growth, sent for  processing at the OMRF facility in Oklahoma City where it was 
sequenced using Illumina.  The resulting transcript counts were further processed in the OMRF 
facility by allignment with the PAO1 genome resulting in the number of reads corresponding to 
each PAO1 gene. Experiment 1, which included the first replica (WT, Δsmc and ΔΔ) contained an 
average of 82% rRNA.  Therefore, rRNA was first excluded from all replicas before further 




the formula described in section 2.9.B. Reads were further processed in house for noise as 
described above.  
The final plots after thresholding for noise for WT is shown in Figure 4-1. After 
thresholding, we see that the noise is reasonable (removal of straight lines at -1 (log2 of zero), 
and that most of the genes are equally expressed. Following noise thresholding, pair-wise 
comparisons were made as scatter plots of log2 average RPKMM values (Figure 4-2).   These 
plots indicate that most genes have the same level of expression as evidenced by the fact that 
they lie mostly on the diagonal line over a long range.  The diagonal line is where we expect no 
change between the two samples.  There is a group of genes that are not equally expressed.  
These particular genes are more probable to be differentially expressed genes the further they 
are located away from the diagonal, a line indicating no change in expression.   These are 
particularly likely to be differentially expressed for higher value RPKMM values in which noise 
becomes less likely a factor.   
RPKMM values were then averaged according to the method described in section 2.9.D. 
and calculated for the corresponding ratios determined as RPKMM sample/RPKMM WT (fold 






Figure 4- 1: Scatter plots of WT replica 1 vs WT replica 2.  Plot with no threshold (left) and with 
threshold (right). 
 
Figure 4- 2: Scatter plots of WT replica 1 vs mksB replica 1.  Plot with no threshold (left) and 





4.3  Δsmc, ΔmksB, and Δsmc ΔmksB display distinct patterns of regulation 
Differentially expressed genes for Δsmc, ΔmksB and Δsmc ΔmksB (ΔΔ) were determined 
as ratios of RPKMM values relative to PAO1 WT at a 2 fold threshold.  Of the 5666 genes in PA, 
612 genes were differentially upregulated and 645 were downregulated.  However, a subset of 
differentially expressed genes was found to be unique for each condensin mutant. 
Venn diagrams generated for differentially expressed genes showed that there is little 
overlap between condensin mutants for upregulated genes (Figure 4-3).  157 PAO1 Δsmc genes 
that were upregulated shared 6 genes with PAO1 ΔmksB, 25 with ΔΔ and only 7 with all three 
mutants.  PAO1 ΔmksB showed 73 upregulated genes, sharing 12 of those with ΔΔ.  439 ΔΔ 
upregulated genes were found total. Overall, differentially expressed genes were found to be 
uniquely expressed for the individual mutants rather than overlapped.  It is interesting that the 
ΔΔ mutant is actually different than either single mutant implying little synergystic effect  for 
upregulated genes.   
In contrast, downregulated genes showed much more overlap for differentially 
expressed genes between the PAO1 ΔmksB and PAO1 ΔΔ samples.  Of the 512 PAO1 ΔmksB 
downregulated genes, 137 overlapped with PAO1 ΔΔ 15 with PAO1 Δsmc and 15 with all three 
mutants.  For the PAO1 ΔΔ downregulated genes, only 1 was overlapped with PAO1 Δsmc.  
PAO1 Δsmc showed 126 total downregulated genes.  Overall, downregulated genes resulted in 
significant overlap between the PAO1 ΔΔ and PAO1 ΔmksB mutants, whereas PAO1 Δsmc 
remained differentiated for both up and downregulated genes.   This indicates that ΔΔ is 




independent from PAO1 ΔΔ and PAO1 ΔmksB for both up and downregulated genes.  This 
indicates that Δsmc has its own regulatory realms, while ΔΔ and ΔmksB share many regulatory 
pathways for downregulation. 
 
Figure 4- 3:  Venn diagram of signficiant genes for condensin strains.  Left: upregulated, right: 
downregulated. 
 
Principle Component analysis, or PCA, was used to analyze fold change values (log2 
RPKMM ratio) for 5484 genes for each PAO1 condensin mutant, a reflection of the total gene 
base.  The results (Figure 4-4) show that PAO1 Δsmc, PAO1  ΔmksB, and PAO1 ΔΔ are opposite 
to one another along the first and second principle components (WT is located at 0,0).  
Therefore, alignment of any one particular sample to another sample was not seen, indicating 





Figure 4- 4:  PCA analysis of Δsmc, ΔmksB and ΔΔ.  Reduced dimensions of genes into a single 
point. 
4.4  Hierarchical clustering highlights statistically relevant gene groups  
Hierarchical clustering was performed as described in section 2.3.A.   This method 
highlights differentially expressed genes based on the statistical separation of datapoints based 
on log2 fold change values using the city block p-dist (Equation 2-2) and average linkage 
methods.  The resulting dendrogram and accompanying heat map are found in Figure 4-5.   
The heatmap presents differentially expressed genes that are upregulated above 1.5 
fold change as red and downregulated as green, black for unchanged. The dendrogram based 
on each sample indicates a separation between Δsmc and the other two mutants ΔmksB and 




genes are within one larger group indicated by the fact that most nodes are found after an early 
split at the top.  Outlier clusters can be found prior to this major node split. 
 
Figure 4- 5:  Hierarchical clustering analysis of fold change values for PAO1 condensin strains.  
Expression values are represented in a heat map. Each gene is represented by a single row and 
each sample by a single column. Upregulated genes (>1.5 fold) are in red, downregulated genes 
(>1.5 fold) are in green.  Dendrogram on the left shows genes separated into outlier clusters 





4.5  Clustering analysis reveals differentially regulated pathways in 9 major 
clusters 
Hierarchical clustering allowed visual representation of the 5485 linkages determined in 
the dendrogram.  In order to more efficiently process this large number of linkages for all three 
condensin mutants, we performed cluster analysis.   
The first step for cluster analysis is determining how many differential clusters there are.  
The elbow method is one of many methods which provides a crude estimate of the optimal 
cluster number in a given dataset.  This method estimates the optimum cluster number by 
approximating a relative elbow, or intersection point on a plot of unexplained variance vs 
postulated number of clusters.  Using the elbow method as described in methods (section 
2.10.E), it was determined that there were roughly 18 optimum clusters which is what we used 
as a starting point to begin analysis with as seen in Figure 4-6.  This number allows splitting of 
the dendrogram into clusters of genes based on statistical relevance.  
PCA analysis was performed based on this cluster determination as described in section 






Figure 4- 6:  Elbow method for determining optimum cluster number 
 
 
Figure 4- 7  PCA analysis of determined 18 clusters. 
 
Utilizing a pathway database, we obtained information regarding the number of hits for 




Initial screening of our PCA plot indicated outlier genes which based on proximity and pathway, 
were merged with their associated larger cluster.  This resulted in a total of 9 final clusters.   
Summarization of the percent of biological pathways was performed for each cluster 
(using MATLAB) and is shown along with the merged PCA plot in Figure 4-8.  This is summarized 
in a pie diagram in Figure 4-9 and in a Table 4-1.  
 
Figure 4- 8:  PCA analysis of merged 9 clusters with pathways.  Pathways show percent of 





4.6  Cluster Results show major pathways involved in virulence 
Pathways which show distinct clusters indicate significant differentiation in gene 
expression based on hierarchical clustering.  The following refers to Figure 4-8, Figure 4-9, and 
Table 4-1.  Hypothetical genes with unknown function made up 33% (150/455) of genes in 
outlier clusters and 44% (2393/5485) of all genes.   
The type 3 secretion system (T3SS) as previously discussed, is implicated in the acute 
infection phase.  This pathway forms a single cluster which has no overlap or spread into other 
clusters.  This indicates a concise regulation pattern throughout the regulon. T3SS genes made 
up 85% of cluster 5 and 95% of the entire regulon.  This reveals differentiation of the entire 
T3SS regulon.  
The type 6 secretion system (T6SS) as previously discussed, is implicated in the chronic 
infection phase.  Genes in this path are spread widely across clusters 2 and 3 indicating a fairly 
widespread range for how the T6SS is regulated between mutants.  T6SS made up 47% of 
cluster 2 and 8% of cluster 3.  Further inquiry shows that T6SS HSI-1 was found in both clusters 
2 and 3, however, only T6SS HSI-2 was found in cluster 2 (11 genes) while T6SS HSI-3 was found 
in cluster 3 (6 genes).   This overlap indicates that there is a larger range of regulation for HSI-1, 
but HSI-2 and HSI-3 were clearly separated and regulated distinctly between the three 
condensin mutants. 
Iron acquisition was found spread across two clusters, making up 18% of cluster 1 and 
7% of cluster 3.  (Figure)The iron uptake pathway is large, encompassing several different 




like pyocyanine.  Iron (not including pyoverdine, pyocyanin or pyochelin or no p,p,p) also 
includes other TonB dependent siderophore, enterobactin, haemophore, and xenosiderophore 
uptake systems.   The iron group was found to be differentiated for most iron groups.  All 
affected pyochelin genes were distributed in cluster 3.  In contrast, Iron (non p,p,p) which 
includes siderophore homologues and other groups just described was found primarily in 
cluster 1 (Table 4-1).  Pyoverdine genes were distributed evenly between the two clusters at 
proximal regions of both clusters. 
Biofilm (non pel/psl) genes were also distributed in two different clusters making up 
20% in cluster 2 and 10% in cluster 3.  This regulon coexists with the T6SS pathway and was 
therefore expected to be found in clusters 2 and 3.  This pathway was partly separated on the 
basis of exopolysacharides, where all differentially regulated psl exo-polysacharide genes were 
found in cluster 3 (9 genes).  18 non pel/psl genes were found in cluster 2 while 18 were found 
in cluster 3.  The separation of biofilm genes coincides with type 6 secretion where biofilm 
genes related to T6SS HSI-3 are found in cluster 3 and those related to T6SS HSI-1 and T6SS HSI-
2 are distributed in cluster 2.   
The BexR regulon, involved in virulence switching, was found exclusively in cluster 1 
making up 15% of the overall cluster.  Many of the genes were found on the periphery and 
upper portions of the cluster indicating a high differentiation from the central insignificant 
cluster. 
Five out of the 6 total α2-macroglobulin homologue genes (magABCDEF operon), were 




of these proteins.  The proteins are proposed to be involved in host evasion through emulation 
of human α2-macroglobulin by trapping and inactivating external proteases aiding in bacterial 
defense and survival (1.4.F).   
Bacteriophage pf1 genes showed some overlap between cluster 7 and cluster 3.  
Bacteriophage Pf1 genes made up the entire cluster 7 including 6 genes, while 5 genes were 
spread into cluster 3.  As these clusters are spread fairly far apart, indicates either pockets 
within the regulon that were differentially regulated or stochastic behavior of the genes. 
Sulfur genes were found exclusively in cluster 1 making 20% of the overall cluster.   
Nitrogen was found in small numbers in significant clustering analysis.  Two genes were 
found in cluster 4 and two genes were found in cluster 6.  These clusters are spaced in different 
directions on the x and y coordinate indicating oppositely regulated genes.   
Denitrification made up 14 percent of cluster 6 for a total of 5 genes.  No overlap was 
seen with any other cluster indicating that these genes differentiated consistently.   
 




Table 4- 1:  Table for major identified pathways of transcriptomics study.  Results shows 
pathways along with their associated groups (clusters) G1 through G8, number of gene hits, 
number of genes per regulon, and percent of genes within each group.  N represents the total 
number of genes in the group along with the associated number of genes with known 
pathways.   The pathway for Iron Acquisition (non p/p/p) stands for iron acquisition genes not 
including pyoverdine, pyocyanin, or pyochelin genes.  Three pathways from the type 6 secretion 
system incorporating different groups from the Hcp Secretion Island (HSI) are represented as 
T6SS HS1-I, HS-2, and HS-3.  Biofilm formation (non pel/psl) represents biofilm genes not 





Overall, major virulence pathways were found to make up the majority of the outlier 
clusters of differentially expressed genes.  These groups included type 3 and type 6 secretion 
systems, iron uptake, sulfur metabolism, the bexR regulon, biofilm formation, Nitrogen 
metabolism, bacteriophage pf1 genes and toxins (included in the secretion systems).    
4.7  Condensin mutants show unique transcriptomic profiles 
Pathways which were identified using hierarchical statistical clustering and cluster 
analysis, were then analyzed for the individual condensin mutant profiles.  The distributions for 
the most affected pathways are visualized as violin plots with overlaying box plots in Figure 4-
10 which are referenced to in the next three sections according to each condensin mutant.  
These include pathways for the T3SS, T6SS, BexR, psl, pel, biofilm, pyoverdine, pyochelin, and 
pyocyanin.  Additional pathways include quorum sensing, two-component systems and cell 
motility pathways. A table incorporating fold change values for genes in affected pathways 
having at least one gene >1.5 fold from each mutant strain, are found in Table 4 in the 
Appendix.   
The percent of differentially expressed genes for affected pathways for either 2 fold, 1.5 
to 2 fold, or no change was plotted in Figure 4-11.  A corresponding table for the number of 
genes having fold changes of a minimum of 2 fold or between 1.5 and 2 fold is found in Table 4-
3.   Average fold changes for each path is found in Table 4-2.  On account of their size and 
diversity, virulence factors effectors and virulence regulators were analyzed by looking at their 




Together, this information is referenced in the next three sections relating to each 
condensin mutant.  Gene descriptions are derived from KEGG, Virulence factor database (VFDB) 
and PseudoCAP.  Additional information is derived from literature sources (see section 1.4.E 
and 2.10.B). Iron (non p,p,p) refers to the enterobactin, siderophore, and haemophore 
mediated iron uptake groups not including pyoverdine, pyocyanin or pyochelin.  Biofilm (not 
pel/psl) includes the biofilm pathway not including the pel and psl groups. Significant fold 






Figure 4- 10:  Gene expression distributions for major identified pathways.  Box plots and 




Table 4- 2:  Table of average fold changes for major regulons. Dark green represents 2 fold and 
greater downregulation, light green represents 1.5 to 2 fold downregulation.  Red represent 2 
fold and greater upregulation, pink represent 1.5 to 2 fold upregulation.  Types 2, 3 and 6 
secretion systems are denoted as T2SS, T3SS, and T6SS respectively.  The biofilm pathway not 
including pel or psl genes are show as biofilm (no pel/psl).  Iron (non p,p,p) represents iron 
uptake genes not including pyoverdine, pyochelin or pyocyanin.  TCS represents the two-
component regulatory system.  
 
Paths ∆smc ∆mksB  ∆∆
T3SS -8.62 1.72 1.13
T6SS HSI-1 1.75 -10.29 -4.29
T6SS HSI-2 0.93 -4.72 -1.63
T2SS -0.35 -0.42 1.03
BexR 3.39 -3.02 -1.74
Psl 1.46 -1.78 -1.17
Pel 1.74 -1.70 -0.11
Biofilm (no pel/psl) 0.33 -3.23 -0.69
C-di-GMP 0.36 -0.62 0.11
Pyochelin -0.93 -4.50 1.90
Pyoverdine 1.43 -1.79 0.04
Pyocyanin 0.01 -0.90 1.05
Iron (non p,p,p) 1.31 -0.94 0.88
Sulfur 3.08 -0.06 0.55
Bacteriophage -3.46 -9.60 -5.80
Denitrification 1.07 -0.50 0.91
Nitrogen -0.22 -0.33 0.60
Quorum sensing 0.09 -0.25 0.85
Viruence Regulators 0.22 -0.74 0.62
Simga factors 0.84 -0.37 0.95
Flagella 0.42 -0.58 1.16
Type IV Pili -0.86 0.00 0.90
Chemotaxis 0.28 -0.18 1.13
Alginate -0.39 -0.43 1.32
Fimbriae 0.75 -1.23 0.83




4.7.A  Δsmc transcriptomic profile  
Several pathways were upregulated in the Δsmc strain.  Significant upregulation was 
seen for the entire BexR regulon (Figure 4-10).  The psl and pel exo-polysaccharide pathways, 
associated with biofilm formation, showed clear distributions of upregulation even at lower fold 
change values (Figure 4-10).  The hemagglutinin gene, also associated with biofilm formation, 
was moderately upregulated by 1.8 fold.  The type 6 secretion system HSI-1 (T6SS HSI-1), 
pyoverdine, sulfur, iron (non p,p,p), denitrification, and biofilm (non pel/psl) formation groups 
showed many significant upregulated genes while the majority showed generalized upregulated 
distributions at lower fold change values (Figure 4-10), Figure 4-11). In addition, all 6 genes for 
α2-macroglobulin homolog operon involved in protease inactivation and host evasion, were 
moderately upregulated (Table 4) (see section 1.4.F for more details on the α2-macroglobulin 
homolog). 
Two pathways were found to be significantly downregulated in Δsmc, the type 3 
secretion system (T3SS) and bacteriophage pf1 genes as seen by their fold change distributions 
(Figure 4-10).   
Several sigma factors showed significantly increased expression for genes which 
regulate iron uptake including pvdS (PA2426) a regulator for pyoverdine, PA1300 for haem 
uptake, fiuI (PA0472) for ferrichrome uptake, hasI (PA3410) haem uptake, and a probable sigma 
factor for pyocin (PA4896) (Table 4).  In addition, several virulence factors were significantly 
affected.  Significantly increased expression of regulators include bexR (PA2432), which 




(PA0612) which represses T3SS.  ppyR (PA2663) was moderately increased which regulates psl 
production.  Significantly decreased expression was seen in regulators exsE (PA1711), exsD 
(PA1714), exsC (PA1710), and exsA (PA1713) which are involved in the regulation of T3SS as 
well as rsmY (PA0527.1) a regulatory RNA gene (Table 4). 
Significant upregulation was seen for the protease PA0277 and the aprA toxin gene 
found in the type 1 secretion system and the BexR regulon.  Moderate upregulation was seen in 
the major hemolysin gene PA2462, as well as the hydrolase, PA0126 (Table 4).  hisJ (PA2923), a 
histidine transport ATP-binding protein was down regulated significantly. 
The c-di-GMP pathway, also associated with biofilm formation, was only slightly 
upregulated in some genes but did not include the wsp genes (Figure 4-11, Table 4).  Slight 
reductions, with mostly no changes were seen in pyochelin and alginate and the two-
component system (TCS) (Figure 4-10, Figure 4-11)). No major effect was seen in quorum 
sensing, HCN toxins, pyocyanin, or the type 2 secretion system (T2SS) (Table 4). 
Overview of downregulated Δsmc genes: 
Type 3 secretion system (T3SS):  The entire distribution of T3SS genes in Δsmc was 
significantly downregulated with an average of -8.6 fold across the regulon (Figure 4-10) (Table 
4-2).  98% of T3SS (40/41) were significantly downregulated >2 fold (Table 4-3, Figure 4-11).  
Included in this are the toxins exoT (-11 fold), exoY (-14 fold), and exoS (-16 fold).  17 psc genes 
ranged from -2.8 to -9.6 fold change.  exsC/E/D, and exoS genes were also downregulated (-5 to 




significantly upregulated (2.1 fold) and exsA, a gene coding for a transcriptional activator of 
T3SS, was downregulated -6 fold (Table 4). 
Bacteriophage pf1:  Most bacteriophage pf1 genes were downregulated significantly 
with two genes showing moderate upregulation (between 1.5 and 2 fold), giving an average of -
3.6 fold for the regulon.  73% (11/15) of genes were downregulated >2 fold (Table 4-3) (Figure 
4-11).   
Pyochelin genes showed a slight distribution of downregulation where all genes are 
distributed below 2 fold.  The average for the regulon is -0.9 fold (Figure 4-10).   No genes were 
changed greater than 2 fold.  36% (4/11) genes were downregulated between 1.5 and 2 fold 
(Table 4-3) (Figure 4-11).   
Alginate was only slightly reduced with 14% (4/28) of genes downregulated between 
1.5 and 2 fold. The algF gene was slightly reduced by 1.7 fold (Table 4-3, Figure 4-11).   
hisJ, a gene coding for a histidine transport ATP-binding protein was downregulated 
significantly at -3.5 fold. 
Overview of upregulated Δsmc genes: 
Type 6 secretion system HSI-1 (T6SS-HSI-1):  T6SS HSI-1 genes showed a clear but 
moderate upregulation in its distribution with a pocket of genes > 2 fold and an overall regulon 
average of 1.8 fold (Figure 4-10).   16% (7/43) of genes were upregulated greater than 2 fold.  
The majority of the regulon, 65% (28/43) genes, was expressed between 1.5 and 2 fold  (Figure 




translational regulator of Hcp-HSI which acts on Fha1, a core scaffolding protein, was 
moderately upregulated (1.8 fold)  as well as fha1 (moderate 1.8 fold) (Table 4).   
BexR: The majority of the BexR regulon shows a significant distribution for upregulated 
genes in Δsmc with an average of 3.4 fold change for the entire regulon (Figure 4-10, Table 4-2).   
61% (11/18) of genes in the BexR regulon were upregulated greater than 2 fold (Figure 4-11, 
Table 4-3) For Δsmc, the bexR regulator gene itself was significantly upregulated by 9.2 fold.  
The aprA gene, encoding metalloproteinase, was upregulated by 2.3 fold.  Other distinctly 
highly regulated genes included PA1202, a probably hydrolase (9.6 fold), and a number of 
hypothetical genes affected by the BexR regulator, PA1203 (4.6 fold), PA2430 (7.3 fold), 
PA2431(5.4 fold), and PA2598 (4.3 fold) (Table 4).   
Sulfur: The sulfur uptake regulon showed significant upregulation with several genes 
above 10 fold, giving an overall average of 3.1 for the regulon (Table 4-2, Table 4-3).  37% 
(19/51) of genes were upregulated > 2 fold.  3 of these genes are in the cys operon with cysA 
being upregulated 6.0 fold and cysW being upregulated 4.4 fold.  The greatest affected genes 
included PA3442 though PA3446 which are involved in the transport of sulfonate under sulfur 
starvation.  The fold change values include the following:  PA3442 (6.2 fold), PA3443 (46.6 fold), 
PA3444 (26.7 fold), PA3445 (11.5 fold), and PA3446 (3.6 fold). 9.8% (5/53) additional genes 
were upregulated between 1.5 and 2 fold (1.4.F).  
Pyoverdine: Pyoverdine genes were mostly moderately upregulated with a pocket of 
genes showing significant upregulation >2 fold with an overall regulon average of 1.4 fold 




particularly high, pvdS, encoding a pyoverdine sigma factor, upregulated at 5.5 fold and pvdA 
upregulated at 4.8 fold.  Most genes were upregulated moderately under 2 fold (Figure 4-11).  
27% (7/26) genes were upregulated between 1.5 and 2 fold.  Uptake of ferripyoverdine in P. 
aeruginosa occurs via the FpvA receptor protein and requires the energy-transducing protein 
TonB1.  PvdS is a sigma factor which activates expression of FpvA (see section 1.4.E for details).  
Δsmc showed significant upregulation for pvdS (5.5 fold), tonB1 (2.1 fold), and fpvA (moderate 
1.8).   
Psl: The psl path showed a clear but moderate distribution of upregulation even at 
lower fold change values (Figure 4-10) with an average regulation change of 1.5 fold. 13% 
(2/15) of genes were upregulated greater than 2 fold while 47% (7/15) were upregulated 
between 1.5 and 2 fold. A single gene was downregulated between 1.5 and 2 fold.  Therefore, 
most psl genes were slightly upregulated for Δsmc.   
Pel: Pel, was mostly moderately upregulated in Δsmc with one gene above 2 fold and a 
total average of 1.7 (Figure 4-10).  14% (1/7) of genes was upregulated greater than 2 fold and 
43% (3/7) genes between 1.5 and 2 fold.   
Hemagglutinin (PA0041):  Hemagglutinin, a filamentous adhesion protein associated 
with biofilm formation and pathogenicity was also up regulated moderately by 1.8 fold (see 
section 1.4.E for details). 
Biofilm (non pel/psl):  Although most of the distribution of biofilm (non pel/psl) genes 
showed no change at zero, pockets of genes were found both moderately up and 




account of fluctuation throughout this larger regulon, the average was at 0.3 fold (Figure 4-1).  
6.6% (6/91) genes were upregulated greater than 2 fold.  These genes are the same genes also 
involved in the type 6 HSI-1  secretion system which is related to biofilm formation (Table 4).  
13% (12/91) of genes of Δsmc were upregulated between 1.5 and 2 fold (6 of these from Type 6 
SS HSI-1).  Four genes were moderately down regulated between 1.5 and 2 fold).  Δsmc 
moderately upregulated both siaA (PA0172) 1.8 fold , encoding a threonine kinase regulator,  
and siaD, 1.9 fold,  encoding a diguanylate cyclase that synthesizes c-di-GMP.  An affect was 
also seen on the cdrA/B genes encoding proteins that promote biofilm, with cdrA (PA4625) 
upregulated at 2.3 fold and cdrB (PA4624) upregulated at 2.3 fold.  
Pyocyanin: Most of the distribution for pyocyanin showed minimal change with an 
overall average of 0.01 (Figure 4-1).  A single gene, phzF2 (PA1904) was found out of 17 which 
upregulated at 2.7 fold, and a single gene, phzB2 (PA1900), was upregulated between 1.5 and 2 
fold. 
Iron not including pyoverdine, pyochelin or pyocyanin (iron non p/p/p): The iron 
pathway was distributed widely with the largest density of distribution showing genes at 1.5 
fold and higher indicated most are moderately upregulated.  The overall average of the regulon 
is 1.3 (Table 4-2).  26% (15/58) genes were significantly upregulated above 2 fold.  Most genes 
were moderately upregulated with 20% (12/58) of the genes being upregulated between 1.5 
and 2 fold.  Together, this shows that almost 50% of the genes are upregulated greater than 1.5 
fold change (Figure 4-11).  Of the 13 significant genes, three of are xenosiderophore genes, 3 
heme uptake and degradation genes and one probable iron/ascorbate oxidoreductase.  The 




(PA3268) 3.5 fold.  The heme uptake and degradation genes included hemO (heme oxygenase) 
(5.1 fold), PA4709 phuS (hemin uptake) (2.9 fold), and phuR (3.1 fold).  The iron oxido-
reducatase (PA4191) was upregulated at 4.6 fold.  Only 1 gene was significantly downregulated, 
fepD (PA4160) at -2.6 fold and 2 genes were down regulated between 1.5 and 2 fold. Iron sigma 
factors were upregulated including PA0472 (2.2 fold), and PA1300 (2.4 fold), pvdS (PA2426) at 
5.5 fold, and a factor for pyocin (PA4896) by 2.6 fold (Table 4). 
Denitrification:  The overall distribution shows upregulation of more than half of the 
genes in the regulon (Figure 4-11) although the average for the regulon was around 1 fold.   
Upregulated genes corresponded to all operons except the nar genes which showed genes with 
moderate and slight downregulation.   27% (7/26) genes were significantly upregulated greater 
than 2 fold and 31% (8/26) were moderately upregulated between 1.5 and 2 fold.  Only 4% 
(1/26) was downregulated between 1.5 and 2 fold (Table 4-3).   
a2-macro globulin homolog operon: All 6 genes for α2-macroglobulin homolog operon 
were moderately upregulated (Table 4). 
C-di-GMP: C-di-GMP genes mostly showed no change with a small number being 
upregulated.  10.5% (2/19) of genes were significantly upregulated greater than 2 fold.  These 
included PA4624 and PA4625.  10.5% (2/19) were moderately upregulated between 1.5 to 2 
fold (Figure 4-11).  These included genes PA0169 and PA0170.  Genes in the wsp operon were 
not affected here (Table 4). 
Additional affected genes included upregulation of the protease PA0277 at 2.4 fold and 




repair protein PA4172 was found to be upregulated by 2.2 fold.  The hemolysin gene (PA2462) 
was found to increase by 1.7 fold.   
Sigma factors and Virulence regulators: 
Sigma factors:  Several sigma factors were upregulated.  13% (4/31) sigma factor genes 
were significantly upregulated while 19% (6/31) were upregulated moderately between 1.5 and 
2 fold (Figure 4-11).  Significantly upregulated genes included pvdS (PA2426), a pyoverdine 
sigma factor regulator at 5.5 fold and three RNA polymerase sigma factors associated with iron 
uptake; PA1300 (2.4 fold), PA0472 (2.3 fold).  PA3410 was upregulated at 2.0 fold.    A probable 
sigma-70 factor (ECF) for pyocin, PA4896, was upregulated 2.6 fold in Δsmc (Table 4).  
Virulence Regulators:  Several virulence regulators were both up and downregulated.  
3/95 genes were significantly upregulated while 7/95 genes were moderately upregulated. 
ppkA (PA0074) was upregulated 1.8 fold. The significantly upregulated genes include bexR 
(PA2432) at 9.2 fold, and ptrB encoding a protein which represses T3SS, at 2.1 fold.  The ppyR 
gene, encoding a regulator of the psl operon, was moderately upregulated at 1.6 fold as well 
as pppA (PA0075) encoding a protein which phosphorylates FhaI and acts on pyocyanin and 
T6SS, at 1.6 fold.   4/100 genes were significantly downregulated while 1/100 genes were down 
regulated moderately.  Significantly downregulated genes include exsC (PA1710) at -4.7 fold, 
exsE (PA1711) at -5.5 fold, exsA (PA1713) at -5.9 fold, and exsD (PA1714) at -5.3 fold. rsmZ was 
downregulated by -4.6 fold rsmY was unchanged.  rsmA however, was not affected (Table 4-3, 





Notable pathways with no major effect: 
As a note, quorum sensing genes and genes in the GacA/RsmA system, and HCN genes 
(Figure 4-10) were not affected in Δsmc (see table sigma factors and regulators).  T2SS:  The 
entire regulon for T2SS was unaffected (Table 4).  In addition, cellular motility including Type IV 
pili, flagella and chemotaxis genes were not affected. 
4.7.B  ΔmksB transcriptomic profile 
ΔmksB showed marked decreases in regulation for a number of different pathways. 
Significant downregulation was seen for the entire T6SS HSI-1 and pyochelin pathways.  The 
majority of gene distribution was down regulated for the BexR, bacteriophage pf1, psl and the 
T6SS HSI-2 pathways (Figure 4-10, Figure 4-11).   
The pyoverdine (iron uptake), pel (exo-polysacharide contributing to biofilms), and 
biofilm (non pel/psl) groups showed significantly downregulated genes while the majority 
showed a generalized down regulated distribution at nearly 2 fold (Figure 4-10, Figure 4-11). 
The hemagglutinin gene, also associated with biofilm formation, was downregulated -5.7 fold.  
Iron (non p/p/p) significantly downregulated many genes while the main distribution showed 
slight downregulation less than 1.5 fold.  T2SS and c-di-GMP showed moderate downregulation 
(Figure 4-11). In addition, all 6 genes for α2-macroglobulin homolog operon involved in host 
evasion, were significantly down regulated (Table 4). 
T3SS was the only group upregulated in ΔmksB.  Many genes were upregulated 





Several toxins were reduced.  Significant downregulation was seen for the hydrogen 
cyanide genes, hcnA/B/C, the hemolysin gene, PA2462, a phospholipase gene, pldA, and a 
stress responding hydrolase, PA0126.  A protease, PA0277, was downregulated greater than 
100 fold.  
In addition, genes for a heat shock protein, dnaJ and dnaK were significantly down 
regulated. ligD, (PA2138), encoding DNA ligase, was significantly down regulated.  hisJ, a 
histidine transport ATP-binding protein was down regulated moderately. 
Denitrification showed significant up and downregulation.  Upregulated genes were 
expressed in the nos the operon.  Significantly downregulated genes were seen in the nor and 
nap operons. 
Several sigma factors and virulence regulators showed significantly decreased 
expression.  Affected genes include regulators for iron uptake, quorum sensing, T6SS, T3SS and 
virulence.  Significantly downregulated iron uptake regulators include pchR (PA4227), a 
regulator for pyochelin, and PA2384, a probable Fur, Fe2+/Zn2+ uptake regulation protein. 
Moderate downregulation was seen for pvdS (PA2426), a regulator for pyoverdine and femI 
(PA1912) involved in mycobactin/ carboxymycobactin uptake.  Decreased expression was seen 
for ppka, which regulates T6SS as well as pppa, a PpkA antagonist.  A repressor for T3SS (prtB), 
the virulence bi-stable switch regulator (bexR), and a virulence regulator (vreI) were 
significantly decreased.  The quorum sensing regulators PA1196 were significantly decreased as 




regulators affected include exsC (PA1710), a regulator for T3SS, and ppyR (PA2663), a regulator 
of psl (Table 4). 
More significant downregulated genes were seen than upregulated that affected 
metabolism.  About 35 different metabolic groups were affected.   Most of these were slight 
with 1-3 genes affected.   Groups with 4 or more genes down regulated include the biosynthesis 
of amino acids (7/143 genes), aminoacyl-tRNA biosynthesis (5/101 genes), carbon metabolism 
(6/127 genes), glycerophospholipid metabolism (4/28 genes), and arginine biosynthesis (4/29 
genes) (Table 4-3).    
Pyocyanin was significantly downregulated in some genes with most of the pathway 
showing no change. Quorum sensing didn’t show many affected genes.  Those affected 
included significant downregulation of two phenazine genes, phzF1 (PA4215) and phzD2 
(PA1902) as well as lasI (PA1432) encoding an autoinducer synthesis protein, and the previous 
mentioned QS regulators.   
The two-component regulatory system (TCS)  was moderately affected overlapping with 
pathways for chemotaxis and C4-dicarboxylate transport.  Cellular motility in general was 
largely unaffected.  Chemotaxis was largely unaffected but showed inconsistency with some 
significant genes that were both up and downregulated.  Fimbriae (related to biofilm) showed 
mostly no change in the regulon with significant downregulation of the cupB2 gene.  
Overview of downregulated ΔmksB genes: 
Type 6 secretion system (T6SS HSI-1): ΔmksB shows significant downregulation in the 




genes were significantly downregulated > 2 fold where 30 of these genes were downregulated 
greater than 5 fold. (Table 4-3).   No genes were downregulated in this regulon.  ppka (PA0074), 
encoding a T6SS regulator, was downregulated (-5.9 fold), as well as fha1 (PA0081) encoding 
the scaffolding protein required for T6SS at -2 fold.   
BexR:  The BexR regulon was significantly downregulated with the greatest distribution 
being found below the 2 fold mark (Figure 4-10).  The overall average of the regulon is -3 fold.   
39% (7/18 ) were downregulated greater than 2 fold and 17% (3/17) were downregulated 
between 1.5 and 2 fold.   The bexR regulator gene (PA2432) itself was found to be 
downregulated by -4.6 fold.  aprA, encoding the metalloprotease regulated by BexR, was 
reduced moderately at -1.5 fold.   PA1202, a probable hydrolase was reduced -14.3 fold, 
PA2483 by -11 fold and the hydrolase (PA1203) by -2.5 fold). Other genes in this regulon 
included hypothetical genes (Table 4).   
Pyochelin: ΔmksB revealed significant and consistent downregulation of all pyochelin 
genes giving an average of -4.5 for the regulon (Figure 4-10).  100% (11/11)  genes were 
downregulated below -2 fold with 5 genes being downregulated  below -4 fold in the phc 
operon (average -4.5). The fptA receptor gene for pyochelin was down regulated by -3.2 fold. 
ΔmksB is clearly downregulated for pyochelin (Table 4-3, Table 4).   
Psl:  The majority of the psl regulon was downregulated with more than half distributed 
below the 2 fold mark.  The overall average of the regulon is -1.8 fold (Figure 4-10).    60% 




downregulated between 1.5 and 2 fold.  Interestingly, a single outlier was upregulated, the psl 
regulator gene ppyR (PA2663) at 2.3.  
Pel:  Pel genes shows downregulation of genes with the greatest density just below the 
2 fold region giving an average fold change of the regulon of -1.7 (Figure 4-1).  29% (2/7) genes 
were downregulated significantly while 43% (3/7) of genes were down regulated between 1.5 
and 2 fold.   
Biofilm (non pel/psl): Although the main distributions of genes are nominal, a large 
group of genes are significantly downregulated in ΔmksB with an average of -3.2 fold for the 
entire regulon (Figure 4-1).  33% (30/91) genes were downregulated > 2 fold and 6.6% (6/91) of 
genes between 1.5 and 2 fold.  A single gene was up regulated moderately between 1.5 and 2 
fold. (Table 4-1, Figure 4-2). The significantly affected genes mostly belong to the T6SS HSI-1 
and T6SS HSI-2 secretion systems with fold change ranging from -2 to -50.  3 genes that were 
downregulated between 1.5 and 2 fold are attributed to quorum sensing.  ΔmksB 
downregulated both siaA and siaD genes with siaA (PA0172) at -3.3 fold and siaD (PA0169) at -
3.2 fold.  Downregulation was also seen on the cdrA/B genes with cdrA (PA4625) 
downregulated at -2.3 fold and cdrB (PA4624) downregulated at 2.1 fold (Table 4).     
Pyoverdine:  Pyoverdine was downregulated in ΔmksB with the greatest distribution of 
genes just below 2 fold.  The average of the regulon is -1.8 (Figure 4.10).  31% (8/26) genes 
were significantly downregulated while 27% (7/26) were downregulated moderately (1.5 to 2 
fold) 4% (1/26) were upregulated moderately (Table 4-3, Figure 4-11).  The fpvA gene was 




7 genes were downregulated between 1.5 and 2 fold and 1 was upregulated 1.5 and 2 fold.  
ΔmksB also showed downregulation for pvdS, a gene for the pyoverdine sigma factor regulator, 
(-1.9 fold), and tonB1 (-1.1 fold).   
Pyocyanin: Most of the distribution for pyocyanin showed minimal change with a couple 
of genes which were significantly downregulated giving an average of -.9 out of 17 genes total 
(Figure 4-1 (Figure 4-1).  The two significantly downregulated genes included phzD2 (PA1902) at 
-2.9 fold and phzF1 (PA4215) at --2.7 fold.   
Iron (non p/p/p). The majority of the distribution of iron (non p/p/p) genes were 
moderately downregulated with a smaller group of genes that were significantly down 
regulated around -4 fold.  The overall average for the regulon is -0.9 (Figure 4-3).  About 14% 
(8/58) genes were significantly downregulated  greater than 2 fold and about 7% (4/58) down 
regulated between 1.5 and 2 fold.  The significantly affected genes include those from 
enterobactin and siderophore mediated iron uptake.  These genes include fepG (PA4161) -2.1 
fold, tonB2(PA0197) -4.6 fold), and exbB1 (PA0198) -3.4 fold, fiuR (PA0471 fold) -2.4, and viuB 
(PA2033) -2.6 fold, and femR (PA1911) -3.4 fold. The single upregulated gene included fecA 
(PA3901) 2.0 fold.   Three additional genes were downregulated between 1.5 and 2 fold, 
including femA and two sigma factors, femI (PA1912) and PA3899 (Table 4-3, Table 4).   
Bacteriophage pf1: Bacteriophage pf1 genes were significantly downregulated with the 
greatest part of its distribution downregulated greater than 8 fold.  The average of the regulon 
is -9.6 (Figure 4-2).  73% (11/15) genes were significantly downregulated while a single gene 




hypothetical and include PA0717 through PA0720 and PA0722 which downregulated in a range 
from -8 to -15 fold.    
Quorum sensing:  A small number of genes were significantly affected in quorum 
sensing (Figure 4-2).  3/99 were significantly downregulated.  Those include, lasI which was 
downregulated at -2.6 fold, phzD2 (PA1902) at -2.9 fold, and phzF1 (PA4215) at -2.7 fold.  In 
addition to these, a regulator of RhlrI, PA1196, was downregulated by -2.4 fold.  Additional 
quorum sensing sigma factor genes that were affected included qscR (-2.9 fold) and qteE (-2.4 
fold), anti-sigma factors.  11/99 genes were moderately downregulated.  1/99 genes were 
significantly upregulated while 7/99 genes were moderately upregulated. The moderately 
affected genes were both up and downregulated.  The upregulated gene is a hypothetical 
protein, PA3320 (Table 4-3, Table 4). 
α2-macroglobulin homolog operon: All 6 genes for α2-macroglobulin homolog operon 
were significantly downregulated (Table 4). 
Type 6 secretion system HSI-2 (T6SS HSI-2): ΔmksB showed significant differentially 
expressed genes for the majority of the T6SS-HS2 system.  ΔmksB showed significant 
downregulation in this pathway with an average fold change of -4.7 (Figure 4-11).  52% (14/27) 
of genes were downregulated greater than 2 fold.  Three genes were moderately 
downregulated (1.5 to 2 fold) and zero were upregulated.  All genes in the order from PA1656 
to PA1670 were significantly affected ranging from -3.8 to -15 fold decrease in expression.     
Hydrogen cyanide genes hcnA/B/C were all significantly downregulated at -2.4, -2.6, 




The hemolysin gene PA2462 was also significantly downregulated at -5.8 fold. 
The hemagglutinin gene PA0041 was significantly downregulated at -5.7 fold. 
Additional affected genes included significant downregulation of the protease PA0277 
at -146 fold and   a key responder gene to oxidative stress PA0126 at -19 fold.   
dnaJ, a gene encoding a heat shock protein involved in bacterial translocation across 
host cells, was found to be downregulated by -2.3 fold.  dnaK, encoding another heat shock 
protein, was downregulated by -2.5 fold.  
hisJ, encoding a histidine transport ATP-binding protein was downregulated moderately 
at -1.9 fold. 
pldA (PA3487), encoding a phospholipase gene, was downregulated -2.5 fold.  Other 
phospholipases were not affected (Table 4). 
ligD (PA2138), a gene for for DNA ligase, was significantly downregulated at -3.5 fold. 
Metabolism: A large number of metabolic genes were affected> 2 fold in mksB (Table 4-
3).  Of these, about three times as many genes were downregulated as compared to 
upregulated.  These ranged across 35 different metabolic groups.  The number of genes 
affected in each metabolic group mostly ranged from 1 to 2 genes for upregulated and 1 to 3 
for downregulated genes.  Groups that showed a slight affect with 4 or more downregulated 
genes include: Biosynthesis of amino acids (7 /143 genes), aminoacyl-tRNA biosynthesis (5/101 
genes), carbon metabolism (6/127 genes), glycerophospholipid metabolism (4/28 genes), and 




Type 2 secretion system (T2SS): shows moderate downregulation (with a couple of 
significantly downregulated genes) of about 25% of the gene distribution (Figure 4-2). 
C-di-GMP: c-di-GMP shows only moderate downregulation (no significantly affected 
genes) of about 20% of the regulon.  21% (4/19) of genes were signficantly downregulated 
between >2 fold.  (Figure 4-2).  (Table 4). 
Two-component regulatory system (TCS):  TCS was moderately affected showing 
several significant up and downregulated genes.  Of the 202 genes in this regulon, 2 were 
significantly upregulated and 6 were significantly downregulation.  TCS genes overlapped with 
several other pathways.  For upregulated genes, 2 TCS genes are involved in chemotaxis.  In 
down regulated genes, two overlapped with C4-dicarboxylate transport, two with chemotaxis, 
one with biofilm and one with antibiotic resistance (PA0749).  
Overview of upregulated ΔmksB genes: 
Type 3 secretion system (T3SS): T3SS shows a clear upregulation in its distribution of 
genes with a large pocket of genes greater than 2 fold and an overall regulon average of 1.7 
fold (Figure 4-10).  24% (10/41) genes were upregulated greater than 2 fold and 42% (17/41) 
between 1.5 and 2 fold (Table 4-3).   The ptrB gene was found to be significantly downregulated 
at -2.7 fold which acts in repressing type 3 secretion.   
Notable pathways with no major effect: 
The following pathways showed mostly no change however, many had at least one significantly 




Sulfur:  Sulfur genes were mostly unaffected.  Most of the distribution of sulfur genes in 
ΔmksB is insignificantly up and downregulated with a few significantly downregulated genes 
giving an average fold change of -0.06 (Figure 4-1).  8% (4/51) genes were downregulated >2 
fold while 10% (5/51) were downregulated moderately.  13.7% (7/51) were upregulated 
moderately (Table 4-3).   
Chemotaxis: ΔmksB did not show a consistent distribution in the chemotaxis regulon.  
Both up and downregulation of genes were seen with an overall average of -0.2 fold (Figure 4-
11).   6.7% (3/45) of genes were significantly upregulated, 11% (5/45) genes were moderately 
upregulated.  Significantly upregulated genes included the pctA, PA2561, and PA4502 genes.  
Moderately upregulated genes include pctC and pctB.  4% (2/45) were significantly 
downregulated and 11% (5/45) were moderately downregulated.  Downregulated genes 
included those in the chemotaxis methyl-esterase operon.   
Type IV pili was largely unaffected in ΔmksB (Figure 4-11).  Type IV pili showed one 
significantly downregulated gene fimT (PA4549) at -2.5 fold with an overall average of 0.004.  
Two genes were moderately up and 2 genes were moderately downregulated in this regulon.   
Flagella: flagella genes were largely unaffected (Figure 4-11) 
Fimbriae: The overall distribution of cup genes involved in Fimbriae was largely 
unaffected, however cupB2 (PA4085) showed a significant downregulation at -5.5 fold.  Two 
other genes were moderately affected, cupA5 (PA2132) and cupB4 (PA4083) was moderately 
upregulated.   




Denitrification: Denitrification showed significant up and downregulation.  Upregulated 
genes were expressed in the nos operon.  Significantly downregulated genes were seen in the 
nor and nap operons.  19% (5/26) of genes were significantly upregulated while 27% (7/26) of 
genes were significantly downregulated.  
Sigma factors and Virulence regulators: 
Sigma factors:  One sigma factor gene was significantly downregulated and 6 
moderately out of 31 genes.  The significantly downregulated gene included PA0472 (-2.2 fold), 
which is involved in iron uptake. Moderately downregulated genes include algU, mucA and the 
iron uptake sigma factor, and pvdS.  No sigma factor genes were significantly upregulated.  
Two genes were moderately upregulated.   
Virulence Regulators:  most virulence regulators were down significantly 
downregulated.  13/95 genes were significantly downregulated while 11/95 genes were 
moderately downregulated.   A full list of genes affected and their fold change values are in 
Table 4-4.  Significantly downregulated genes that regulate iron uptake include, pchR and 
PA2384.  Some of the significant genes include ppka (5.9 fold) associated with T6SS, and pppA 
(-10 fold) a T6SS post translational antagonist.  Also affected included prtB (-2.4 fold) a 
repressor for T3SS, bexR (-4.6 fold), and vreI , a gene encoding a virulence regulator, at -2.5 
fold.  Quorum sensing sigma factor regulator genes affected include the quorum sensing 
repressor gene, qscR (-2.9 fold), the quorum sensing post translational repressor gene, qteE (-
2.4 fold).  Iron uptake sigma factors affected include pchR (PA4227) pyochelin regulator at -3.1 




addition, rsmZ was downregulated by -16.6 fold. rsmY was downregulated by -4.1 fold. The 
rsmA gene involved in signaling was downregulated -2.1 fold.  2/95 genes were significantly 
upregulated while 3/95 genes was upregulated moderately.  The significantly upregulated 
genes include exsC, an anti-activator of exsA which regulates T3SS at 2.0 fold and ppyR (a 
regulator of psl) at 2.3 fold. The gacA gene did not show any significant effects on ΔmksB (Table 
4).  
4.7.C  Δsmc ΔmksB transcriptomic profile 
Two pathways were found to be significantly downregulated in the delta double strain 
across the entire regulon, T6SS HSI-1 and bacteriophage pf1 genes (Figure 4-10).  The T6SS HSI-
2 and psl pathways show a large portion of the regulon downregulated with a small pocket of 
moderately upregulated genes (Figure 4-11).  In contrast to T6SS, T3SS showed moderate 
upregulation with the majority of genes being upregulated just below 1.5 fold.   Pyochelin 
showed significant upregulation for the majority of its gene distribution. The hemagglutinin 
gene, associated with biofilm formation, was downregulated -3 fold. 
Biofilm (non pel/psl), TCS and the denitrification pathways show distinct patterns of up 
and downregulation.  For biofilm, downregulated genes overlapped with the T6SS and rsmA 
(PA0905) while upregulated genes overlapped with quorum sensing genes and gacA (PA2586).  
For TCS, downregulated genes overlapped with chemotaxis (5 genes), C4-dicarboxylate 
transport (5 genes), and biofilm (3 genes) while downregulated genes overlapped with 




the nos, nar and nor operons.  Marginal downregulation of denitrification was seen in the nap 
operon.   
BexR showed moderate downregulation of roughly 30% of its genes > 1.5 fold including 
a small pocket of significantly down regulated genes (Figure 4-10).  T2SS, denitrification and 
iron (non p,p,p) showed moderate upregulation with roughly 30% of its gene distribution 
including small pockets of significant gene expression.  Quorum sensing, T2SS, and iron (non 
p,p,p), significantly upregulated several genes showing an overall moderate upregulation in its 
distribution for 20-30% of the regulons. Many quorum sensing genes were affected for the rhl, 
phenazine and pqs genes, with the majority showing moderate upregulation.  Some of the 
significantly affected genes include rhlB (PA3473) and pqsA (PA0096) and phzF2 (PA1904) 
(Table 4-3) . In addition, 5/6 genes for α2-macroglobulin homolog operon involved in host 
evasion were significantly downregulated (Table 4). 
C-di-GMP was stochastic with affected genes, showing some significantly 
downregulated genes as well as a general moderate (1.5 to 2 fold) upregulation of the regulon 
(60%).  Sulfur, pel, pyocyanin, and Type IV pili showed largely no affect with only minor 
distributions above no fold change. 
Marginal affects were seen in other groups including alginate, chemotaxis, nitrogen 
metabolism and pyoverdine.  These groups showed slight upregulation of roughly 20 percent of 
the regulon including small pockets of significant upregulation and a few down regulated genes.   
Significant downregulation was seen for the protease PA0277 (-76 fold), a responder to 




transport ATP-binding protein gene, hisJ (PA2923).  Two DNA repair genes including sbcD 
(PA4281) was significantly upregulated while ung (PA0750) was significantly downregulated. A 
probable DNA invertase gene for DNA recombination (PA3867) was also significantly 
upregulated.  Genes for Lipase A (PA2862 lipA) and Lipase B (PA3997 lipB) were both 
upregulated at just under 2 fold (Table 4).  
Several sigma factors and virulence regulators were significantly affected which are 
involved in alginate, iron uptake, quorum sensing, T6SS, T3SS, virulence as well as cell division.  
Affected sigma factors include significant upregulation of algU (PA0762) for alginate regulation, 
as well as fpvI (PA2387) a sigma factor in pyoverdine uptake, PA4896 for siderophore uptake 
and two quorum sensing regulators, mvfR (PA1003) and amiC (PA3364). 
Upregulated virulence regulators include mexR (PA0424), which negatively regulates 
multidrug efflux systems, psrA a positive transcriptional regulator gene of T3SS, mvfR (PA1003), 
a regulator gene in the quorum sensing path, tpbA (PA3885) which negatively regulates biofilm, 
mraZ (PA4421) encoding a transcriptional regulator and cell division protein, gacA (PA2586), a 
response regulator gene,  and wzz (PA3160), an o-antigen chain length regulator (Table 4-4). As 
a note, rsmA (PA0905) and the central iron regulator gene, fur (PA4764), were not changed.  
Downregulated virulence regulator genes include PA2384, an iron uptake regulator, ppkA which 
regulates T6SS, pppA an antagonist of PpkA, ptrB a negative regulator for T3SS, bexR a virulence 
bi-stable switch regulator involving the aprA toxin gene, and both rsmZ and rsmY, small RNA 




More significant upregulated genes were seen than downregulated that affected 
metabolism.  About 35 different metabolic groups were affected.   Most of these were slight 
with 1-3 genes affected (Table 4-3).   Groups with 4 or more genes upregulated include: Valine, 
leucine, isoleucine degradation (7/47 /genes), arginine and proline metabolism (6/47 genes), 
butanoate metabolism (4/41 genes), pentose phosphate pathway (6/26 genes), phenylalanine 
metabolism (6/26 genes),  Glycolysis/glucogenesis 4/35, propanoate metabolism 6/47, 
biosynthesis of amino acids 9/143, pyruvate metabolism 4/59, and carbon metabolism 11/127. 
Overview of downregulated ΔΔ genes: 
Type 6 secretion system HSI-1 (T6SS HSI-1): ΔΔ showed significant downregulation for 
nearly the entire regulon with an average of -4.3 fold (Figure 4-10).  Almost all of the genes 
were significantly downregulated. 81% (35/43) of genes were significantly upregulated greater 
than 2 fold.  9 of these genes were affected over 5 fold.  ppka was downregulated (-3.5 fold), 
however, fha1 showed no change in expression compared to WT (1.3 fold) (Table 4).   
BexR.   The bexR regulon was significantly downregulated with the majority of the 
distribution below 2 fold.  The average of the regulon was -1.7.  (Figure 4-10).  11% (2/18) of 
genes were significantly downregulated greater than 2 fold while 1 gene was downregulated 
significantly.  28% (5/18) of genes were downregulated moderately.  The bexR (PA2432) 
regulator gene was downregulated at -4.6 fold which activates both aprA (-1.0 fold) and 
hydrolase PA1202 (-10.9 fold) and other downstream genes (PA1203 at -1.9 fold).   
Psl:  ΔΔ distinctly showed significant downregulation of the majority of the regulon 




regulated, greater than 2 fold (Figure 4-1).   27% (5/15) of genes upregulated between 1.5 and 2 
fold.  The outliers were determined to be PA5452 (wbpW) at 1.9 fold, involved in 
phosphomannose isomerase/GDP-mannose, algA at 1.29 fold, and pslA  at 1.2 fc (Table 4-3).   
Type 6 secretion system HSI-2 (T6SS HSI-2): ΔΔ showed significant differentially 
expressed genes in the T6SS-HIS-2 system with downregulation seen in the majority of the 
regulon.  ΔΔ showed downregulation in this pathway with an average fold change of -1.6 (Table 
4-2).  44% (12/27) of genes were downregulated greater than 2 fold.  Two genes were 
moderately downregulated and four moderately upregulated (1.5 to 2 fold).  All genes in the 
order from PA1657 to PA1669 (except PA1667 qt -1.9 fold) were significantly affected ranging 
from -2  to -5.9 fold decrease in expression (Table 4-3).   These genes are all hypothetical.  
Bacteriophage pf1: ΔΔ was significantly downregulated for bacteriophage pf1 genes 
with average of -5.8 (Figure 4-1).  60% (9/15) of genes for ΔΔ were downregulated greater than 
2 fold.   
Additional affected genes included significant downregulation of the protease PA0277 
at -76 fold and PA0126, a key responder gene to oxidative stress at -29 fold.   
Toxins for hydrogen cyanide genes hcnA/B/C were all significantly downregulated at -14 
fold, -3 fold, and -2 fold respectively. The hemolysin gene PA2462 was also significantly 
downregulated at -5.8 fold.   
sbcD (PA0750), encoding a base excision repair protein was downregulated -2 fold.   




The hemolysin gene PA2462 was also significantly downregulated at -3 fold.   
In addition, 5/6 genes for α2-macroglobulin homolog operon were significantly down 
regulated (Table 4). 
Overview of upregulated ΔΔ genes: 
Type 3 secretion system (T3SS):  ΔΔ revealed moderate to low upregulation of T3SS 
with most of the distribution below around 1.5 fold for an average of 1.1 for the entire regulon 
(Figure 4-10). Only one gene was upregulated significantly, exoS (PA3841) at 2.5 fold.  10% 
(4/41) of genes were upregulated moderately between 1.5 and 2 fold.  These genes included 
(pscT, pcrG, pcrH, and exsB).  No genes were downregulated (Table 4-1).  ptrB was found to be 
significantly downregulated (-2.7 fold) which encodes a protein that acts in deactivating type 3 
secretion.  The psrA gene, encoding an activator of T3SS was significantly upregulated at 3.2 
fold.  
Pyochelin: ΔΔ was clearly upregulated for pyochelin genes showing most of the 
distribution of genes upregulated slight under 2 fold with an average of the regulon at 1.9 
(Figure 4-10).  27% (3/11) of genes were significantly upregulated while 55% (6/11) were 
moderately upregulated (1.5 to 2 fold).  Significantly upregulated genes include pchA (PA4231) 
at 2.0 fold and pchB (PA4230) at 3.4 genes and fptA (PA4221) at 2.7 fold (Table 4).  
Iron (non p/p/p). The overall distribution shows a slightly greater density of upregulated 
genes just below 1.5 fold.  The average of the regulon is 0.9.    9% (5/58) of genes were 
significantly upregulated while 29% (17/58) genes were moderately upregulated.  The 




2.4 fold, bfrB at 2.3 fold, and PA4156 at 2.1 fold.  Only a single gene was significantly 
downregulated and no genes were moderately down regulated.  The downregulated gene 
includes oprC at -3.2 fold (Table 4-3, Table 4).   
Lipases were upregulated in ΔΔ.  Lipase A and Lipase B were both upregulated at just 
under 2 fold (1.99 FC).  
Quorum sensing: Many quorum sensing genes were significantly upregulated including 
some for rhl, las and pqs genes.   The overall distribution shows moderate upregulation for 
almost 30 percent of genes and slight upregulation for more than 75% of genes.  %10 (10/99) 
genes were significantly upregulated while 17% (17/99) were moderately upregulated.  Some of 
the significantly upregulated genes include plcH (PA0844) at 2.9 fold, braD (PA1073) at -2.2 
fold, phzD2 (PA1902) at 3.8 fold, pqsA (PA0996) at 2.9 fold,  amiC (PA3364) at 2.6 fold, and rhlB 
(PA3473) at 2.5 fold .  rhlI was upregulated at 1.7 fold.  mvfR, a quorum sensing transcriptional 
regulator gene, was upregulated 2.0 fold. lasI and PA1196 were moderately upregulated 
showing a 1.4 fold for both genes.  mexG and mexH were moderately down regulated at -1.6 
fold and -1.9 fold respectively (Table 4). 
Fimbriae:  ΔΔ cup genes encoding fimbriae shows upregulation cupB and cupC genes 
and downregulation or no change for cupA genes.  The overall average of all cup genes was 
0.96.  21% (2/14) genes.  Significantly upregulated genes included cupC2 at 3 fold, cupB3 at 3.1 
fold. Moderately upregulated genes included cupB1,cupB4, and cupB6.  No significant 
downregulation was seen.  The two moderately down regulated genes included cupA1 and 




Chemotaxis: ΔΔ shows upregulation for some chemotaxis genes with an average of 1.1 
fold.  13% 6/45) of genes were significantly upregulated while 22% (10/45) genes were 
moderately upregulated.   No genes were significantly downregulated, and 4% (2/45 genes) 
were moderately downregulated.   
Alginate:  Alginate was upregulated for some genes showing a slight upregulation for 
the pathway at an average of 1.3 fold.  2/28 genes were upregulated significantly, 6/28 were 
upregulated moderately. Most of the regulon was unchanged.  The two significantly 
upregulated genes include algU and PA4033. No genes were significantly downregulated, and 1 
gene was moderately downregulated. 
Type 2 secretion system (T2SS): T2SS shows moderate upregulation with 9% (4/45) of 
genes were significantly upregulated and 24% (11/45) of genes were moderately upregulated.  
No genes were downregulated.  The remaining 65% are found just below 15 fold.   
Base excision repair proteins/DNA repair:  sbcD (PA4281) encoding a base excision 
repair protein/DNA repair was upregulated 2 fold.  The DNA invertase/DNA recombination gene 
PA3867 was upregulated 3 fold.  
Metabolism: A large number of metabolic genes were affected> 2 fold in ΔΔ (Table 4-3).  
Of these, about five times as many genes were upregulated as compared to downregulated.  
These ranged across 35 different metabolic groups.  Groups that showed an affect of 4 or more 
upregulated genes include: Valine, leucine, isoleucine degradation (7/47 /genes), arginine and 
proline metabolism (6/47 genes), butanoate metabolism (4/41 genes), pentose phosphate 




propanoate metabolism 6/47, biosynthesis of amino acids 9/143, pyruvate metabolism 4/59, 
and carbon metabolism 11/127. 
Pathways with distinct up and downregulation: 
Biofilm (non pel/psl):  Significant genes for biofilm are both upregulated and 
downregulated in ΔΔ.  Overall, a pattern could be found that ΔΔ was downregulated in the 
biofilm pathway related to T6SS and rsmA genes, but upregulated in terms of quorum sensing 
and gacA genes.   
The main distribution of biofilm genes in ΔΔ is seen slightly above zero.  Pockets of 
significantly up and downregulated genes are expressed with a greater distribution of 
significant genes that are downregulated (Figure 4-10).  The average of the regulon is-0.7 fold.  
23% (21/91) of genes were significantly downregulated while 4% (4/91) were moderately 
downregulated.  Of the downregulated genes greater than 2 fold in ΔΔ, 13 genes belong to T6SS 
HSI-1, 4 genes to T6SS HSI-2, and two genes to T6SS HSI-3.   
8% (7/91) of genes were significantly upregulated while 12% (11/91) of genes were 
moderately upregulated.  The six upregulated genes greater than 2 fold include the following, 
gacA involved in the regulation of biofilm, rhlB involved in quorum sensing, mvfR, encoding a 
transcriptional regulator, and two genes that are part of the HptB dependent secretion system.  
Additionally, 10 genes were upregulated for ΔΔ between 1.5 and 2 fold including 3 genes from 
the wsp operon and alg44. Two genes included pqsB and phnB associated with quorum sensing.   




siaD (PA0169) at -2.8 fold.  Downregulation was also moderately seen on the cdrA/B genes with 
cdrA (PA4625) downregulated at -1.4 fold and cdrB (PA4624) at -1.4 fold (Table 4-3, Table 4).     
Two-component regulatory system (TCS):  of the 202 genes in this regulon, 18 were 
significantly upregulated (32 moderately).  6 genes were significantly downreguled (14 
moderately).  The upregulated TCS genes overlapped with several other pathways.  For 
upregulated genes, five TCS genes are involved in C4-dicarboxylate transport, five in 
chemotaxis, three in biofilm, three as regulators and  one in iron uptake.  The six significantly 
down regulated genes were found to be exclusively apart of Cytochrome c/b genes (Table 4).     
Denitrification: Denitrification showed general upregulation which included the nos, nar 
and nor operons.  Marginal downregulation of denitrification was seen in the nap operon. 
Denitrification shows most of the distribution is upregulated with almost half being greater 
than 1.5 fold.4% One gene was significantly upregulated while 42% (11/26) of genes were 
moderately upregulated. The nos genes were significantly downregulated while three from the 
nap operon were downregulated moderately (Table 4).   
C-di-GMP: C-di-GMP genes were stochastic with affected genes, showing several 
significantly downregulated genes along with a general moderate upregulation  of the regulon.  
10.5% (2/19) of genes were significantly downregulated greater than 2 fold.  26% (5/19) were 
moderately upregulated between 1.5 to 2 fold (Figure 4-1) (Table 4). 
Notable pathways with no major effect:   




Pyoverdine:  Most genes were unchanged with a small pocket of significant genes that 
are upregulated and a single gene that was significantly downregulated.  The average of the 
regulon is 0.04 fold. 12% (3/26) of genes were upregulated significantly while 15% (4/26) were 
upregulated moderately.  Significantly upregulated genes include pvcA, pvcD and tonB1, the 
energy transducer for pyoverdine was upregulated 2.3 fold and fpvI, encoding a sigma factor for 
pyoverdine was upregulated 2.4 fold.  fpvR, encoding the anti-sigma factor was not changed. 
4% (1/26) of genes were downregulated significantly with 12% (3/26) of genes downregulated 
moderately. The significantly down regulated gene included fpvA , the pyoverdine receptor by -
3.9 fold.  pvdS was downregulated by -1.9 fold (Table 4-3) 
Pyocyanin: ΔΔ did not show significant regulation changes in the pyocyanin pathway 
(average of 1.0 fold).  Out of 17 total genes in the regulon, one gene, phzF2, was significantly 
upregulated greater than 2 fold.  One gene was moderately upregulated and one 
downregulated between 1.5 and  fold.   
Sulfur: Overall, the majority of this distribution was insignificant with the majority of its 
gene distribution above and below a fold change of 1 with an overall average of 0.6.  The one 
significant gene that was upregulated was PA2595 at 3.3 fold.  ΔΔ showed downregulation of a 
specific pocket of cys operon genes including cysA at -2.1 fold, and cysI at -3.1 fold.  An 
additional gene in the same operon which was closely regulated was cysW at -1.95 fold (Table 
4-3, Table 4). 
Type IV Pili had little affect with slight upregulation for some genes. 6/34 genes were 





Flagella:  Only 2/47 genes were affected in the flagella pathway indicating not much 
change.  2/47 genes were significantly upregulated, motA (PA4854) and PA3526.  Most genes 
had no change, and no genes were downregulated. 
Sigma factors and Virulence regulators: 
Sigma factors were slightly upregulated for some genes in ΔΔ. 3/31 genes were 
significantly upregulated, eight were upregulated moderately.  Only one gene was moderately 
down regulated.  Significantly affected upregulated genes included algU (PA0762) at 2.3 fold, 
fpvI (PA2387) at 2.4 fold, and PA4896 involved in iron uptake for pyocin at 6 fold.    
Virulence Regulators:  Significant genes were both up and downregulated in ΔΔ with 
more genes being upregulated.  8/95 genes were significantly upregulated while 17/95 genes 
were moderately upregulated.   Several genes were significantly upregulated including mexR 
(2.9 fold),  psrA (3 fold), a quorum sensing transcriptional regulator gene, mvfR (2 fold), a 
quorum sensing repressor gene, qscR (1.9 fold), and amiC (PA3364 2.6 fold).  tpbA (2 fold) 
encoding a repressor of biofilms with significantly upregulated.   mraZ (PA4421) encoding a 
transcriptional regulator and cell division protein was upregulated 2 fold and gacA at 2 fold, 
and an o-antigen chain length regulator, wzz (PA3160) at 2 fold.   
9/100 were significantly down regulated while 2/100 were moderately. Some of 
significantly down regulated genes include ppkA (-3.5 fold), ptrB (-2.7 fold), and bexR (-4.5 
fold), pppA (-3.7 fold), PA2384 (-2.2 fold) a response regulator for iron uptake, a haemolysin 




2 fold. rsmA was not changed.  A full list of genes affected and their fold change values are in 
Table 4.  
 
Figure 4- 11: Summary of affected pathways for each PAO1 condensin deletion strain.  
Affected pathways summarized in a plot as the percent of total genes in each path that are 




4.8  Comparison of relative expression levels in pathways for condensin mutant 
strains shows both an overlap and marked differences  
ΔmksB and Δsmc are oppositely regulated for biofilm (non pel/psl), psl, T3SS, T6SS HSI-I, 
the BexR regulon and α2-macroglobulin homologs.  ΔΔ expression overlaps with ΔmksB in these 
pathways while showing unique upregulation of some biofilm genes.  ΔmksB and ΔΔ expression 
levels in T3SS are overlapped and directly opposite to the expression levels of Δsmc.  Both 
ΔmksB and ΔΔ moderately increase expression levels in T3SS while Δsmc shows a marked 
reduction (Figure 4-1).  The opposite trend is seen for T6SS HSI-1, where both ΔmksB and ΔΔ 
are overlapped showing significant downregulation, while Δsmc is moderately upregulated 
(Figure 4-10). This same pattern of overlap is observed for several pathways including T6SS HSI-
2, BexR and psl (Figure 4-10, Figure 4-11).  It should be noted that the ΔΔ strain shows less 
pronounced expression level changes in these pathways when overlapped as seen in their 
averages for each regulon (Table 4-2) and general expression levels (Table 4).  This observation 
also holds when observing effector expression levels (Figure 4-12).   
Overlap between ΔmksB and ΔΔ is also seen in the biofilm pathways.  In this path, Δsmc 
shows pockets of upregulation while ΔmksB has a larger distribution of genes that are 
downregulated.  ΔΔ shows both up and downregulated genes (Figure 4-11).  The 
downregulated genes overlap with those in ΔmksB but the upregulated genes occur in a 
different set other than those affected in Δsmc.  Therefore, ΔΔ shows overlap with ΔmksB for 
down regulated biofilm genes, while having unique divergence for some upregulated biofilm 
genes.  Several toxins and genes for host evasion genes were downregulated in both ΔmksB and 




and the α2-macroglobulin homolog genes.  Δsmc showed significant upregulation for the 
PA0277 protease and PA1202 hydrolase and a moderate upregulation of hemolysin as well as 
all α2-macroglobulin homolog genes.  
ΔmksB and Δsmc are oppositely regulated for several iron uptake genes and specific 
operons in denitrification. ΔΔ shows overlap for both strains in the pyoverdine path, while 
primarily showing overlap with Δsmc in the iron (non p,p,p) and denitrification groups. In 
addition, ΔΔ uniquely shows moderate upregulation of an additional denitrification operon.  In 
the pyoverdine pathway, ΔΔ shows a combination of overlap for both ΔmksB and Δsmc.  Δsmc 
shows a clear general upregulation while ΔmksB shows significant downregulation.  In the ΔΔ 
strain, the overall result is a stochastic effect in regulation for pyoverdine pathway with no 
major shift in overall distribution (Figure 4-10). Δsmc is significantly upregulated for many genes 
in the iron (non p,p,p) path while ΔmksB shows many significantly down regulated genes.  ΔΔ 
shows overlap with Δsmc for many of the affected upregulated genes (Table 4).  Denitrification 
shows a large set of upregulated genes in Δsmc that is associated with the nor and nos gene 
operons.  ΔmskB shows downregulation of genes in the nap operon and upregulation for genes 
in the nos operon.  ΔΔ expression levels shows overlap between both ΔmksB and Δsmc with 
upregulation in the nor and nos operons and downregulation of the nap operon. In addition to 
this overlap, ΔΔ also uniquely shows moderate upregulation of genes in the nar operon.  As a 
note, ΔΔ expression levels are more moderate compared to either strain (Table 4).    
Similar regulation for all strains:  Bacteriophage pf1 genes showed similar expression 




significant downregulation. HCN toxins were reduced in all strains, although substantially more 
for ΔmksB and ΔΔ compared to Δsmc. 
All three strains show unique regulation in certain pathways.  For the sulfur pathway, 
Δsmc shows upregulation and ΔmksB shows downregulation.  ΔΔ is stochastically regulated 
with no overlap for either ΔmksB or Δsmc and is overall, marginally affected.  The ΔΔ strain 
shows a marked divergence from either single deletion for the majority of the pyochelin 
pathway which is expressed at an average of almost 2 fold while ΔmksB is markedly reduced 
and Δsmc shows no change.  Quorum sensing genes were for the most part unaffected in both 
Δsmc and ΔmksB with exceptions in some outlier genes.  ΔΔ shows a clear but moderate 
upregulation indicating ΔΔ uniquely regulates aspects of quorum sensing.  Flagella, Type IV pili, 
chemotaxis and alginate show no change in Δsmc, and nominal downregulation of some genes 
in ΔmksB.  ΔΔ shows unique upregulation of pockets of genes in these regulons.  Proteases on 
average are moderately increased in Δsmc while decreased in ΔmksB and not affected in ΔΔ 
(Figure 4-5).  Lipases show increased expression for ΔΔ but no change for the other strains 
(Figure 4-5).  Nitrogen metabolism showed clear downregulation in ΔmksB however, Δsmc and 
ΔΔ are both stochastically regulated.  For the nitrogen pathway, there is little overlap between 
the three strains (Table 4).   
Overall, Δsmc and ΔmksB revealed opposite expression trends for growth and virulence 
genes as well as the major secretion systems, T3SS and T6SS.  ΔΔ revealed overlap for ΔmksB 
for growth and secretion systems while showing overlap with Δsmc for iron uptake genes. In 
addition, Large groups of genes were uniquely expressed across all samples indicating 





Figure 4- 12:  Average fold change of virulence effectors.   
 
4.9  Many affected virulence regulators show both overlap and marked 
differences between strains 
The fold change values for affected virulence regulators and sigma factors are plotted in 
Figure 4-13.  For iron uptake regulators, Δsmc showed significant upregulation while ΔΔ showed 
generally moderate increases (except for PA2384).  ΔmksB was for the most part, 
downregulated for regulators in iron uptake (Figure 4-5).  PA4896, a sigma factor for pyocin, 
was significantly upregulated in both Δsmc and ΔΔ and moderately upregulated in ΔmksB.  
Δsmc significantly upregulated the sigma factor for pyoverdine regulation, pvdS. In contrast 
ΔmksB was significantly decreased and ΔΔ decreased slightly.  The haem uptake regulator hasI 




negligible. PA1300, encoding a haem uptake regulator gene (similar to fecI) as well as fiuI 
(PA0472), encoding a regulator for ferrichrome uptake, was significantly upregulated in Δsmc 
and marginally upregulated in ΔΔ. In contrast, ΔmksB showed no effect for PA1300 and was 
significantly decreased in fiuI (PA0472).  fpvI, encoding a sigma factor for pyoverdine, was 
significantly down regulated in ΔΔ and moderately in Δsmc.  PA2050, involved in metal uptake, 
showed a moderate increase in expression for Δsmc and a slight decrease in expression for ΔΔ.  
pchR was significantly downregulated in ΔmksB with no effect seen in Δsmc or ΔΔ (Figure 4-5).  
PA2384, a Probable Fur, Fe2+/Zn2+ uptake regulation protein gene, was significantly 
downregulated in both ΔmksB and ΔΔ.   
Overlap between ΔmksB and ΔΔ is seen for several regulators related to biofilm and the 
T6SS HSI-1 pathways which is opposite to Δsmc expression, with the exception of the ppyR 
regulator.  The siaA and siaD and cdrA and cdrB genes as well as ppkA and pppA regulators 
were downregulated in both ΔmksB and ΔΔ and upregulated in Δsmc coinciding with the 
regulatory pattern in the biofilm pathways. Interestingly, ppyR, a regulator for psl production 
and pyoverdine, was moderately upregulated in Δsmc and significantly up regulated in ΔmksB 
which is in conflict with the expression levels seen from both psl and biofilm (non pel/psl).  The 
alginate regulators, algU, and the alginate/twitching motility regulator, amrZ ,were upregulated 
in ΔΔ. However, tbpA, which encodes a protein that acts as a negative repressor of biofilms, 
was significantly upregulated in ΔΔ with no affect in the other strains (Figure 4-5). 
The bexR regulator gene (PA2432) was downregulated in both Δsmc and ΔΔ while 




including genes aprA, protease PA1202.  vreI, another virulence regulator gene, was also down 
regulated in ΔmksB however, no affect was seen in other strains.   
Regulators for T3SS showed overlapped expression levels for ΔmksB and ΔΔ which were 
opposite to Δsmc regulation. Both ΔmksB and ΔΔ showed reduced expression of several T3SS 
regulators while Δsmc showed increased expression. Both ΔmksB and ΔΔ showed significant 
decreased expression of ptrB, a repressor of the T3SS, while Δsmc was upregulated coinciding 
with the T3SS pathway being decreased in Δsmc and increased in ΔmksB and ΔΔ.  In addition, 
Δsmc showed significantly decreased expression of the exs genes involved in regulating ExsA, an 
activator for T3SS.  These genes include exsE/C/D/A.  In contrast, these genes were moderately 
upregulated for both ΔmksB and ΔΔ.   exsC was significantly upregulated in ΔmksB.  In addition, 
the gene for the psrA activator of ExsA was upregulated in ΔΔ, highlighting another manner in 
with T3SS could be switched on.  
rsmZ and rsmY were significantly down regulated for all three strains (zero for rsmY 
Δsmc). The gacA gene was significantly upregulated for ΔΔ but no affect was seen for the other 
strains.  rsmA was significantly down regulated in ΔmksB and significantly upregulated in ΔΔ 
with no change in Δsmc. Downregulation of rsmZ and rsmY does not look attributable to GacA. 
RsmA regulation, however, could be affected from a lack of sequestering by rxmZ and rsmY.   
Several quorum sensing regulators and genes were upregulated in ΔΔ.  ΔmksB showed 
marginal change and ΔΔ was largely unaffected.  In ΔmksB, the qscR and qteE repressor genes 
were significantly downregulated, including a gene for the LasI autoinducer.  ΔΔ showed 




quorum sensing repressor.  Several genes were affected including the rhlI and lasI autoinducer 
genes (Table 4-4). 
Interestingly, ΔΔ uniquely showed upregulation of the alginate regulator (algU (PA0762) 
and the alginate and twitching motility regulator, amrZ (PA3385)), a multidrug resistance 
operon repressor gene, mexR (PA0424), a gene encoding a regulator and cell division protein, 
mraZ and an O-antigen chain length regulator gene, wzz (PA3160).   
 
Figure 4- 13:  log2 fold change of virulence regulators and sigma factors. 
 
4.10  Condensin Mutant Profiles Summary 
Each condensin mutant exhibits a unique transcriptomic profile  
Analysis of the differentially expressed genes in these pathways revealed unique 
regulation for each condensin mutant (Figure 4-14).   For many of these pathways, opposite 
regulation was seen between Δsmc and ΔmksB condensin mutants .  Intriguingly, Δsmc 




ΔmksB followed patterns for acute infection (planktonic growth state with enhanced T3SS) 
(Figure 4-6).  Major pathways that were oppositely regulated included T3SS, T6SS HSI-1, BexR, 
iron uptake, biofilm formation (psl, hemagglutinin) and sulfur metabolism.    
ΔΔ showed overlap with ΔmksB that was opposite to Δsmc for many pathways related 
to growth and secretion systems including the T6SS, T3SS, bexR, biofilm formation (psl and 
hemagglutinin).  In contrast, ΔΔ overlapped with Δsmc for several iron regulation genes (iron 
sigma factors/regulators, TonB1 and siderophore mediated iron uptake).  Interestingly, ΔΔ also 
showed unique expression for several pathways and genes.   
Overall, all three strains maintained unique profiles including the ΔΔ strain which 
reflected more than just the sum of the single deletions.  The unique regulatory patterns for 
each strain was partially indicated previously with a Venn diagram depicting 2 fold overlap of 
significant genes (Figure 4-3).  This reveals that condensin regulation is more than additive and 





Figure 4- 14:  Venn diagram showing overlapping pathways and genes for PAO1 condensin 
strains. 
4.11  Regulators correlate with many pathways affected in condensin deletions 
Many regulators show relative expression levels that correlate with down stream 
pathways. Figure 4-6 maps regulators with expected down stream phenotypes as reported in 
literature along with the fold change for each mutant.   
 Both the ptrB repressor and exsA activator show correlation of expression levels with 
T3SS in all three strains as indicated (Figure  4-6).   The pchR regulator for pyochelin correlated 
with expression levels of the pyochelin regulon for ΔmksB.  pchR upregulated slighly at 1.3 fold 
for both the Δsmc and ΔΔ strains however, the expression levels for pyochelin were differed.   




several signficantly affected genes.   Therefore no correlation was seen in Δsmc and only a 
slight correlation is seen for ΔΔ. 
Pyoverdin matched well with the expression levels of pvdS and the pyoverdin regulon 
for both Δsmc as well as ΔmksB.  On account of the stochastic up and downregulation of 
pyoverdin genes in ΔΔ, pvdS only partially correlated with phenotype in ΔΔ.   
Expression of the bexR regulator (PA2432)  correlated very well with nearly all genes  in 
the BexR regulon with the highest correlation with PA1202 for all mutants.  An exception is  
seen for the aprA toxin gene which is strain dependent.  In Δsmc, expression levels of the aprA 
toxin gene  strongly correlated with the bexR, however, at a lower  magnitude (9 fold vs 2 fold).   
In ΔmksB, bexR only moderately correlated with expression of aprA whereas,  no correlation 
was seen in ΔΔ.   
RsmA pathway:  rsmZ and rsmY sequester RsmA, resulting in sessile characteristics 
including T6SS production, biofilm, and pel/psl production.  In addition, sequestering results in 
increased pyocyanin and HCN production.  In contrast, free RsmA produces planktonic 
phenotypes including T2SS, T3SS, cell motility and lipases.  rsmY and rsmZ were signficantly 
downregulated for all strains (rsmY = 0 in Δsmc). In addition rsmA was signficiantly 
downregulated in ΔmksB while unchanged in Δsmc and ΔΔ.  rsmY/Z and rsmA expression levels 
do are not correlate with phenotypes in Δsmc which shows expression patterns related to a 
sessile lifstyle, slight reductions in HCN genes and no change in pyocyanin.  rsmY and rsmZ are 
correlated with phenotypes in ΔmksB which shows reduced biofilm regulation, reduced HCN 




For the ΔΔ strain, the RsmA pathway is correlated with phenotypes related to the 
planktonic state however, it is only partially correlated with the pycyanine phenotype which is 
stochastic in ΔΔ.  
The T6SS and biofilm formation pathways are highly connected in which they share 
many genes for both pathways.  The siaA/siaD genes directly affect c-di-GMP levels which in 
turn promotes biofilm formation.  Expression levels of siaA and siaD shows a strong correlation 
to biofilm phenotype for all three strains.  This is also true for the cdrA/B genes which also 
promotes biofilm formation by activating psl production. 
ppyR, a regulator for pyoverdine and an activator of psl production (and biofilm) shows 
increased expression in ΔmksB and no change for the other strains. This regulator shows a 
negative correlation with expression levels of psl in ΔmksB strain, and no correlation with the 
other strains. 
T6SS HSI-1 is regulated by the phophorlation of the FHA domain of the Fha1 protein by 
the PpkA regulator.  Its antagonist is the PppA regulator.  For all strains, ppkA shows a strong 
correlation for T6SS expression.  pppA shows no correlation despite its high expression changes 
in all strains. 
For quorum sensing regulators in condensin deletion strains, correlation is only partial 
for phenotypes and is strain dependent.  No correlation was seen for vreI which acts on the 
LasR regulator.  In addition, no correlation was seen for qteE, encoding a repressor of LasR, as 
well as qscR, which encodes a repressor of LasR and RhlR.  Downregulation of PA1196 in ΔmksB 




correlation for the expression of xcpP/R, lasB, toxA or pyocyanin expression levels.  PA1196 
shows no correlation for the other strains. 
MvfR positively regulates a number of downstream genes including T6SS HSI-2 , aprA, 
xcpP, lasB, toxA, hcn genes (through PQS), pyocyanin (through PQS), rhlA/rhlB (through PQS and 
LasRI/RhlRI regulation), lasA, xcpR, rpoS.  In addition, it negatively regulates the T6SS HSI-1 
system.  For all strains, mvfR was only partially correlated with phenotype.  mvfR was 
upregulated by 2 fold in ΔΔ which correlated with upregulation of lasB, toxA, and xcpP and 
significant downregulation of T6SS HSI-1.  mvfR however, did not correlate with other 
downstream phenotypes.   
In Δsmc, mvfR was only moderately correlated with the expression of the aprA toxin 
gene but no other phenotypes.  Similarly, in ΔmksB, mvfR was only correlated with reduced HCN 











Figure 4- 15:  Map of pathways and regulators related to their expression levels.  A diagram 
depicting the expression levels of regulators in orange and pathways in blue.  Post translational 
regulators are marked in dark blue.  Green arrows indicate positive regulation, red negative 
regulation.  The three numbers in each box correlate to each condensin mutant.  On the left, 1, 
represents the fold change value for Δsmc, 2 represents the fold change value for ΔmksB and 3 
represents the fold change value for ΔΔ.  * indicates connected pathways. The effect of RsmA is 
conditionally based on if it is sequestered by rsmY and rsmX and is represented with dashed 
lines.   
 
Table 4- 3  Number of significant and moderately affected genes in each pathway.  Table for 
the number of genes having fold changes of a minimum of 2 fold or between 1.5 and 2 fold for 
each strain for the indicated pathways.  Pathways shown include those with at least one 





























































































































































































Type I Secretion System 1 1 0 0 0 0 2 0 0 1 0 0 5
Type 3 Secretion System 0 0 1 40 10 17 0 0 1 4 0 0 41
Type 6 secretion system HSI-1 7 28 0 0 0 0 1 41 0 0 5 35 43
Type 6 Secretion System HSI-2 0 4 0 0 0 0 3 14 0 4 2 12 27
Type 6 Secretion System HSI-3 2 6 1 0 0 0 2 11 1 3 4 2 26
Type 2 Secretion System 0 0 1 0 0 3 11 2 4 11 0 0 45
BexR Regulon 11 0 0 0 0 0 3 7 0 0 5 2 18
Psl exopolysaccharide 2 7 0 0 1 0 2 9 0 1 4 5 15
Pel exopolysaccharide 1 3 0 0 0 0 3 2 0 1 0 0 7
Biofilm formation (non pel/psl) 6 12 4 0 0 1 6 30 7 11 4 21 91
C-di-GMP signalling pathway 2 2 1 0 0 0 0 4 0 5 0 2 19
Pyochelin 0 0 4 0 0 0 0 11 3 6 0 0 11
Pyoverdine 6 7 0 0 0 1 7 8 3 4 3 1 26
Pyocyanin 1 1 1 0 0 0 1 2 1 1 1 0 17
Iron Acquisition (non p/p/p) 15 12 2 1 1 2 4 8 5 17 0 1 58
Sulfur relay system 1 1 2 1 0 3 1 0 5 7 1 0 19
Sulfur metabolism 19 5 0 0 0 4 7 4 1 5 3 2 51
Bacteriohage pf1 0 2 0 11 0 0 1 11 2 0 2 9 15
Denitrification 7 8 1 0 5 0 2 7 1 11 3 0 26
Nitrogen metabolism (no denitrification) 2 1 1 2 0 1 3 2 5 4 1 1 33
Quorum sensing 1 4 4 0 1 7 11 3 10 17 4 1 99
Virulence Factors 13 20 8 3 0 5 20 47 13 37 10 16 223
Virulence Regulators 3 7 1 4 2 3 9 14 8 17 1 8 95
Sigma Factors 4 6 0 0 0 1 6 1 3 7 1 0 31
Flagellar assembly 0 1 0 0 0 0 3 0 2 7 0 0 47
Type IV pili 0 0 2 0 0 2 2 1 0 6 1 0 34
Bacterial chemotaxis 0 2 1 1 3 5 5 2 6 10 2 0 45
Alginate 0 0 4 0 0 1 5 0 2 6 1 0 28
Fimbriae 1 1 0 0 0 0 0 2 2 3 2 0 14
Two-component system 1 14 7 3 2 17 16 6 18 32 14 6 202
α2-macroglobulin homolog synthesis 0 6 0 0 0 0 0 6 0 0 1 5 6
Lipases 0 1 0 0 0 0 3 1 0 2 0 0 7
HCN toxin 0 0 0 0 0 0 0 3 0 0 0 3 3
Haemolysins 0 1 0 0 0 0 0 1 0 0 0 1 2
Proteases 2 0 0 0 0 0 2 2 2 1 0 1 11
Toxins 1 1 0 3 0 2 2 5 1 1 0 5 13
Phospholipases 0 1 0 0 0 0 2 1 0 1 0 0 5
Phenazine biosynthesis 1 2 2 0 0 0 3 3 2 5 2 0 29
Ribosome 0 0 1 1 0 2 0 1 1 1 5 1 68
RNA degradation 0 0 0 0 0 1 1 2 1 2 1 0 15
Protein export 0 0 0 0 0 1 0 1 0 1 1 1 18
Base excision repair 1 0 0 0 0 0 0 0 1 0 0 1 13
Non-homologous end-joining 0 0 1 0 0 0 0 1 0 0 0 0 2
Adherence: LPS O-antigen 0 0 0 0 0 0 2 1 2 4 0 0 20
Rhamnolipid biosynthesis 0 0 1 0 0 0 1 0 1 0 0 0 3
	Peptidases 1 0 0 0 0 0 2 0 0 2 0 0 6
	Lipopolysaccharide biosynthesis proteins 0 0 0 0 0 0 1 0 1 0 0 0 1
	Polyketide biosynthesis proteins 0 0 1 0 0 0 0 1 0 1 0 0 1
	Transcription factors 0 0 0 0 1 2 11 3 5 20 1 0 81
	Transcription machinery 4 5 0 0 0 2 6 1 4 6 1 0 26
	Transfer RNA biogenesis 0 1 0 0 0 1 0 0 1 0 0 0 7
	Chaperones and folding catalysts 0 0 0 0 0 0 0 3 1 5 0 0 15
	Chromosome and associated proteins 0 0 0 0 0 1 1 0 1 7 0 0 28
	DNA repair and recombination proteins 0 0 0 0 0 1 0 0 1 1 0 0 7
	Exosome 0 0 1 0 0 1 0 1 0 2 0 0 5
	Antimicrobial resistance genes 0 4 1 1 0 0 4 5 7 8 2 1 49
Glycolysis / Gluconeogenesis 1 2 0 0 1 3 2 2 4 9 2 1 35
Citric acid cycle (TCA cycle) 0 3 0 0 1 3 2 1 2 5 4 0 31
Pentose phosphate pathway 1 1 1 0 1 1 2 1 6 1 1 0 26
Biosynthesis of unsaturated fatty acids 0 0 0 0 0 1 1 1 0 2 0 0 13
Biosynthesis of siderophore group nonribosomal peptides 0 0 1 0 0 0 0 6 2 4 0 0 7
Biosynthesis of secondary metabolites 5 9 10 0 5 36 18 18 24 55 19 9 336
Microbial metabolism in diverse environments 5 15 7 3 5 21 30 13 29 49 14 4 280
Biosynthesis of antibiotics 5 10 8 1 3 28 16 13 23 38 20 5 267
Carbon metabolism 0 6 3 0 2 17 7 6 11 17 8 5 127






Pentose and glucuronate interconversions 0 0 0 0 0 1 2 0 1 1 1 0 7
Galactose metabolism 0 1 0 0 0 0 1 0 1 0 1 0 5
Fatty acid biosynthesis 0 2 0 1 1 9 2 2 0 4 0 1 26
Fatty acid degradation 0 2 2 0 0 5 4 2 3 8 0 0 32
Synthesis and degradation of ketone bodies 2 1 1 0 0 2 2 1 0 2 0 0 10
Ubiquinone and other terpenoid-quinone biosynthesis 1 0 0 0 0 1 0 2 1 3 0 0 18
Oxidative phosphorylation 2 2 1 1 2 10 3 1 3 3 7 6 57
Arginine biosynthesis 0 1 1 0 0 1 0 4 2 4 1 0 29
Purine metabolism 0 0 4 0 1 7 3 2 4 9 3 0 84
Pyrimidine metabolism 0 0 4 0 0 8 2 2 1 1 1 0 45
Alanine, aspartate and glutamate metabolism 1 1 3 0 0 7 2 0 2 4 3 0 37
Glycine, serine and threonine metabolism 3 2 1 1 1 6 1 2 2 9 5 4 49
Monobactam biosynthesis 1 0 0 0 0 0 0 1 1 0 1 0 9
Cysteine and methionine metabolism 1 1 0 0 0 2 2 2 0 3 5 1 41
Valine, leucine and isoleucine degradation 3 5 1 0 1 5 9 2 7 8 1 0 47
Geraniol degradation 0 1 1 0 0 1 1 0 3 6 0 0 16
Valine, leucine and isoleucine biosynthesis 0 0 1 0 1 0 0 1 2 4 0 0 20
Lysine biosynthesis 0 0 0 0 0 0 0 2 2 0 0 0 15
Lysine degradation 0 2 1 0 0 4 3 0 0 4 1 0 19
Arginine and proline metabolism 2 1 1 2 2 1 5 3 6 5 9 0 47
Histidine metabolism 0 2 1 0 0 2 2 1 2 7 2 0 24
Tyrosine metabolism 2 1 0 0 0 1 2 3 2 9 1 0 27
Phenylalanine metabolism 1 1 0 0 1 3 1 1 6 8 1 0 26
Tryptophan metabolism 0 2 2 0 1 3 6 0 1 7 2 0 27
Phenylalanine, tyrosine and tryptophan biosynthesis 0 0 0 0 0 2 1 0 1 9 1 0 30
beta-Alanine metabolism 1 1 2 1 1 5 4 2 3 3 3 0 26
Taurine and hypotaurine metabolism 2 2 1 0 0 0 3 1 0 1 0 0 9
Phosphonate and phosphinate metabolism 0 1 1 0 1 0 2 0 1 1 0 0 10
Cyanoamino acid metabolism 0 1 3 0 0 2 1 3 0 1 0 5 11
Glutathione metabolism 0 2 1 0 1 1 2 1 2 5 2 0 26
Starch and sucrose metabolism 1 0 1 0 0 0 2 2 1 5 1 0 16
Amino sugar and nucleotide sugar metabolism 0 2 0 0 0 1 6 0 2 4 3 0 36
Streptomycin biosynthesis 0 0 0 0 0 0 0 0 1 1 0 0 8
Peptidoglycan biosynthesis 0 0 0 1 0 0 0 0 0 2 0 0 20
Glycerolipid metabolism 0 0 0 1 0 0 0 1 0 6 0 0 14
Glycerophospholipid metabolism 0 1 0 0 0 0 1 4 1 4 1 2 28
alpha-Linolenic acid metabolism 0 0 0 0 0 0 0 0 1 0 0 0 3
Sphingolipid metabolism 0 0 0 0 0 0 0 1 0 0 0 0 2
Pyruvate metabolism 1 5 1 0 2 8 7 2 4 13 2 0 59
Xylene degradation 0 0 0 2 0 0 3 0 0 0 1 0 5
Chloroalkane and chloroalkene degradation 0 0 0 0 0 0 0 1 0 1 0 0 8
Naphthalene degradation 0 0 0 0 0 0 0 1 0 0 0 0 2
Aminobenzoate degradation 0 0 1 0 1 1 4 1 1 6 0 0 15
Glyoxylate and dicarboxylate metabolism 0 3 4 1 0 7 4 0 3 11 3 3 56
Nitrotoluene degradation 0 0 0 0 0 1 1 0 1 0 0 0 2
Propanoate metabolism 1 5 1 0 1 9 7 2 6 8 1 0 47
Styrene degradation 1 1 0 0 1 0 2 1 2 5 0 0 12
Butanoate metabolism 2 1 3 0 1 5 4 2 4 8 2 0 41
C5-Branched dibasic acid metabolism 0 0 1 0 1 0 0 2 1 3 0 2 14
One carbon pool by folate 0 0 1 0 0 2 0 0 2 3 0 3 18
Methane metabolism 0 1 1 0 0 5 1 1 1 5 4 2 26
Thiamine metabolism 1 1 0 0 0 2 1 0 1 2 1 0 13
Riboflavin metabolism 2 0 0 0 0 0 0 0 1 2 0 0 11
Vitamin B6 metabolism 0 0 0 0 0 1 0 1 0 0 1 0 9
Pantothenate and CoA biosynthesis 0 0 3 0 1 3 3 1 2 3 1 0 23
Biotin metabolism 0 2 0 0 0 2 1 2 0 2 0 1 21
Folate biosynthesis 0 0 1 3 0 3 4 2 9 6 0 0 29
Porphyrin and chlorophyll metabolism 0 1 2 0 1 4 3 1 2 4 5 0 43
Aminoacyl-tRNA biosynthesis 0 2 1 3 0 0 0 5 1 3 2 4 101
Fatty acid metabolism 0 3 1 1 1 13 5 3 3 8 0 1 48
Degradation of aromatic compounds 0 0 0 2 0 0 6 2 3 3 1 0 26
Biosynthesis of amino acids 3 2 4 0 1 13 3 7 9 21 7 4 143
beta-Lactam resistance 0 1 0 3 0 0 1 3 2 2 1 0 27
Vancomycin resistance 0 1 0 0 0 1 0 1 0 0 1 0 8
Cationic antimicrobial peptide (CAMP) resistance 1 1 1 1 0 1 2 2 1 2 2 0 28




Chapter 5:  Nucleotide bias, replication and segregation in asymmetric 
chromosomes 
5.1  Introduction 
Sections 5.2, 5.4 and 5.5 of this chapter has been published in the following: Segregation 
but Not Replication of the Pseudomonas aeruginosa Chromosome Terminates at Dif.  Bijit K. 
Bhowmik, April L. Clevenger, Hang Zhao, Valentin V. Rybenkov mBio Oct 2018, 9 (5) e01088-18; 
DOI: 10.1128/mBio.01088-18. 
Deletion of the mksB condensin gene causes a large chromosomal inversion in the PAO1 
genome, significantly altering alignment of oriC, the origin of replication, and dif, the 
chromosomal dimer resolution site [4].  These markers are prominent sites related to a 
nucleotide usage bias known as GC skew. GC skew is an underlying signaling code in bacterial 
DNA where there is an abundance of guanines on the leading strand and cytosines on the 
lagging strand.  GC skew is utilized as a prediction tool for locating oriC and dif based on GC 
skew switch points (switch in abundance between guanines and cytosines).   
Typically, bacteria have symmetrical layouts where their terminus of replication and dif 
site align (Figure 5-1 A).  Segregation and replication are highly coordinated at their start sites 
indicated by the close proximity between oriC and parS, the initiation site in segregation.  This 
coordination allows greater efficiency during growth and decreases the probability of 
developing problems on account of stalled processes.    How dependent these processes are on 
each other is not exactly clear as symmetrical alignment makes it difficult to distinguish 




PAO1-UW has an asymmetric chromosome where one arm is 56% longer than the other.  
In this strain, the chromosome is longitudinally aligned between oriC and dif, where dif is 
asymmetrically aligned from the opposite of oriC [5] (Figure 5-1 B).  
Here, we used the asymmetrical PAO1-UW as a model strain for studying the 
coordination between segregation, replication and nucleotide bias.  The terminus of replication 
was determined to be directly opposite from oriC [16] (Figure 5-2).   In contrast, the terminus of 
segregation ends asymmetrically at the dif site [5].  This confirmation of markers for 
segregation and replication in an asymmetric strain allowed us to study their coordination with 
nucleotide bias.  In this chapter, we performed GC skew analysis on the asymmetric PAO1-UW 
strain, as well as on a larger scale for all sequenced bacterial chromosomes in the NCBI 
database [6], using bioinformatic analysis.   
 
Figure 5- 1:  Symmetric and asymmetric chromosomal layouts.  (A) symmetric chromosomal 




Asymmetric layout in PAO1 where dif, the chromosomal dimer resolution site, is misaligned 
relative to the opposite of oriC. 
 
Figure 5- 2:  Chromosome map of the asymmetrical PAO1-UW strain.  The map shows the 
terminus of replication directly opposite from oriC and the terminus of segregation at the 
asymmetrical dif [5]. 
5.2  GC-skew switches polarity at dif, not opposite from oriC for PAO1-UW 
GC skew analysis was first performed on the PAO1-UW strain with code generated in 
MATLAB (Figure 5-3).  GC skew was calculated as (G-C)/(G+C) where G represents the number 
of guanines and C, the number of cytosines from the positive DNA strand.   Analysis was done 
using a 1 kb sliding window.  oriC was determined as the first switch in GC skew polarity which 
initiated a positive GC skew.  The terminus of replication was determined directly opposite of 
oriC as verified experimentally using marker frequency analysis [5].  The dif site for Xer C/D 
recombination includes the sequence (GATTCGCATAATGTATATTATGTTAAAT) [220] which is 
located at 2.4 Mbp.  The results show that there is an abundance of guanines between oriC and 




strand).  GC skew switches polarity approximately 15 kb from the dif site, 682 kb away from the 
terminus of replication.  Therefore, in the asymmetrical PAO1-UW chromosome, GC switches at 
dif but not the terminus of replication.   
FtsK is a DNA translocase motor protein which brings together two dif sites guided by 
numerous KOPS (FtsK orienting polar sequences; 5′-GGGNAGGG-3′), which are distributed 
asymmetrically along both arms from oriC to dif ) [221]. KOPS sequences were therefore 
plotted for both the plus and minus strand as a comparison to GC skew.  The KOPS skew shows 
correlation and switching at the same point that GC skew switches raising the question as to 






Figure 5- 3:  GC, CGC, and KOPS skew of PAO1-UW.   (A) Distribution of dif locations in the 
bacterial genomes GC-skew (black) and CGC-skew (red), with oriC, dif, and the replication 
terminus (top) and locations of KOPS sites (bottom) in the chromosome of PAO1-UW indicated. 
5.3  KOPS sequences are independent from GC skew 
Analysis of the number of KOPS sequences on each strand showed that 153 and 34 
KOPS were on the positive and negative strands of the short chromosome arm.  On the long 
arm, 75 and 57 KOPS were found on the negative and positive strands.  Calculation of the 
contribution of excessive guanines shows that 595 guanines were contributed to the short arm 
and 1,070 to the long arms.  Total guanine excess for the short arm is 45,815 and 81,859 for the 
long arm.  KOPS sequences therefore do not significantly contribute to GC skew. 
To test if these processes are independent, we analyzed how other sequences similar to 
KOPS with varying % G and % C would contribute to the excessive GC skew.   The excess KOPS 
hits and excessive GC-skew for both the short and long chromosomal arms were calculated as 
the following (Equations 5-1, 5-2): 
                                       
Equation 5- 1  Excess KOPS hits  
Excess KOPS hits = KOPS hits (plus strand) – KOPS hits (minus strand)  
    
Equation 5- 2   Excess GC-skew 
Excess GC-skew =  
𝐸𝑥𝑐𝑒𝑠𝑠 𝐾𝑂𝑃𝑆 ℎ𝑖𝑡𝑠 ∗ (𝐾𝑂𝑃𝑆 𝐺′𝑠−𝐾𝑂𝑃𝑆 𝐶′𝑠)
𝑡𝑜𝑡𝑎𝑙 𝐺′𝑠+𝑡𝑜𝑡𝑎𝑙 𝐶′𝑠





 The KOPS sequence modified with two permutations was tested for a total of 16 queries 
along with one extra query.  The actual KOPS sequence is query 10 - GGGCAGGG.  Five controls 
were used that show the effect of excess guanines in different ways. The results for KOPS 
analysis is found in Figure 5.4. Interestingly, a modified version of KOPS, query 2 - GAGCAGGG, 
contributed the highest frequency of excess KOPS hits and overall highest percentage of 
excessive guanines.  This sequence, however, did not contain the greatest number of guanines.  
KOPS still showed a high frequency of hits and contribution to excessive guanines relative to the 
other sequences including those with a higher number of guanines in their sequence.  Overall, 
the results show that the prevalence of KOPS hits and ultimately contribution to excessive 
guanines is not based on sheer number of guanines within the KOPS sequence.  This indicates 





Figure 5- 4:  10x % excess G-C skew contribution for varying KOPS query sequences.  Plot 
shows values for both the short and long arms of the chromosome. 
  
5.4  6% of analyzed chromosomes are asymmetric 
After determining that the PAO1-UW chromosome is asymmetric for dif relative to oriC, 
we next determined the prevalence of asymmetry across all bacterial strains. In order to do 
this, we first performed a blast analysis of 8,530 complete sequenced chromosomes obtained 
from the NCBI database [6] with a consensus dif sequence 
(AATTCGCATAATGTATATTATGTTAAAT).  Approximately half (4,055) of the chromosomes were 
found to have a full dif sequence.  Next, chromosomes were filtered for having two consistent 




location for oriC was determined from the first GC skew switch point.  The terminus of 
replication was calculated directly opposite from oriC as experimentally determined in the 
PAO1 model organism [5]. 
Overall, about 6% of all chromosomes are asymmetric for dif relative to the terminus of 
replication (for more details and figures [5]). Asymmetrical chromosomes were defined as 
having a significant (5% or greater) distance between dif and the terminus of replication.  This 
range was outside of 3.3 standard deviations of a Guassian fit (99% confidence interval) (Figure 
5-5).    
 
Figure 5- 5: Prevalence of asymmetric chromosomes. Numbers of chromosomes with the 
indicated genomic separation between dif and the replication terminus.  The data were fit to a 




predicted terminus of replication were considered asymmetric resulting in 6% asymmetric 
chromosomes.  
5.5  GC skew aligns with dif, not the terminus of replication for both 
symmetrical and asymmetrical chromosomes 
Next we analyzed the overall distributions of distances between the GC skew switch 
points and dif as well as the GC skew switch points and the terminus for both symmetrical and 
asymmetrical chromosomes.  On average, dif was 13 kb away from the switch as opposed to 71 
kb for the terminus of replication[5]).  The overall results show that GC switch aligns with dif 
but not the terminus of replication (Figure 5-6).  This was found to be true in in both symmetric 
and asymmetric chromosomes. In addition, the overall distribution of distances between the 
GC-switch and dif was indistinguishable between the two types of chromosomes (Figure 5-7)  






Figure 5- 6:  Comparison of the distribution of distances of the GC-switch to dif and the 
expected terminus of replication for symmetric and asymmetric chromosomes. 
 
 
Figure 5- 7: Distribution of distances between GC-switch and dif for the percent of symmetric 









Pseudomonas aeruginosa is a major opportunistic pathogen capable of causing a variety 
of acute and chronic infections. The progression into different infection states is due in part to 
lifestyle switching.  PA is equipped with a large regulatory network geared for adapting and 
circumventing environmental stressors.  The ability to form biofilms is an intrinsic aspect for its 
survival.   
Two different families of condensins are in P. aeruginosa, MksBEF and SMC-ScpAB. 
Physiological assays revealed opposite lifestyle states for the ΔmksB and ∆smc strains where 
deletion of smc produced sessile biofilm growing cells and deletion of mksB produced 
planktonic growing cells with reduced biofilm formation [1].  Transcriptomic analysis coincided 
with physiological assays while revealing that PAO1 condensins are global regulators of gene 
expression.  These changes affected a number of different virulence and growth pathways. 
Remarkably, ΔmksB reflected expression profiles in the acute infection phase while Δsmc 
reflected those in the chronic infection phase implying a significant role of condensins in 
infection progression. 
Phenotype for the double deletion strain in physiological assays was dominated by 
ΔmksB [1].  This control over the growth state implicates MksB as a dominant factor for growth 
regulation.   Expression patterns for the double deletion strain revealed overlap for growth 
genes with ΔmksB and iron uptake genes with Δsmc.  Together, each condensin profile revealed 
hundreds of uniquely regulated genes including the double deletion strain indicating that many 




Regulation by MksB was found to be dependent on conformation through an ATPase 
mutation study.  Additional physiological assays revealed that condensin phenotype is both 
context and strain dependent.  Complementation analysis of mksB revealed an underlying 
genetic context resulting in regulatory plasticity.  Investigation of PA14 revealed strain 
dependence of condensin phenotypes implying that regulatory plasticity may contribute to 
diversity in different strains. 
Condensins are global regulators involved in infection progression: 
Transcription analysis revealed broad global regulation patterns between condensin 
deletion strains in PAO1.  For single deletion strains, ∆smc and ∆mksB, regulatory patterns for 
growth and virulence were strikingly opposite and reminiscent of acute and chronic infection 
phases.  ∆smc upregulated genes involved in biofilm formation including a number of adhesion 
genes, the BexR regulon, T6SS, and iron uptake.  Downregulated genes included the T3SS 
pathways.  This profile reflects the sessile lifestyle state and chronic infection phase. ΔmksB 
downregulated T6SS, the BexR regulon, biofilm formation, iron uptake and adhesion genes and 
upregulated T3SS reflecting planktonic growth and the acute infection phase.   
These trends correlate with the expression levels of several virulence regulators; PtrB 
and ExsA/B/C/D/E which regulate T3SS, the SiaA/D and CdrA/B genes which regulate c-di-GMP 
and biofilm, PvdS which regulates pyoverdine, BexR which regulates AprA toxin and other 
virulence factors, and PpkA which regulates T6SS. These findings implicate condensins as global 




Interestingly, the double deletion strain showed overlap with ΔmksB for genes related to 
growth including biofilm and adhesion genes as well as the Types 3 and 6 secretion systems and 
the BexR regulon including associated virulence regulators.  In this regard, the double deletion 
strain reflected planktonic growth and the acute infection phase.  Overlap with ∆smc was also 
seen for several iron uptake genes.  However, a major affected iron uptake pathway in ∆∆, 
pyochelin, did not resemble either single deletion strain. 
Overall, all three condensin mutant strains revealed hundreds of uniquely regulated 
genes.  These results show that the manner of regulation by condensins is not merely additive.  
While growth regulation was dominated by mksB, each deletion strain contributed a unique 
transcriptional profile where the delta double strain reflected more than just the sum of the 
single deletion strains.  This implies that condensins are independently integrated into the 
regulatory network with special programs.   
For all condensin mutant strains, both virulence and growth programs were significantly 
affected implying an inherent link in regulation between these regulatory pathways. A 
connection between growth and virulence pathways can allow easier conversion between 
major infection phases where alterations in growth subsequently results in major changes to 
virulence programs.  This link implicates PAO1 condensins as global regulators of infection 
progression.   
The study on ATPase point mutations illuminated aspects of how condensins control 
gene expression.  Interestingly, MksB phenotype is conformational dependent and does not 




for the ∆smc strain [1].  How these specific conformations contribute to regulation remains to 
be determined.  Regulatory effects by condensins could very well be related to their roles as 
chromosome maintainers.  One possibility is that specific conformations are necessary in 
chromosome scaffolding, which may contribute to overall chromosome structure and 
subsequent regulatory effects. 
Context dependence of condensin phenotypes reveals regulatory plasticity; a possible 
mechanism for adaptation and evolution: 
Physiological assays showed that condensin phenotype is both context and strain 
dependent.  Using the degron system and ATPase point mutations, we showed that MksB is 
linked with biofilm formation; however, significant cis effects or even secondary consequences 
of the mksB deletion prevented complementation through the reincorporation of mksB.  Cis 
effects include a number of factors including cis regulatory elements (CRE’s) (i.e. silencers and 
enhancers) and epigenetic factors (such as methyl groups, miRNA, or sRNA) which can regulate 
gene expression. Less direct factors related to chromosome structuring could also play a role in 
gene expression.  This study highlights irrevocable changes to the chromosome resulting from a 
mksB deletion, however, further studies are necessary to confirm the exact nature of how the 
chromosome has been altered.  
One possibility for secondary effects includes a recent discovery by Dr. Bijit Bhowmik, 
which showed that a mksB deletion results in a large chromosomal inversion between two 
rRNA sites 2.2 Mbp away [4].  This finding raises the possibility that chromosomal 




may play a role in holding the chromosome in a particular stable topology which prevents 
inversion.  Its removal or decrease could result in instability in maintaining this particular 
topology, resulting in inversion and irreversible alterations to the chromosome.  Subsequently, 
mksB regulation of gene expression may reside in how it maintains chromosome integrity.   
Overall, context dependence of condensin phenotypes reveals regulatory plasticity.  
mksB phenotype is dependent on more than just the association of genes to functions, it also 
resides on a genetic context.  This genetic context to condensin regulation allows additional 
diversity within the regulatory network. 
Physiological studies on PA14 revealed that condensin phenotypes are strain 
dependent.  PA14 condensin displayed markedly smaller effects on phenotype than PAO1.  
These results implicate differences in how condensins are integrated into their regulatory 
network. This study, however, is limited in that phenotypes are determined by physiological 
assays alone and does not include gene expression profiles. Further transcriptomic analysis on 
PA14 condensin mutations is needed to better illuminate their regulatory effects which may be 
diminished by additional factors.   
Regulatory plasticity could allow greater diversity across strains and species, serving as a 
possible mode for adaptation and species formation.   The PAO1 system may have incorporated 
condensins in a manner that allowed substantial regulatory benefits that contribute to disease 
progression and virulence in addition to their roles in chromosome maintenance.  Regulatory 





GC skew alignment with dif but not the terminus of replication is possibly due to integration 
during early bacterial evolution: 
An inversion in the chromosome caused by mksB illuminated a major shift of the 
chromosome dimer resolution site, dif relative to the origin of replication, oriC [4].  This 
asymmetry provided a unique opportunity to study aspects of segregation and replication which 
are otherwise indiscernible in symmetric chromosomes.  The chromosome is highly integrated 
into an inherent code known as GC skew. This code has been used as prediction markers for oriC 
and dif.   One of the prominent proposals regarding the origin of GC skew is that it is due to a 
higher incorporation of guanines in the leading strand during replication.  This proposal is 
consistent for its alignment with oriC, however, it does not explain the consistent alignment 
with dif and whether this skew is also aligned with the terminus of replication.  This study 
differentiated segregation and replication processes in an asymmetrical chromosome model to 
study their coordination along with GC skew.   
Using marker frequency analysis, replication was found to terminate opposite from oriC, 
despite asymmetry of the PAO1-UW chromosome [5].  In contrast, segregation terminated at 
the asymmetric dif [5] .  This allowed confirmation of the relative locations for both the 
terminus of replication and the terminus of segregation in asymmetric chromosome types and 
showed that they are not coordinated.   
GC skew analysis of the PAO1 model organism revealed alignment with dif but not the 
terminus of replication.  This finding showed that in the asymmetric chromosome in which 




at the terminus of segregation, rather than the expected terminus of replication.  Extending this 
study to all sequenced bacterial chromosomes also showed that dif, not the terminus of 
replication, exclusively aligns with GC skew in both symmetric and asymmetric chromosomes 
(6% of the chromosomes analyzed).     
In order to reconcile these observations for GC skew alignment on the premise that GC 
skew is generated during replication, we propose that the dif sequence likely integrated itself 
near the GC skew switch early in evolution. The XerC/D recombinase system recombines DNA at 
dif sites, helping to separate chromosome dimers.  It is possible that dif sites, found in ancient 
DNA, may have recombined with each other and were integrated at the GC switch point 
proximal to the terminus of replication early in bacterial evolution. This could explain why most 
bacterial chromosomes having a full dif sequence are symmetrically aligned for dif and the 
terminus of replication along with GC skew.  Subsequent alterations to chromosomes across 
bacterial strains during evolution would affect the orientation between oriC and dif while 
maintaining their locations at GC skew switch points.  This could account for the lack of 
alignment of GC skew observed for the terminus of replication.  Further analysis will be required 
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Table 1:  List of plasmids used in studying P. aeruginosa physiology 
Plasmids Description Source or 
reference 
General vectors   
pFLP2 ApR; Site-specific excision vector  
 
[190] 




pEXG2 GmR; Scarless deletion plasmid [194] 
pEX18Ap ApR; Deletion plasmid [190] 
pYM101 ApR; Source of lacIq gene and the T7 early 
promoter PT7(A1/04/03)  
 
[193] 
PAO1 study   
pEX-∆mksB::mksB ApR; GmR; mksB knock-in plasmid for 
mksB1 used for complementation 
This study 
pEX-mksB-D864A ApR; GmR; mksB-D864A ATPase point 
mutation plasmid 
This study 
pEX-mksB-E865Q ApR; GmR; mksB-E865Q ATPase point 
mutation plasmid 
This study 
pEX-mksB-S829R ApR; GmR; mksB-S829R ATPase point 
mutation plasmid 
This study 
pEX-mksB-Das4 ApR; GmR; ClpXP mediated degradation of 
MksB protein 
This study 
pEXG2-sspB GmR; sspB deletion plasmid [194] 
pUCP22-SspB (pSspB) ApR; SspB expression vector under araC-
ParaBAD control  
This study 
pUCP-mksB ApR; MksB-His8 expression vector under 
araC-ParaBAD control 
[27] 
PA14 study   
pEX-∆smc ApR; GmR; smc deletion plasmid [27] 





pEX-∆mksB2 ApR; GmR; mksB2 deletion plasmid for 
mksB2 in PA14 
This study 
pEX-lac-mksB2 ApR; GmR; lacIq-PT7 insertion plasmid for 
mksB2 
This study 








Table 2:   List of strains used in studying P. aeruginosa physiology.  GmR-FRT designates a 
gentamicin resistance marker flanked by two FRT sequences.  ΔGm-scar designates removal of 
GmR-FRT by flippase (Flp) recombination at the FRT sequences, leaving an FRT sequence at the 
noted locus.  
Strain Relevant genotype or description Source or 
reference 
E. coli strains   
SM10 (λ pir) thi thr leu tonA lacY supE recA::RP4-2-
Tc::Mu KmR λpir 
[190] 
DH5α supE44 DlacU169 hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
Novagen 
PAO1 strains   
PAO1 WT lacIq+ delta(lacZ)M15+ tetA+ tetR+ ATCC 47085 
PAO1 Δsmc PAO1-Lac Δsmc::∆Gm [1] 
PAO1 ΔmksB PAO1-Lac ΔmksB::∆Gm [1] 
PAO1 Δsmc ΔmksB PAO1-Lac Δsmc ΔmksB::∆Gm [1] 
PAO1 Mks’ PAO1-Lac lacIq-PT7-mksB; used for mksB 
complementation 
[1] 
PAO1 ∆mksB-P22-mksB PAO1-Lac ∆mksB + pUCP22-mksB; used for 
mksB complementation 
[1] 
PAO1 ∆mksB::mksB PAO1-Lac ∆mksB::mksB-scar; knock-in strain 
used for mksB complementation 
This study 
PAO1 mksB-E865Q PA01-Lac mksB-E865Q This study 
PAO1 mksB-S829R PA01-Lac mksB-S829R This study 





PAO1 ∆sspB PA01-Lac ∆sspB; used in the degron system This study 
PAO1 Das4 PAO1-Lac ∆sspB mksB::mksB-Das4; used in 
the degron system 
This study 
PAO1 Das4-pUCP22 PAO1-Lac-∆sspB mksB::mksB-Das4  + 
pUCP22 empty vector;  used in the degron 
system 
This study 
PAO1 Das4-PsspB PAO1-Lac ∆sspB mksB::mksB-Das4 
+pUCP22-SspB expression vector; used in 
the degron system 
This study 
PA14 strains   
PA14 WT Clinical isolate UCBPP-PA14 [172] 
PA14 lacB2 PA14-lacIq-PT7-mksBEF2 This study 
PA14 lacB2 ∆smc::GmR PA14-lacIq-PT7-mksBEF2 ∆smc::GmR-FRT This study 
PA14 lacB2 ∆smc PA14-lacIq-PT7-mksBEF ∆smc::∆Gm-scar This study 
PA14 lacB2 ∆B1::GmR PA14-lacIq-PT7-mksBEF2 ∆mksB1::GmR-FRT This study 
PA14 lacB2 ∆B1 PA14-lacIq-PT7-mksBEF2 ∆mksB1::∆Gm-scar This study 





PA14 lacB2 mksB1 ∆smc PA14-lacIq-PT7-mksBEF2 ∆mksB1 
∆smc::∆Gm-scar 
This study 
PA14 ∆B2::GmR PA14 ∆mksB2::GmR-FRT This study 
PA14 ∆B2 PA14 ∆mksB2::∆Gm-scar This study 
PA14 ∆B1::GmR PA14 ∆mksB1::GmR-FRT This study 
PA14 ∆B1 PA14 ∆mksB1::∆Gm-scar This study 
PA14 ∆smc::GmR PA14 ∆smc::GmR-FRT This study 





PA14 ∆B2 ∆B1::GmR PA14 ∆mksB2 ∆mksB1::GmR-FRT This study 
PA14 ∆B2 ∆B1 PA14 ∆mksB2 ∆mksB1::∆Gm-scar This study 
PA14 ∆B1 ∆B2::GmR PA14 ∆mksB1 ∆mksB2::GmR-FRT This study 
PA14 ∆B1 ∆B2 PA14 ∆mksB1 ∆mksB2::∆Gm-scar This study 
PA14 ∆smc ∆B2::GmR PA14 ∆smc ∆mksB2::GmR-FRT This study 
PA14 ∆smc ∆B2 PA14 ∆smc ∆mksB2::∆Gm-scar This study 
PA14 ∆smc ∆B1::GmR PA14 ∆smc ∆mksB1::GmR-FRT This study 
PA14 ∆smc ∆B1 PA14 ∆smc ∆mksB1::∆Gm-scar This study 
PA14 ∆∆∆::GmR PA14 ∆mksB1 ∆mksB2 ∆smc::GmR-FRT This study 
PA14 ∆∆∆ PA14 ∆mksB1 ∆mksB2 ∆smc::∆Gm-scar This study 
















For generating pex-ΔmksB2 left 
flank, forward primer + KpnI site, 
384 bp upstream from the mksB2 






For generating pEX-ΔmksB2 left 
flank, reverse primer + BlpI site, 5bp 






For generating pEX-ΔmksB2 right 
flank, forward primer + RsrII site, 
476 bp upstream from mksB2 stop 
codon.   
Apa4 CCGCCAAGCTTCGACGCGGCACCTTCGA
AG 
For generating pEX-ΔmksB2 right 
flank, reverse primer + HindIII site, 
546 bp downstream from mksB2 
stop codon. 
Apa5 CCGCCAAGGAATACAGTCGTCGAGC For generating pEX-ΔmksB2-ΔmksG 
right flank, forward primer + RsrII 




For generating pEX-ΔmksB2-ΔmksG 
right flank, reverse primer + HindIII 
site, 412 bp downstream from mksG 
stop codon. 
Apa7 CGATCGAGTTCGTCCGAC PCR check primer for mksB2 deletion 
located 480 bp downstream from 




For replacement of mksBEF2 
promoter with LacIq-PT7 promoter, 
forward primer + KpnI site, 783 bp 







For replacement of mksBEF2 
promoter with LacIq-PT7, reverse 
primer + SpeI and EcoRI sites, 




For replacement of mksBEF2 
promoter with LacIq-PT7, forward 
primer + SpeI and EcoRI sites, 22 bp 
upstream from mksF start codon. 
P4 CCGCC CTGCAG ATTCGCGCCTTTGGAAC For replacement of mksBEF2 
promoter with LacIq-PT7, reverse 
primer + PstI site, 939 bp 











For generating pEX-ΔmksB::mksB 
complementation plasmid left flank, 
reverse primer + BlpI site, located at 
the mksB stop codon, used to 
amplify upstream portion of mksB 








For generating pEX-ΔmksB::mksB 
complementation plasmid left flank, 
forward primer + BamHI site,  520 
bp upstream of the mksB start 
codon (used to amplify upstream 






For generating pEX-ΔmksB::mksB 
right flank, forward primer + SbfI 
site, used to amplify FRT-down 




For generating pEX-ΔmksB::mksB 
complementation plasmid right 
flank, reverse primer + HindIII site, 
used to amplify FRT-down mksB 








For generating pEX-mksB-Das4, 
forward primer + KpnI site, 528 bp 





For generating pEX-mksB-Das4, 
reverse primer + Das4 linker, located 





For generating pEX-mksB-Das4, 
reverse primer complementary to  







For generating pUCP22-sspB, 
forward primer + PacI site, located 
at the start codon of sspB gene, 








For generating pUCP22-sspB, 
reverse primer + XbaI site, located 
at the stop codon of sspB gene, 




For generating mksB ATPase point 
mutation constructs, forward 
primer + KpnI site, 866 bp upstream 






For generating mksB ATPase point 
mutation constructs, reverse primer 
+ BlpI site, located at the mksB stop 





For generating pEX-mksB-D864A, 
forward primer, 237 bp upstream of 
the mksB stop codon, contains point 







GTCCGCCGCCTCGGCCAGGTAGTAGGG For generating pEX-mksB-D864A, 
reverse primer, 237 bp upstream of 
the mksB stop codon, contains point 
mutations for D864A (GAC to GCC). 
Opa185 CCTACTACCTGGACCAGGCGGCGGACAT
C 
For generating pEX-mksB-E865Q, 
forward primer, 237 upstream of 
the mksB stop codon, contains point 
mutations for E865Q (GAG to CAG). 
Opa186 GATGTCCGCCGCCTGGTCCAGGTAGTAG
G 
For generating pEX-mksB-E865Q, 
reverse primer, 237 upstream of the 
mksB stop codon, contains point 
mutations for E865Q (GAG to CAG). 
Opa187 GACGGCGCCGCCCGCAATGGCACCACC For generating pEX-mksB-S829R, 
forward primer, 345 bp from the 
mksB stop codon, contains point 
mutations for S829R (TCC to CGC) 
Opa188 GGTGGTGCCATTGCGGGCGGCGCCGTC For generating pEX-mksB-S829R, 
reverse primer 345 bp from the 
mksB stop codon, contains point 





Table 4   Table of fold change values for PAO1 condensin mutants in affected pathways. 
(minimum 1.5 fold for any sample) 
 
T3SS T2SS
Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ
PA0044 exoenzyme T (exoT) -10.9 1.3 1.5 PA0677 putative type II secretion system protein (PA0677) 1.5 -1.4 1.7
PA2191 adenylate cyclase ExoY (exoY) -13.7 1.5 -1.0 PA0679 hypothetical protein (PA0679) -1.1 -1.6 -1.3
PA3841 exoenzyme S (exoS) -15.7 1.5 2.1 PA0681 HxcT pseudopilin (PA0681) -1.5 -1.7 1.1
PA1692 translocation protein in type III secretion (PA1692) -6.1 1.7 1.3 PA0682 putative type II secretion system protein (PA0682) -1.1 -1.7 -1.0
PA1693 type III secretion system protein (pscR) -3.8 1.9 1.4 PA0685 putative type II secretion system protein (PA0685) 1.1 -1.7 -1.2
PA1694 type III secretion system protein (pscQ) -9.6 1.9 1.1 PA0686 putative type II secretion system protein (PA0686) -1.0 -1.8 1.2
PA1695 translocation protein in type III secretion (pscP) -8.6 2.7 1.3 PA0844 hemolytic phospholipase C precursor (plcH) 1.4 -1.6 1.3
PA1696 translocation protein in type III secretion (pscO) -8.1 2.2 1.1 PA1382 type II secretion system protein (PA1382) 1.2 -1.3 2.0
PA1697 type III secretion system ATPase (PA1697) -11.6 1.9 1.1 PA1871 LasA protease precursor (lasA) -1.1 -1.6 1.2
PA1698 Type III secretion outer membrane protein PopN precursor (popN) -19.5 1.6 -1.1 PA1948 membrane protein component of ABC ribose transporter (rbsC) 1.3 -2.4 2.4
PA1699 hypothetical protein (PA1699) -8.0 2.2 1.3 PA2671 hypothetical protein (PA2671) -1.1 1.2 2.0
PA1700 hypothetical protein (PA1700) -8.0 2.6 1.0 PA2672 type II secretion system protein (PA2672) -1.3 -2.3 -1.1
PA1701 hypothetical protein (PA1701) -18.5 2.1 1.1 PA2673 type II secretion system protein (PA2673) -1.2 -1.8 1.6
PA1702 hypothetical protein (PA1702) -5.0 2.0 1.2 PA2674 type II secretion system protein (PA2674) -1.3 1.5 1.2
PA1703 type III secretory apparatus protein PcrD (pcrD) -9.1 1.4 1.1 PA2675 type II secretion system protein (PA2675) 1.1 1.0 1.8
PA1704 transcriptional regulator protein PcrR (pcrR) -4.1 2.1 1.3 PA2676 type II secretion system protein (PA2676) 1.2 -2.0 1.6
PA1705 regulator in type III secretion (pcrG) -11.8 1.8 1.7 PA2862 lactonizing lipase precursor (lipA) -1.3 1.1 1.9
PA1706 type III secretion protein PcrV (pcrV) -13.7 1.6 1.4 PA3096 general secretion pathway protein L (xcpY) -1.2 1.1 1.6
PA1707 regulatory protein PcrH (pcrH) -17.5 1.6 1.7 PA3098 general secretion pathway protein J (xcpW) -1.8 1.1 1.6
PA1708 translocator protein PopB (popB) -15.4 1.5 1.5 PA3100 general secretion pathway outer membrane protein H precursor (xcpU) -1.0 1.7 1.7
PA1709 translocator outer membrane protein PopD precursor (popD) -12.2 1.6 1.5 PA3102 general secretion pathway protein F (xcpS) -1.1 -1.0 1.6
PA1710 ExsC (exsC) -4.7 2.0 1.5 PA3104 secretion protein XcpP (xcpP) -1.1 1.6 2.0
PA1711 ExsE (exsE) -5.5 1.9 1.4 PA3296 alkaline phosphatase (phoA) -1.2 -1.7 1.4
PA1712 exoenzyme S synthesis protein B (exsB) -5.0 1.6 1.7 PA3319 non-hemolytic phospholipase C precursor (plcN) 1.0 1.1 1.6
PA1713 transcriptional regulator ExsA (exsA) -5.9 1.2 1.4 PA3724 elastase LasB (lasB) 1.0 1.4 3.2
PA1714 ExsD (exsD) -5.3 1.4 1.3 PA4813 lipase LipC (lipC) -1.3 -2.0 1.3
PA1715 type III export apparatus protein (pscB) -8.5 1.3 1.2
PA1716 Type III secretion outer membrane protein PscC precursor (pscC) -5.5 1.3 1.4 T6SS HSI-2
PA1717 type III export protein PscD (pscD) -5.1 1.3 1.4 PA1653 transcriptional regulator (PA1653) 1.1 1.2 1.6
PA1718 type III export protein PscE (pscE) -5.9 2.1 1.2 PA1655 putative glutathione S-transferase (PA1655) 1.2 -1.1 1.6
PA1719 type III export protein PscF (pscF) -6.5 1.6 1.3 PA1656 hypothetical protein (PA1656) 1.1 -6.6 -1.5
PA1720 type III export protein PscG (pscG) -11.6 2.0 1.4 PA1657 hypothetical protein (PA1657) 1.4 -10.5 -5.4
PA1721 type III export protein PscH (pscH) -5.6 1.5 1.2 PA1658 hypothetical protein (PA1658) 1.4 -10.3 -4.3
PA1722 type III export protein PscI (pscI) -7.0 1.6 1.5 PA1659 hypothetical protein (PA1659) 1.1 -9.0 -2.6
PA1723 type III export protein PscJ (pscJ) -7.1 1.4 1.4 PA1660 hypothetical protein (PA1660) 1.1 -5.2 -2.0
PA1724 type III export protein PscK (pscK) -5.6 1.4 1.2 PA1661 hypothetical protein (PA1661) 1.1 -6.0 -4.1
PA1725 type III secretion system protein (pscL) -4.8 1.3 -1.1 PA1662 ClpA/B-type protease (PA1662) 1.4 -5.3 -3.0
PA2191 adenylate cyclase ExoY (exoY) -13.7 1.5 -1.0 PA1663 putative transcriptional regulator (PA1663) 1.3 -9.6 -5.9
PA3217 hypothetical protein (cyaB) -1.5 1.0 -1.1 PA1665 hypothetical protein (PA1665) 1.2 -15.0 -5.0
PA3841 exoenzyme S (exoS) -15.7 1.5 2.1 PA1666 hypothetical protein (PA1666) 1.4 -8.8 -3.3
PA3842 chaperone (PA3842) -15.5 2.5 1.4 PA1667 hypothetical protein (PA1667) 1.4 -3.9 -1.9
PA1668 hypothetical protein (PA1668) 1.5 -9.3 -3.4
T6SS HSI-1 PA1669 hypothetical protein (PA1669) 1.3 -5.6 -4.0
PA0070 hypothetical protein (PA0070) 2.0 -10.7 -5.4 PA1670 serine/threonine phosphoprotein phosphatase Stp1 (stp1) 1.7 -6.4 -2.7
PA0071 hypothetical protein (PA0071) 1.6 -2.8 -1.8 PA1671 serine-threonine kinase Stk1 (stk1) 1.6 -2.0 -1.0
PA0072 hypothetical protein (PA0072) 2.0 -6.0 -3.3 PA1672 hypothetical protein (PA1672) 1.7 1.1 1.6
PA0073 ABC transporter ATP-binding protein (PA0073) 1.7 -12.6 -4.5 PA1673 hypothetical protein (PA1673) -1.1 -1.4 -1.6
PA0074 serine/threonine protein kinase PpkA (ppkA) 1.8 -5.9 -3.5 PA1675 hypothetical protein (PA1675) 1.2 -1.5 1.3
PA0075 PppA (pppA) 1.6 -10.3 -3.7 PA1676 hypothetical protein (PA1676) -1.4 -1.8 1.2
PA0076 hypothetical protein (PA0076) 1.7 -7.5 -2.7 PA1677 hypothetical protein (PA1677) 1.1 -1.0 1.7
PA0077 IcmF1 (icmF1) 2.2 -7.9 -3.2
PA0078 hypothetical protein (PA0078) 2.0 -7.6 -3.7 BexR
PA0079 hypothetical protein (PA0079) 1.7 -6.1 -2.7 PA0572 hypothetical protein (PA0572) 2.4 -1.3 1.2
PA0080 hypothetical protein (PA0080) 1.5 -13.6 -2.8 PA1202 putative hydrolase (PA1202) 9.7 -14.3 -10.8
PA0081 Fha1 (fha1) 1.8 -2.0 1.3 PA1203 hypothetical protein (PA1203) 4.9 -2.5 -1.9
PA0082 hypothetical protein (PA0082) 2.2 -12.0 -2.9 PA1204 hypothetical protein (PA1204) 3.7 -1.7 -1.2
PA0083 hypothetical protein (PA0083) 2.3 -25.6 -9.8 PA1205 hypothetical protein (PA1205) 3.5 -2.1 -1.3
PA0084 hypothetical protein (PA0084) 2.3 -27.4 -9.0 PA1249 alkaline metalloproteinase precursor (aprA) 2.3 -1.5 1.1
PA0085 Hcp1 (hcp1) 2.0 -50.3 -18.9 PA2430 hypothetical protein (PA2430) 7.3 -2.5 -1.2
PA0086 hypothetical protein (PA0086) 2.0 -6.9 -4.6 PA2431 hypothetical protein (PA2431) 5.5 -2.5 -1.7
PA0087 hypothetical protein (PA0087) 1.7 -35.1 -4.9 PA2432 bistable expression regulator BexR 9.2 -4.6 -4.6
PA0088 hypothetical protein (PA0088) 2.0 -19.1 -7.3 PA2433 hypothetical protein (PA2433) 4.6 -11.3 -1.1
PA0089 hypothetical protein (PA0089) 1.9 -18.4 -10.1 PA2698 putative hydrolase (PA2698) 4.3 -1.7 -1.9
PA0090 ClpV1 (clpV1) 2.1 -17.4 -8.8 PA4205 hypothetical protein (mexG) 1.2 -1.3 -1.6
PA0091 VgrG1 (vgrG1) 1.8 -12.2 -7.2 PA4206 RND efflux membrane fusion protein precursor (mexH) 1.1 -1.4 -1.9
PA0092 hypothetical protein (PA0092) 1.4 -3.5 -3.4
PA0093 hypothetical protein (PA0093) 1.7 -5.5 -3.6 a2-Macroglobulin Homologue
PA0094 hypothetical protein (PA0094) 1.8 -6.2 -4.5 PA4487 hypothetical protein (PA4487) 1.6 -4.3 -3.7
PA0095 hypothetical protein (PA0095) 1.7 -4.0 -2.4 PA4488 hypothetical protein (PA4488) 1.5 -5.1 -2.9
PA0096 hypothetical protein (PA0096) 1.9 -4.2 -3.0 PA4489 hypothetical protein (PA4489) 1.7 -6.6 -4.5
PA0097 hypothetical protein (PA0097) 1.5 -14.1 -4.3 PA4490 hypothetical protein (PA4490) 1.6 -5.0 -4.0
PA0098 3-oxoacyl-(acyl carrier protein) synthase (PA0098) 1.7 -8.0 -2.8 PA4491 hypothetical protein (PA4491) 1.6 -5.5 -4.4
PA0099 hypothetical protein (PA0099) 1.8 -6.2 -1.6 PA4492 hypothetical protein (PA4492) 1.7 -2.4 -1.7
PA0100 hypothetical protein (PA0100) 1.5 -2.9 -1.8
PA0101 hypothetical protein (PA0101) 1.5 -3.2 -2.2
PA1844 hypothetical protein (PA1844) 1.5 -9.7 -6.0 Pyocyanin
PA1845 hypothetical protein (PA1845) 1.2 -8.0 -4.3 PA1900 phenazine biosynthesis protein (phzB2) 1.7 -1.7 1.4
PA2684 hypothetical protein (PA2684) 1.7 -5.3 -2.7 PA1902 phenazine biosynthesis protein PhzD (phzD2) -1.4 -2.9 -1.9
PA2685 hypothetical protein (PA2685) 1.8 -3.6 -1.5 PA1904 phenazine biosynthesis protein (phzF2) 2.7 1.5 3.8
PA2702 hypothetical protein (PA2702) 1.5 -4.1 -3.2 PA4212 phenazine biosynthesis protein PhzC (phzC1) 1.0 1.2 1.8
PA2774 hypothetical protein (PA2774) 1.6 -4.6 -3.9 PA4215 phenazine biosynthesis protein (phzF1) -1.4 -2.7 1.3
PA2775 hypothetical protein (PA2775) 1.6 -4.8 -2.0 PA4217 hypothetical protein (phzS) -1.5 -1.0 1.3
PA3484 hypothetical protein (PA3484) 1.8 -7.3 -3.4
PA3485 hypothetical protein (PA3485) 1.3 -7.7 -2.9








Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ Locus Tag General Description and Gene Name
PA2232 phosphomannose isomerase/GDP-mannose pyrophosphorylase (pslB)1.56 -1.86 -1.38 PA0715 hypothetical protein (PA0715) 1.8 1.4 3.3
PA2233 glycosyl transferase (pslC) 1.56 -1.60 -1.06 PA0716 hypothetical protein (PA0716) 1.9 -1.1 2.7
PA2234 PslD (pslD) 2.09 -2.24 -1.73 PA0717 hypothetical protein (PA0717) -7.1 -29.4 -14.4
PA2235 hypothetical protein (pslE) 2.12 -2.16 -2.22 PA0718 hypothetical protein (PA0718) -6.6 -28.8 -8.3
PA2236 hypothetical protein (pslF) 1.98 -2.57 -1.89 PA0719 hypothetical protein (PA0719) -4.0 -13.0 -8.0
PA2237 putative glycosyl hydrolase (pslG) 1.94 -2.46 -1.85 PA0720 helix destabilizing protein of bacteriophage Pf1 (PA0720) -7.8 -16.6 -13.6
PA2238 hypothetical protein (pslH) 1.88 -2.05 -2.27 PA0722 hypothetical protein (PA0722) -5.7 -10.7 -16.2
PA2239 putative transferase (pslI) 1.44 -2.65 -2.00 PA0723 coat protein B of bacteriophage Pf1) (coaB) -7.1 -14.7 -14.4
PA2240 hypothetical protein (pslJ) 1.57 -2.46 -1.85 PA0724 putative coat protein A of bacteriophage Pf1 (PA0724) -3.4 -5.4 -3.2
PA2241 hypothetical protein (pslK) 1.46 -2.23 -2.47 PA0725 bacteriophage protein (PA0725) -2.1 -3.1 -2.3
PA2242 hypothetical protein (pslL) 1.68 -2.62 -2.20 PA0726 hypothetical protein (PA0726) -2.1 -4.6 -1.8
PA2663 psl and pyoverdine operon regulator, PpyR 1.15 2.26 -1.07 PA0727 hypothetical protein (PA0727) -2.9 -3.4 -2.3
PA5452 phosphomannose isomerase/GDP-mannose WbpW (wbpW) 1.15 -1.29 1.90 PA0728 bacteriophage integrase (PA0728) -2.2 -3.2 -1.6
PA0729 hypothetical protein (PA0729) -1.2 -1.6 -1.2
Pel
PA3058 PelG (pelG) 1.16 -1.06 1.55
PA3059 PelF (pelF) 1.45 -1.74 1.17 Pyoverdine
PA3060 PelE (pelE) 1.75 1.13 1.33 PA2254 pyoverdine biosynthesis protein PvcA (pvcA) -1.2 1.5 1.8
PA3061 PelD (pelD) 1.89 -2.51 -1.47 PA2256 pyoverdine biosynthesis protein PvcC (pvcC) -1.0 -1.6 1.0
PA3062 PelC (pelC) 1.79 -4.30 -1.05 PA2257 pyoverdine biosynthesis protein PvcD (pvcD) 1.5 -1.3 2.2
PA3063 PelB (pelB) 2.62 -1.64 -1.16 PA2385 3-oxo-C12-homoserine lactone acylase PvdQ (pvdQ) 2.1 -3.4 -1.5
PA3064 PelA (pelA) 1.50 -1.78 -1.10 PA2386 L-ornithine N5-oxygenase (pvdA) 4.8 -2.4 -2.0
PA2387 FpvI (fpvI) 1.6 -1.3 2.4
Biofilm (no Pel/Psl) PA2392 PvdP (pvdP) 1.6 -1.9 -1.5
PA0074 serine/threonine protein kinase PpkA (ppkA) 1.84 -5.92 -3.52 PA2393 putative dipeptidase precursor (PA2393) 1.8 -1.4 1.2
PA0075 PppA (pppA) 1.61 -10.27 -3.69 PA2394 PvdN (pvdN) 1.4 -2.0 -1.3
PA0076 hypothetical protein (PA0076) 1.74 -7.54 -2.71 PA2395 PvdO (pvdO) 2.9 -1.6 1.6
PA0077 IcmF1 (icmF1) 2.17 -7.94 -3.20 PA2396 pyoverdine synthetase F (pvdF) 1.6 -1.7 -1.0
PA0079 hypothetical protein (PA0079) 1.68 -6.07 -2.66 PA2397 pyoverdine biosynthesis protein PvdE (pvdE) -1.0 -1.8 1.6
PA0081 Fha1 (fha1) 1.81 -2.03 1.29 PA2398 ferripyoverdine receptor (fpvA) 1.8 -5.1 -3.9
PA0082 hypothetical protein (PA0082) 2.19 -11.99 -2.86 PA2399 pyoverdine synthetase D (pvdD) 1.4 -2.2 -1.1
PA0083 hypothetical protein (PA0083) 2.33 -25.57 -9.76 PA2400 probable non-ribosomal peptide synthetase (pvdJ) 1.2 -2.6 -1.4
PA0084 hypothetical protein (PA0084) 2.30 -27.39 -8.96 PA2402 peptide synthase (PA2402) 1.6 -2.2 -1.1
PA0085 Hcp1 (hcp1) 2.02 -50.33 -18.88 PA2413 diaminobutyrate--2-oxoglutarate aminotransferase (pvdH) 3.3 -2.6 1.1
PA0089 hypothetical protein (PA0089) 1.87 -18.40 -10.05 PA2424 peptide synthase (pvdL) 1.5 -2.2 -1.5
PA0090 ClpV1 (clpV1) 2.10 -17.43 -8.76 PA2426 extracytoplasmic-function sigma-70 factor (pvdS) 5.5 -1.9 -1.9
PA0169 hypothetical protein (PA0169) 1.68 -3.19 -2.79 PA4168 second ferric pyoverdine receptor FpvB (fpvB) -1.1 -1.3 1.8
PA0172 hypothetical protein (PA0172) 1.76 -3.28 -2.24 PA5531 transporter TonB 2.1 -1.1 2.3
PA0263 secreted protein Hcp (hcpC) 1.89 1.45 -1.03
PA0649 anthranilate synthase component II (trpG) 1.10 -1.21 1.59
PA0905 carbon storage regulator (rsmA) 1.26 -2.06 1.22 Pyochelin
PA0996 coenzyme A ligase (pqsA) -1.07 1.30 2.87 PA4221 Fe(III)-pyochelin outer membrane receptor precursor (fptA) -1.12 -3.25 2.67
PA0997 beta-keto-acyl-acyl-carrier protein synthase-like protein (pqsB) -1.48 1.06 1.59 PA4222 ABC transporter ATP-binding protein (PA4222) -1.63 -2.97 1.52
PA1000 quinolone signal response protein (pqsE) -1.56 -1.58 -1.02 PA4223 ABC transporter ATP-binding protein (PA4223) -1.51 -3.04 1.45
PA1001 anthranilate synthase component I (phnA) 1.11 -1.58 -1.62 PA4224 pyochelin biosynthetic protein PchG (pchG) -1.98 -7.80 1.51
PA1002 anthranilate synthase component II (phnB) 1.33 -1.16 1.72 PA4225 pyochelin synthetase (pchF) -1.27 -5.39 1.75
PA1003 Transcriptional regulator MvfR (mvfR) 1.50 -1.45 2.04 PA4226 dihydroaeruginoic acid synthetase (pchE) -1.24 -4.35 1.66
PA1432 autoinducer synthesis protein LasI (lasI) 1.07 -2.64 1.43 PA4227 transcriptional regulator PchR (pchR) 1.32 -3.13 1.32
PA1657 hypothetical protein (PA1657) 1.41 -10.51 -5.38 PA4228 pyochelin biosynthesis protein PchD (pchD) -1.24 -6.73 1.78
PA1658 hypothetical protein (PA1658) 1.43 -10.33 -4.31 PA4229 pyochelin biosynthetic protein PchC (pchC) -1.60 -7.33 1.77
PA1661 hypothetical protein (PA1661) 1.06 -6.04 -4.11 PA4230 isochorismate-pyruvate lyase (pchB) -1.03 -2.66 3.35
PA1662 ClpA/B-type protease (PA1662) 1.40 -5.30 -3.03 PA4231 salicylate biosynthesis isochorismate synthase (pchA) 1.04 -2.85 2.06
PA1667 hypothetical protein (PA1667) 1.40 -3.89 -1.88
PA1669 hypothetical protein (PA1669) 1.34 -5.63 -3.96
PA1670 serine/threonine phosphoprotein phosphatase Stp1 (stp1) 1.71 -6.44 -2.70 Denitrification
PA1976 sensor histidine kinase 1.07 -1.58 -1.03 PA0516 heme d1 biosynthesis protein NirF (nirF) 1.5 1.1 1.3
PA2360 hypothetical protein (PA2360) 1.25 -3.84 -1.14 PA0518 cytochrome c-551 precursor (nirM) 1.6 1.4 1.0
PA2361 hypothetical protein (PA2361) 1.41 -1.81 1.12 PA0520 regulatory protein NirQ (nirQ) 1.8 -1.5 1.5
PA2363 hypothetical protein (PA2363) 1.11 -2.26 -1.18 PA0521 putative cytochrome c oxidase subunit (PA0521) 1.5 -2.1 1.1
PA2365 hypothetical protein (PA2365) 1.71 -2.75 -1.89 PA0522 hypothetical protein (PA0522) 1.7 -2.7 1.5
PA2366 uricase PuuD (PA2366) 1.65 -2.13 -1.64 PA0523 nitric-oxide reductase subunit C (norC) 1.6 -1.4 1.8
PA2367 hypothetical protein (PA2367) 1.20 -3.69 -4.05 PA0524 nitric-oxide reductase subunit B (norB) 1.9 -1.5 1.7
PA2370 hypothetical protein (PA2370) 1.13 -3.43 -2.10 PA0525 putative dinitrification protein NorD (PA0525) 2.2 -1.1 1.6
PA2371 putative ClpA/B-type protease (PA2371) 1.07 -3.07 1.81 PA1172 cytochrome c-type protein NapC (napC) 2.2 -2.5 1.0
PA2569 hypothetical protein (PA2569) -1.10 -1.23 2.03 PA1173 cytochrome c-type protein NapB precursor (napB) 1.6 -2.3 -1.9
PA2586 response regulator GacA (gacA) -1.02 1.30 2.04 PA1174 nitrate reductase catalytic subunit (napA) 1.1 -1.8 -1.0
PA2824 sensor/response regulator hybrid (PA2824) -1.12 1.09 1.64 PA1175 NapD protein of periplasmic nitrate reductase (napD) 1.3 -2.3 -1.1
PA3217 hypothetical protein (cyaB) -1.52 1.04 -1.10 PA1176 ferredoxin protein NapF (napF) -1.2 -2.2 -1.9
PA3345 hypothetical protein (PA3345) -1.36 1.12 1.95 PA1177 periplasmic nitrate reductase protein NapE (napE) 1.1 -2.6 -1.6
PA3346 putative two-component response regulator (PA3346) -1.20 1.06 2.00 PA3392 nitrous-oxide reductase (nosZ) 2.5 3.0 1.8
PA3347 hypothetical protein (PA3347) -1.01 1.73 3.17 PA3393 NosD protein (nosD) 2.5 2.5 2.2
PA3476 autoinducer synthesis protein RhlI (rhlI) 1.25 -1.30 1.71 PA3394 NosF protein (nosF) 2.0 2.4 1.6
PA3478 rhamnosyltransferase chain B (rhlB) -1.13 -1.10 2.48 PA3395 NosY protein (nosY) 2.2 2.2 1.7
PA3479 rhamnosyltransferase chain A (rhlA) -1.68 -1.59 -1.36 PA3396 NosL protein (nosL) 2.4 2.6 1.3
PA3542 alginate biosynthesis protein Alg44 (alg44) 1.13 1.04 1.51 PA3872 respiratory nitrate reductase gamma chain (narI) -1.1 -1.3 1.6
PA3703 chemotaxis-specific methylesterase (wspF) -1.03 1.42 1.88 PA3873 respiratory nitrate reductase delta chain (narJ) -1.2 -1.2 1.8
PA3704 putative chemotaxis sensor/effector fusion protein (wspE) -1.57 1.28 1.32 PA3874 respiratory nitrate reductase beta chain (narH) -1.4 -1.3 1.8
PA3707 hypothetical protein (wspB) -1.17 1.23 1.79 PA3875 respiratory nitrate reductase alpha chain (narG) -1.7 -1.5 2.0
PA3708 putative chemotaxis transducer (wspA) -1.17 1.06 1.82






Sigma Factors Iron (no p,p,p)
Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ
PA0472 RNA polymerase sigma factor (PA0472) 2.3 -2.2 1.6 PA0197 transporter TonB 1.7 -4.6 1.3
PA0762 RNA polymerase sigma factor AlgU (algU) 1.0 -1.7 2.3 PA0198 transport protein ExbB (exbB1) 1.4 -3.4 1.8
PA0763 anti-sigma factor MucA (mucA) -1.0 -1.7 1.3 PA0434 hypothetical protein (PA0434) 2.5 1.2 1.3
PA1300 ECF subfamily RNA polymerase sigma-70 factor (PA1300) 2.4 1.1 1.5 PA0470 Ferrichrome receptor FiuA (fiuA) 1.0 -1.2 1.6
PA1351 ECF subfamily RNA polymerase sigma-70 factor (PA1351) 1.6 -1.2 1.6 PA0471 putative transmembrane sensor (PA0471) 1.9 -2.4 -1.1
PA1363 ECF subfamily RNA polymerase sigma-70 factor (PA1363) 1.6 -1.5 1.3 PA0472 RNA polymerase sigma factor (PA0472) 2.3 -2.2 1.6
PA1912 ECF sigma factor, FemI 1.5 -1.8 -1.0 PA0672 heme oxygenase (hemO) 5.2 -2.5 -1.1
PA2050 RNA polymerase sigma factor (PA2050) 1.5 -1.3 -1.4 PA0929 two-component response regulator (PA0929) 7.1 -1.5 3.0
PA2093 RNA polymerase sigma factor (PA2093) 1.5 -1.7 1.4 PA0931 outer membrane receptor FepA (pirA) 1.7 -1.3 -1.1
PA2387 FpvI (fpvI) 1.6 -1.3 2.4 PA1300 ECF subfamily RNA polymerase sigma-70 factor (PA1300) 2.4 1.1 1.5
PA2426 extracytoplasmic-function sigma-70 factor (pvdS) 5.5 -1.9 -1.9 PA1302 putative heme utilization protein precursor (PA1302) 1.7 -1.0 1.3
PA2467 Anti-sigma factor FoxR (foxR) 1.4 -1.1 1.6 PA1322 putative TonB-dependent receptor (PA1322) 1.1 -1.6 1.1
PA2896 RNA polymerase sigma factor (PA2896) 1.4 -1.0 1.6 PA1363 ECF subfamily RNA polymerase sigma-70 factor (PA1363) 1.6 -1.5 1.3
PA3410 ECF subfamily RNA polymerase sigma-70 factor (PA3410) 2.0 1.1 1.8 PA1910 ferric-mycobactin receptor, FemA -1.0 -1.7 1.2
PA3899 RNA polymerase sigma factor (PA3899) 1.3 -1.8 1.6 PA1912 ECF sigma factor, FemI 1.5 -1.8 -1.0
PA4896 RNA polymerase sigma factor (PA4896) 2.6 1.6 4.0 PA1922 putative TonB-dependent receptor (PA1922) -1.3 -1.3 1.7
PA2033 hypothetical protein (PA2033) -1.3 -2.6 1.1
PA2034 hypothetical protein (PA2034) -1.1 -1.2 1.6
Virulence Regulators PA2050 RNA polymerase sigma factor (PA2050) 1.5 -1.3 -1.4
PA0074 serine/threonine protein kinase PpkA (ppkA) 1.8 -5.9 -3.5 PA2335 TonB-dependent receptor (PA2335) 1.8 1.2 1.5
PA0075 PppA (pppA) 1.6 -10.3 -3.7 PA2384 hypothetical protein (PA2384) 1.3 -5.8 -2.2
PA0169 hypothetical protein (PA0169) 1.7 -3.2 -2.8 PA2466 Ferrioxamine receptor FoxA (foxA) 1.7 -1.4 1.8
PA0172 hypothetical protein (PA0172) 1.8 -3.3 -2.2 PA2467 Anti-sigma factor FoxR (foxR) 1.4 -1.1 1.6
PA0424 multidrug resistance operon repressor MexR (mexR) 1.1 -1.2 2.9 PA2686 two-component response regulator PfeR (pfeR) 1.4 1.6 1.4
PA0527.1 regulatory RNA RsmY 0.0 -4.1 -2.5 PA3268 TonB-dependent receptor (PA3268) 3.5 -1.1 1.6
PA0610 transcriptional regulator PrtN (prtN) 1.4 -1.6 -1.2 PA3269 putative transcriptional regulator (PA3269) -1.0 1.2 1.9
PA0611 transcriptional regulator PrtR (prtR) 1.5 -1.2 -1.0 PA3407 heme acquisition protein HasAp (hasAp) -1.6 -1.3 -1.2
PA0612 repressor, PtrB ' (ptrB) 2.1 -2.4 -2.7 PA3408 heme uptake outer membrane receptor HasR precursor (hasR) -1.1 1.2 1.7
PA0707 transcriptional regulator ToxR (toxR) -1.0 -1.9 1.8 PA3410 ECF subfamily RNA polymerase sigma-70 factor (PA3410) 2.0 1.1 1.8
PA0763 anti-sigma factor MucA (mucA) -1.0 -1.7 1.3 PA3530 hypothetical protein (PA3530) 1.5 -1.0 1.7
PA0764 negative regulator for alginate biosynthesis MucB (mucB) 1.1 -1.9 1.2 PA3531 bacterioferritin (bfrB) -1.3 1.3 2.3
PA0905 carbon storage regulator (rsmA) 1.3 -2.1 1.2 PA3899 RNA polymerase sigma factor (PA3899) 1.3 -1.8 1.6
PA0929 two-component response regulator (PA0929) 7.1 -1.5 3.0 PA3901 Fe(III) dicitrate transport protein FecA (fecA) 1.4 2.0 1.2
PA1003 Transcriptional regulator MvfR (mvfR) 1.5 -1.5 2.0 PA4156 TonB-dependent receptor (PA4156) 2.0 -1.1 2.1
PA1196 putative transcriptional regulator (PA1196) -1.3 -2.4 1.3 PA4160 ferric enterobactin transport protein FepD (fepD) -2.6 -1.3 1.1
PA1431 regulatory protein RsaL (rsaL) 1.4 -1.5 1.3 PA4161 ferric enterobactin transport protein FepG (fepG) -1.1 -2.1 1.0
PA1432 autoinducer synthesis protein LasI (lasI) 1.1 -2.6 1.4 PA4191 iron/ascorbate oxidoreductase (PA4191) 4.4 -1.1 -1.2
PA1710 ExsC (exsC) -4.7 2.0 1.5 PA4514 outer membrane receptor for iron transport (PA4514) 5.5 -1.2 1.7
PA1711 ExsE (exsE) -5.5 1.9 1.4 PA4675 putative TonB-dependent receptor (PA4675) 2.3 -1.3 -1.4
PA1713 transcriptional regulator ExsA (exsA) -5.9 1.2 1.4 PA4708 Heme-transport protein, PhuT ' (phuT) 1.7 -1.4 -1.0
PA1714 ExsD (exsD) -5.3 1.4 1.3 PA4709 putative hemin degrading factor (PA4709) 2.9 -1.4 1.3
PA1799 two-component response regulator, ParR 1.1 -1.2 -1.5 PA4710 heme/hemeoglobin uptake outer membrane receptor PhuR precursor (phuR)3.2 -1.3 1.2
PA1898 putative transcriptional regulator (qscR) 1.5 -2.9 1.9 PA4837 outer membrane protein precursor (PA4837) -1.5 -1.3 1.7
PA2259 transcriptional regulator PtxS (ptxS) 1.4 -1.5 1.9 PA4896 RNA polymerase sigma factor (PA4896) 2.6 1.6 4.0
PA2384 hypothetical protein (PA2384) 1.3 -5.8 -2.2 PA5217 putative binding protein component of ABC iron transporter (PA5217) 2.4 -1.2 1.4
PA2432 bistable expression regulator BexR 9.2 -4.6 -4.6 PA5531 transporter TonB 2.1 -1.1 2.3
PA2463 hypothetical protein (PA2463) 1.6 -3.1 -2.9
PA2467 Anti-sigma factor FoxR (foxR) 1.4 -1.1 1.6
PA2492 transcriptional regulator MexT (mexT) -1.1 1.2 1.8 Sulfur
PA2523 putative two-component response regulator (PA2523) -1.0 -1.1 1.8 PA0184 ABC transporter ATP-binding protein (PA0184) -1.2 -1.8 1.1
PA2586 response regulator GacA (gacA) -1.0 1.3 2.0 PA0186 binding protein component of ABC transporter (PA0186) -1.0 -1.2 1.6
PA2591 transcriptional regulator (PA2591) 1.4 -1.4 1.5 PA0193 hypothetical protein (PA0193) 2.0 1.1 1.3
PA2593 quorum threshold expression protein QteE 1.3 -2.4 1.0 PA0280 sulfate transport protein CysA (cysA) 6.0 1.2 -2.1
PA2663 psl and pyoverdine operon regulator, PpyR 1.2 2.3 -1.1 PA0281 sulfate transport protein CysW (cysW) 4.5 1.1 -2.0
PA2686 two-component response regulator PfeR (pfeR) 1.4 1.6 1.4 PA0282 sulfate transport protein CysT (cysT) 2.9 -1.1 -1.9
PA3006 transcriptional regulator PsrA (psrA) -1.0 -1.8 3.2 PA0283 sulfate-binding protein precursor (sbp) 2.5 1.2 -1.5
PA3269 putative transcriptional regulator (PA3269) -1.0 1.2 1.9 PA0518 cytochrome c-551 precursor (nirM) 1.6 1.4 1.0
PA3364 aliphatic amidase expression-regulating protein (amiC) -1.1 1.1 2.6 PA0589 thiosulfate sulfurtransferase (glpE) 1.1 1.0 1.8
PA3385 alginate and motility regulator Z (amrZ) -1.4 1.9 1.8 PA1393 adenosine 5'-phosphosulfate (APS) kinase (cysC) 1.1 -1.9 1.3
PA3476 autoinducer synthesis protein RhlI (rhlI) 1.2 -1.3 1.7 PA1838 sulfite reductase (cysI) 1.4 1.3 -3.0
PA3542 alginate biosynthesis protein Alg44 (alg44) 1.1 1.0 1.5 PA2104 cysteine synthase (PA2104) 1.3 -2.1 1.1
PA3621.1 regulatory RNA RsmZ -4.6 -16.6 -2.5 PA2105 acetyltransferase (PA2105) 1.2 -1.7 1.3
PA3649 hypothetical protein (PA3649) 1.0 1.2 1.6 PA2310 hypothetical protein (PA2310) 2.2 -1.6 1.3
PA3708 putative chemotaxis transducer (wspA) -1.2 1.1 1.8 PA2357 NADH-dependent FMN reductase MsuE (msuE) 2.3 1.3 -1.3
PA3879 transcriptional regulator NarL (narL) -1.5 -1.0 1.7 PA2595 hypothetical protein (PA2595) 1.6 -1.1 3.3
PA3885 protein tyrosine phosphatase TpbA -1.2 1.0 2.0 PA2596 hypothetical protein (PA2596) 2.4 -1.1 1.3
PA3947 RocR (rocR) 1.0 1.1 1.7 PA2598 hypothetical protein (PA2598) 3.0 -1.3 1.1
PA4080 putative response regulator (PA4080) -1.0 -1.0 1.9 PA2600 hypothetical protein (PA2600) 2.1 1.6 1.4
PA4196 protein BfiR -1.2 -1.5 1.3 PA3107 O-succinylhomoserine sulfhydrylase (metZ) -1.3 1.7 1.1
PA4227 transcriptional regulator PchR (pchR) 1.3 -3.1 1.3 PA3442 aliphatic sulfonates transport ATP-binding subunit (ssuB) 6.2 -1.2 1.4
PA4421 cell division protein MraZ (PA4421) 1.1 1.1 2.0 PA3443 ABC transporter permease (PA3443) 46.6 1.5 1.1
PA5346 hypothetical protein (PA5346) 1.0 1.1 1.8 PA3444 alkanesulfonate monooxygenase (PA3444) 26.7 -2.1 1.2
PA5483 two-component response regulator AlgB (algB) -1.1 -1.7 1.2 PA3445 hypothetical protein (PA3445) 11.5 -2.2 -1.2
PA3446 NAD(P)H-dependent FMN reductase (PA3446) 3.6 1.2 1.3
PA3447 ABC transporter ATP-binding protein (PA3447) -1.1 -1.6 1.6
C-di-GMP PA3448 ABC transporter permease (PA3448) 3.1 1.9 1.8
PA0169 hypothetical protein (PA0169) 1.7 -3.2 -2.8 PA3449 hypothetical protein (PA3449) 2.1 1.1 -1.1
PA0172 hypothetical protein (PA0172) 1.8 -3.3 -2.2 PA3935 taurine dioxygenase (tauD) 3.4 -1.1 1.0
PA2870 hypothetical protein (PA2870) -1.3 -1.1 1.5 PA3936 taurine ABC transporter permease (PA3936) 2.4 -1.8 1.4
PA3343 hypothetical protein (PA3343) -1.3 -1.0 1.5 PA3937 taurine ABC transporter ATP-binding protein (PA3937) 3.9 -2.1 1.3
PA3703 chemotaxis-specific methylesterase (wspF) -1.0 1.4 1.9 PA3938 periplasmic taurine-binding protein precursor (PA3938) 2.0 -1.5 1.2
PA3704 putative chemotaxis sensor/effector fusion protein (wspE) -1.6 1.3 1.3 PA3954 hypothetical protein (PA3954) 1.0 1.4 1.8
PA3707 hypothetical protein (wspB) -1.2 1.2 1.8 PA4442 cysN 1.3 1.5 -1.7
PA3708 putative chemotaxis transducer (wspA) -1.2 1.1 1.8 PA4513 oxidoreductase (PA4513) 1.9 -1.3 1.1
PA4624 hypothetical protein (PA4624) 2.3 -2.1 -1.4





Nitrogen (no detnitrification) Quorum Sensing
Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ
PA1566 hypothetical protein (PA1566) 1.8 1.4 1.9 PA0222 hypothetical protein (PA0222) -1.1 -1.3 1.6
PA1779 assimilatory nitrate reductase (PA1779) -1.4 -1.5 1.2 PA0295 periplasmic polyamine binding protein (PA0295) -1.3 1.7 -1.3
PA1780 assimilatory nitrite reductase small subunit (nirD) 2.2 1.4 1.4 PA0603 ABC transporter ATP-binding protein (PA0603) 1.9 1.7 1.2
PA1783 nitrate transporter (nasA) 3.8 1.7 4.5 PA0604 putative binding protein component of ABC transporter (PA0604) 2.0 1.9 1.4
PA1786 hypothetical protein (PA1786) 1.5 -1.3 2.1 PA0605 ABC transporter permease (PA0605) 1.8 1.5 1.5
PA2040 glutamine synthetase (PA2040) 1.3 -1.0 -1.6 PA0606 ABC transporter permease (PA0606) 1.5 2.0 1.5
PA2442 glycine cleavage system protein T2 (gcvT2) 1.2 1.3 -2.7 PA0649 anthranilate synthase component II (trpG) 1.1 -1.2 1.6
PA3459 glutamine amidotransferase (PA3459) -1.3 -1.8 1.4 PA0844 hemolytic phospholipase C precursor (plcH) 1.4 -1.6 1.3
PA3876 nitrite extrusion protein 2 (narK2) -3.2 -1.8 1.5 PA0996 coenzyme A ligase (pqsA) -1.1 1.3 2.9
PA3877 nitrite extrusion protein 1 (narK1) -4.5 -2.1 1.2 PA0997 beta-keto-acyl-acyl-carrier protein synthase-like protein (pqsB) -1.5 1.1 1.6
PA4588 glutamate dehydrogenase (gdhA) -1.2 -1.2 1.7 PA1000 quinolone signal response protein (pqsE) -1.6 -1.6 -1.0
PA4920 NAD synthetase (nadE) -1.0 -1.5 2.9 PA1001 anthranilate synthase component I (phnA) 1.1 -1.6 -1.6
PA5035 glutamate synthase subunit beta (gltD) -1.6 1.0 1.7 PA1002 anthranilate synthase component II (phnB) 1.3 -1.2 1.7
PA5036 glutamate synthase subunit alpha (gltB) -1.1 1.1 2.4 PA1003 Transcriptional regulator MvfR (mvfR) 1.5 -1.5 2.0
PA5119 glutamine synthetase (glnA) -1.3 1.5 2.0 PA1071 branched-chain amino acid transport protein BraF 1.4 1.0 1.6
PA5173 carbamate kinase (arcC) -1.4 -4.6 1.1 PA1073 branched-chain amino acid transport protein BraD (braD) 1.3 -1.6 1.4
PA1303 signal peptidase (PA1303) 1.2 1.0 -2.2
PA1431 regulatory protein RsaL (rsaL) 1.4 -1.5 1.3
Alginate PA1432 autoinducer synthesis protein LasI (lasI) 1.1 -2.6 1.4
PA0762 RNA polymerase sigma factor AlgU (algU) 1.0 -1.7 2.3 PA1871 LasA protease precursor (lasA) -1.1 -1.6 1.2
PA0763 anti-sigma factor MucA (mucA) -1.0 -1.7 1.3 PA1874 hypothetical protein (PA1874) 1.1 -1.8 1.2
PA0764 negative regulator for alginate biosynthesis MucB (mucB) 1.1 -1.9 1.2 PA1900 phenazine biosynthesis protein (phzB2) 1.7 -1.7 1.4
PA0766 serine protease MucD precursor (mucD) 1.0 1.0 -1.7 PA1902 phenazine biosynthesis protein PhzD (phzD2) -1.4 -2.9 -1.9
PA3385 alginate and motility regulator Z (amrZ) -1.4 1.9 1.8 PA1904 phenazine biosynthesis protein (phzF2) 2.7 1.5 3.8
PA3541 alginate biosynthesis protein Alg8 (alg8) -1.7 -1.3 1.2 PA2569 hypothetical protein (PA2569) -1.1 -1.2 2.0
PA3542 alginate biosynthesis protein Alg44 (alg44) 1.1 1.0 1.5 PA2843 aldolase (PA2843) -1.1 1.5 1.1
PA3545 alginate-c5-mannuronan-epimerase AlgG (algG) -1.0 -1.1 1.8 PA3250 hypothetical protein (PA3250) -1.1 1.2 1.8
PA3546 alginate biosynthesis protein AlgX (algX) -1.5 -1.3 1.3 PA3252 ABC transporter permease (PA3252) 1.2 -1.2 1.6
PA3547 poly(beta-D-mannuronate) lyase (algL) 1.1 -1.1 1.6 PA3253 ABC transporter permease (PA3253) -2.0 -1.8 1.1
PA3548 alginate o-acetyltransferase AlgI (algI) -1.7 -1.2 1.6 PA3254 ABC transporter ATP-binding protein (PA3254) -1.2 1.4 2.0
PA3549 alginate o-acetyltransferase AlgJ (algJ) 1.2 -1.6 1.4 PA3299 acyl-CoA synthetase (fadD1) -1.3 1.7 1.0
PA3550 alginate o-acetyltransferase AlgF (algF) -1.7 -1.0 1.4 PA3300 acyl-CoA synthetase (fadD2) -1.1 1.2 1.9
PA3649 hypothetical protein (PA3649) 1.0 1.2 1.6 PA3319 non-hemolytic phospholipase C precursor (plcN) 1.0 1.1 1.6
PA4033 hypothetical protein (PA4033) -1.2 1.0 2.2 PA3320 hypothetical protein (PA3320) 1.1 2.3 3.1
PA5483 two-component response regulator AlgB (algB) -1.1 -1.7 1.2 PA3361 fucose-binding lectin PA-IIL (lecB) -1.9 -1.3 1.7
PA3364 aliphatic amidase expression-regulating protein (amiC) -1.1 1.1 2.6
Chemotaxis PA3476 autoinducer synthesis protein RhlI (rhlI) 1.2 -1.3 1.7
PA0173 chemotaxis-specific methylesterase (PA0173) -1.3 -2.2 -1.5 PA3478 rhamnosyltransferase chain B (rhlB) -1.1 -1.1 2.5
PA0175 putative chemotaxis protein methyltransferase (PA0175) 1.2 -1.6 1.1 PA3479 rhamnosyltransferase chain A (rhlA) -1.7 -1.6 -1.4
PA0176 aerotaxis transducer Aer2 (aer2) 1.4 -1.6 1.0 PA3649 hypothetical protein (PA3649) 1.0 1.2 1.6
PA0177 putative purine-binding chemotaxis protein (PA0177) 1.5 -1.9 1.2 PA3724 elastase LasB (lasB) 1.0 1.4 3.2
PA0178 putative two-component sensor (PA0178) 1.8 -2.1 -1.0 PA4205 hypothetical protein (mexG) 1.2 -1.3 -1.6
PA0179 putative two-component response regulator (PA0179) 1.6 -1.2 1.8 PA4206 RND efflux membrane fusion protein precursor (mexH) 1.1 -1.4 -1.9
PA1608 chemotaxis transducer (PA1608) 1.1 1.5 1.6 PA4212 phenazine biosynthesis protein PhzC (phzC1) 1.0 1.2 1.8
PA1646 chemotaxis transducer (PA1646) -1.2 -1.8 1.0 PA4215 phenazine biosynthesis protein (phzF1) -1.4 -2.7 1.3
PA1946 binding protein component precursor of ABC ribose transporter (rbsB)-1.0 -1.9 2.0 PA4276 preprotein translocase subunit SecE (secE) -1.2 1.4 1.6
PA2561 putative chemotaxis transducer (PA2561) -1.8 3.9 2.0 PA4804 amino acid permease (PA4804) 1.1 -1.0 2.0
PA2573 chemotaxis transducer (PA2573) 1.2 -1.2 1.6 PA4909 ABC transporter ATP-binding protein (PA4909) -1.0 -1.8 1.1
PA2652 putative chemotaxis transducer (PA2652) -1.4 1.9 1.5 PA4910 branched chain amino acid ABC transporter ATP binding protein (PA4910) 1.2 1.3 2.2
PA2654 putative chemotaxis transducer (PA2654) -1.3 1.7 1.5 PA4913 putative binding protein component of ABC transporter (PA4913) 1.3 -1.1 2.6
PA2920 putative chemotaxis transducer (PA2920) 1.3 1.4 1.9 PA5499 transcriptional regulator np20 (np20) -1.2 -1.4 1.7
PA3348 putative chemotaxis protein methyltransferase (PA3348) -1.1 1.0 1.5
PA4290 chemotaxis transducer (PA4290) 1.3 -1.1 5.3
PA4307 chemotactic transducer PctC (pctC) -2.1 1.8 -1.7 Fimbriae
PA4309 chemotactic transducer PctA (pctA) -1.2 2.1 2.2 PA0993 chaperone CupC2 (cupC2) 2.4 -2.3 3.0
PA4310 chemotactic transducer PctB (pctB) -1.1 1.8 -1.2 PA2128 fimbrial subunit CupA1 (cupA1) 1.4 -1.2 -1.6
PA4502 binding protein component of ABC transporter (PA4502) 1.2 2.6 1.8 PA2129 chaperone CupA2 (cupA2) 1.3 -1.0 -1.6
PA4520 putative chemotaxis transducer (PA4520) -1.2 -1.1 1.6 PA2132 chaperone CupA5 (cupA5) 1.6 1.3 1.0
PA4633 putative chemotaxis transducer (PA4633) 1.0 1.3 1.8 PA4081 fimbrial protein cupB6 (cupB6) -1.1 -1.2 1.7
PA4915 chemotaxis transducer (PA4915) 1.1 -1.3 2.5 PA4083 chaperone CupB4 (cupB4) 1.1 1.2 1.6
PA4954 flagellar motor protein MotA (motA) 1.0 1.1 2.1 PA4084 usher CupB3 (cupB3) 1.0 -1.1 3.1
PA5072 putative chemotaxis transducer (PA5072) -1.5 1.7 1.1 PA4085 chaperone CupB2 (cupB2) -1.5 -5.6 -1.0
PA4086 fimbrial subunit CupB1 (cupB1) 1.0 -1.3 1.7
Type IV Pili
PA3805 type 4 fimbrial biogenesis protein PilF (pilF) -1.1 1.5 1.2
PA4525 type 4 fimbrial precursor PilA (pilA) -1.4 -1.7 -1.0
PA4526 type 4 fimbrial biogenesis protein PilB (pilB) -1.3 -2.0 1.6
PA4527 pseudo (pilC) -1.0 1.1 2.0
PA4528 type 4 prepilin peptidase PilD (pilD) -1.0 -1.2 2.0
PA4547 two-component response regulator PilR (pilR) 1.0 1.5 -1.1
PA4549 type 4 fimbrial biogenesis protein FimT (fimT) -1.6 -2.5 1.2
PA4550 type 4 fimbrial biogenesis protein FimU (fimU) -1.6 -1.1 -1.5
PA5040 Type 4 fimbrial biogenesis outer membrane protein PilQ precursor (pilQ)-1.0 1.0 1.7
PA5041 type 4 fimbrial biogenesis protein PilP (pilP) -1.1 -1.2 2.0
PA5042 type 4 fimbrial biogenesis protein PilO (pilO) -1.1 -1.3 1.6
Flagella
PA1077 flagellar basal body rod protein FlgB (flgB) 1.2 -1.4 1.9
PA1078 flagellar basal body rod protein FlgC (flgC) 1.2 -1.3 1.7
PA1081 flagellar basal body rod protein FlgF (flgF) 1.2 -1.6 2.0
PA1085 flagellar rod assembly protein/muramidase FlgJ (flgJ) -1.0 -1.2 1.5
PA1095 flagellar protein FliS (fliS) 1.1 1.2 1.5
PA1446 flagellar biosynthesis protein FliP (fliP) -1.1 -1.5 1.4
PA1449 flagellar biosynthesis protein FlhB (flhB) 1.5 1.2 1.2
PA1452 flagellar biosynthesis protein FlhA (flhA) 1.1 -1.5 1.3
PA3350 flagellar basal body P-ring biosynthesis protein FlgA (flgA) -1.1 -1.3 1.7
PA3352 hypothetical protein (PA3352) -1.1 1.5 2.0
PA3526 outer membrane protein precursor (PA3526) -1.1 1.4 2.0






Two-Component System Two-Component System
Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ Locus Tag General Description and Gene Name Δsmc ΔmksB ΔΔ
PA0119 C4-dicarboxylate transporter DctA (PA0119) -1.2 -1.5 2.3 PA3714 putative two-component response regulator (PA3714) 1.1 -2.0 1.4
PA0173 chemotaxis-specific methylesterase (PA0173) -1.3 -2.2 -1.5 PA3872 respiratory nitrate reductase gamma chain (narI) -1.1 -1.3 1.6
PA0175 putative chemotaxis protein methyltransferase (PA0175) 1.2 -1.6 1.1 PA3873 respiratory nitrate reductase delta chain (narJ) -1.2 -1.2 1.8
PA0176 aerotaxis transducer Aer2 (aer2) 1.4 -1.6 1.0 PA3874 respiratory nitrate reductase beta chain (narH) -1.4 -1.3 1.8
PA0177 putative purine-binding chemotaxis protein (PA0177) 1.5 -1.9 1.2 PA3875 respiratory nitrate reductase alpha chain (narG) -1.7 -1.5 2.0
PA0178 putative two-component sensor (PA0178) 1.8 -2.1 -1.0 PA3879 transcriptional regulator NarL (narL) -1.5 -1.0 1.7
PA0179 putative two-component response regulator (PA0179) 1.6 -1.2 1.8 PA3910 extracelullar DNA degradation protein EddA -1.1 1.3 2.2
PA0518 cytochrome c-551 precursor (nirM) 1.6 1.4 1.0 PA3925 putative acyl-CoA thiolase (PA3925) -1.0 1.5 -1.4
PA0749 hypothetical protein (PA0749) 1.6 -2.2 -1.5 PA3929 cyanide insensitive terminal oxidase (cioB) 1.6 1.4 1.5
PA0766 serine protease MucD precursor (mucD) 1.0 1.0 -1.7 PA3930 cyanide insensitive terminal oxidase (cioA) 1.9 1.5 1.7
PA0885 C4-dicarboxylate transporter (PA0885) -1.5 -2.3 -1.5 PA4080 putative response regulator (PA4080) -1.0 -1.0 1.9
PA0905 carbon storage regulator (rsmA) 1.3 -2.1 1.2 PA4144 outer membrane protein precursor (PA4144) -2.5 -1.2 -1.1
PA0929 two-component response regulator (PA0929) 7.1 -1.5 3.0 PA4290 chemotaxis transducer (PA4290) 1.3 -1.1 5.3
PA0931 outer membrane receptor FepA (pirA) 1.7 -1.3 -1.1 PA4307 chemotactic transducer PctC (pctC) -2.1 1.8 -1.7
PA1157 two-component response regulator (PA1157) -1.3 -1.1 -1.8 PA4309 chemotactic transducer PctA (pctA) -1.2 2.1 2.2
PA1158 two-component sensor (PA1158) 1.1 1.5 -1.0 PA4310 chemotactic transducer PctB (pctB) -1.1 1.8 -1.2
PA1183 C4-dicarboxylate transporter DctA (dctA) -1.1 -2.7 4.8 PA4429 putative cytochrome c1 precursor (PA4429) -1.5 1.8 -2.4
PA1339 amino acid ABC transporter ATP binding protein (PA1339) 1.4 -1.2 -1.5 PA4430 putative cytochrome b (PA4430) -1.4 1.8 -2.8
PA1340 amino acid ABC transporter membrane protein (PA1340) 1.6 -1.4 -1.6 PA4431 iron-sulfur protein (PA4431) -1.4 1.9 -2.3
PA1341 amino acid ABC transporter membrane protein (PA1341) 1.6 -1.5 -1.3 PA4520 putative chemotaxis transducer (PA4520) -1.2 -1.1 1.6
PA1342 putative binding protein component of ABC transporter (PA1342) 1.6 1.0 -1.3 PA4525 type 4 fimbrial precursor PilA (pilA) -1.4 -1.7 -1.0
PA1438 putative two-component sensor (PA1438) 1.2 -1.5 1.0 PA4547 two-component response regulator PilR (pilR) 1.0 1.5 -1.1
PA1552 Cytochrome c oxidase, cbb3-type, CcoP subunit 1.4 1.3 -1.9 PA4633 putative chemotaxis transducer (PA4633) 1.0 1.3 1.8
PA1552.1 Cytochrome c oxidase, cbb3-type, CcoQ subunit 1.2 1.7 -1.8 PA4885 two-component response regulator (irlR) -1.9 -1.5 -1.7
PA1553 Cytochrome c oxidase, cbb3-type, CcoO subunit 1.5 1.6 -1.8 PA4915 chemotaxis transducer (PA4915) 1.1 -1.3 2.5
PA1554 Cytochrome c oxidase, cbb3-type, CcoO subunit 1.4 1.4 -2.3 PA4954 flagellar motor protein MotA (motA) 1.0 1.1 2.1
PA1555 Cytochrome c oxidase, cbb3-type, CcoO subunit -1.2 -1.4 -1.8 PA5072 putative chemotaxis transducer (PA5072) -1.5 1.7 1.1
PA1556 Cytochrome c oxidase, cbb3-type, CcoO subunit -1.3 -1.3 -2.3 PA5082 putative binding protein component of ABC transporter (PA5082) -1.0 1.1 1.5
PA1557 Cytochrome c oxidase, cbb3-type, CcoO subunit -1.3 -1.2 -3.1 PA5119 glutamine synthetase (glnA) -1.3 1.5 2.0
PA1566 hypothetical protein (PA1566) 1.8 1.4 1.9 PA5124 two-component sensor NtrB (ntrB) 1.0 1.2 3.7
PA1608 chemotaxis transducer (PA1608) 1.1 1.5 1.6 PA5125 two-component response regulator NtrC (ntrC) 1.0 -1.1 1.5
PA1634 potassium-transporting ATPase subunit B (kdpB) 1.1 -1.7 1.4 PA5167 c4-dicarboxylate-binding protein (PA5167) 1.3 -1.2 2.1
PA1646 chemotaxis transducer (PA1646) -1.2 -1.8 1.0 PA5168 dicarboxylate transporter (PA5168) 1.5 1.1 2.3
PA1736 acetyl-CoA acetyltransferase (PA1736) 1.2 -1.7 1.1 PA5169 C4-dicarboxylate transporter (PA5169) 1.2 -1.3 2.5
PA1799 two-component response regulator, ParR 1.1 -1.2 -1.5 PA5483 two-component response regulator AlgB (algB) -1.1 -1.7 1.2
PA1856 cytochrome oxidase subunit (PA1856) 1.4 1.5 1.3 PA5484 two-component sensor (PA5484) -1.0 -1.6 1.2
PA1976 sensor histidine kinase 1.1 -1.6 -1.0 PA5512 sensor histidine kinase MifS 1.1 -1.1 1.9
PA1980 response regulator EraR -2.2 -1.9 -1.1
PA2040 glutamine synthetase (PA2040) 1.3 -1.0 -1.6
PA2523 putative two-component response regulator (PA2523) -1.0 -1.1 1.8
PA2548 hypothetical protein (PA2548) 1.9 1.1 1.8
PA2553 putative acyl-CoA thiolase (PA2553) 1.6 1.6 1.7
PA2561 putative chemotaxis transducer (PA2561) -1.8 3.9 2.0
PA2573 chemotaxis transducer (PA2573) 1.2 -1.2 1.6
PA2583 sensor/response regulator hybrid (PA2583) 1.1 -1.0 1.7
PA2586 response regulator GacA (gacA) -1.0 1.3 2.0
PA2652 putative chemotaxis transducer (PA2652) -1.4 1.9 1.5
PA2654 putative chemotaxis transducer (PA2654) -1.3 1.7 1.5
PA2686 two-component response regulator PfeR (pfeR) 1.4 1.6 1.4
PA2687 two-component sensor PfeS (pfeS) 1.8 1.1 1.3
PA2824 sensor/response regulator hybrid (PA2824) -1.1 1.1 1.6
PA2920 putative chemotaxis transducer (PA2920) 1.3 1.4 1.9
PA3045 putative two-component response regulator (PA3045) -1.2 1.0 2.9
PA3296 alkaline phosphatase (phoA) -1.2 -1.7 1.4
PA3345 hypothetical protein (PA3345) -1.4 1.1 1.9
PA3346 putative two-component response regulator (PA3346) -1.2 1.1 2.0
PA3347 hypothetical protein (PA3347) -1.0 1.7 3.2
PA3348 putative chemotaxis protein methyltransferase (PA3348) -1.1 1.0 1.5
PA3476 autoinducer synthesis protein RhlI (rhlI) 1.2 -1.3 1.7
PA3589 acetyl-CoA acetyltransferase (PA3589) -2.0 1.1 -1.0
PA3658 PII uridylyl-transferase (glnD) -1.1 1.1 1.8
PA3703 chemotaxis-specific methylesterase (wspF) -1.0 1.4 1.9
PA3704 putative chemotaxis sensor/effector fusion protein (wspE) -1.6 1.3 1.3
PA3706 putative methyltransferase (wspC) -1.2 1.1 1.8
PA3707 hypothetical protein (wspB) -1.2 1.2 1.8
PA3708 putative chemotaxis transducer (wspA) -1.2 1.1 1.8
